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1The intriguing area of Koch’s Triangle: where anatomy and electrophysiology come 
together. An overview
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 Introduction
Today, the anatomy of the atrioventricular (AV) junction is being investigated for almost 
00 years. Wilhelm His was the first one to describe a solitary muscular strand running 
septally from atrial to ventricular musculatures [¹]. However, it was the achievement of 
Tawara to show in detail that the specialized muscular system responsible for atrioven-
tricular conduction, the bundle of His, arose from a well-dermarcated collection of his-
tologically discrete atrial cells, which he called the “knoten”, the compact AV node [²]. He 
compared the conduction system that sprang from the “knoten” to a tree, with the atrial 
transitional cells representing the branches, the bundle of His forming the trunk, and the 
Purkinje fibers, ramifying on either side of the muscular ventricular septum, correspond-
ed to the roots. The atrial transitional cells were approaching the compact node from all 
sides. He suggested that the boundary between the node and the bundle was the point at 
which the overall muscular axis entered the insulating tissues of the central fibrous body, 
easily recognized as an anatomic landmark. This distinction is hardly to make on purely 
histologic grounds. 
 The purpose of this review is to address the known architecture and the electrophysi-
ologic mechanisms of the AV node and its direct environment, known as Koch’s Triangle. 
First, the development of the atrioventricular conduction axis is discussed, as well as its 
anatomical location. Secondly, the electrophysiologic characteristics of this intriguing re-
gion is pointed out. In this context, the occurrence of different tachyarrhythmias in the 
triangle of Koch is described. Finally, the most important pitfalls in the treatment of these 
arrhythmias are discussed.
 Embryology of the atrioventricular conduction
The embryogenesis of the cardiac conduction system is fascinating. The embryologic de-
velopment of the conduction system is essential in understanding the significance of the 
transitional cells and the posterior extension of the compact AV node described by Tawara 
[¹]. In the fifth and sixth weeks of development the heart tube loops and balloons to form 
its atrial and ventricular compartments [³,⁴]. Subsequent to looping of the ventricular com-
ponent of the heart tube, a ring of histologically specialized cells that foms the junction 
between the inlet and outlet parts of the ventricular loop is recognized. Because of their 
staining reaction to an antibody (GIN 2, Leu 7, HNK-) derived from the nodose ganglion 
of the chicken heart, which is a marker for the developing interventricular myocardium, it 
has been possible to establish that the entire right ventricular myocardium, including its 
inlet portion, is developed from the distal ventricular component of the primary heart tube. 
The canal myocardium becomes sequestered as an atrial structure [⁵-⁷]. It is visualised that 
with expansion of the right atrioventricular junction the ring of specialized cells passes 
from the crest to the ventricular septum to run within the atrial vestibule [⁸]. At this tran-
sition from atrium to ventricle via the atrioventricular musculature, the specialized cells 
are bordered by the atrioventricular cushion tissues luminally, and by the tissues of the 
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atrioventricular groove epicardially. This area of transition persists in the septated heart 
as the penetrating atrioventricular bundle. The downgrowth of the primary atrial septum 
at the junction of the septum with the posteroinferior atrial wall, brings atrial musculature 
into contact with the GIN 2 positive cells, forming the AV node, and its caudal extension. 
Therefore, because the AV node retains its muscular continuity with the ventricular myo-
cardium, it also retains the slow conduction which initially characterizes all of the canal 
myocardium [⁹]. The junctions between the cells of the atrioventricular ring and those 
derived from the atrial septum become the transitional cells. Finally, the original cells of 
the ring lose their histologic discreteness, and only remnants of the ring are visible in the 
postnatal heart. While earlier in development the ring can be traced in its course entirely 
around the developing aortic root, only the end of it is seen as the ‘dead-end-tract’ [¹⁰]. 
Around the tricuspid valvar orifice they are known as atrioventricular ring tissue, and they 
can, in malformed hearts, function as a substrate for ‘Mahaim’ physiology [¹¹,¹²]. Probably, 
the anomalous connections, known as accessory pathways, that can exist between a wide 
variety of structures of the conduction system, are functionally active remnants of these 
specialized ring cells. Although, accessory atrioventricular connections are common in 
the human foetus, these are usually severed during postnatal morphogenesis [¹³]. Thus 
in normal hearts the penetrating His bundle acts as the only electrical link between the 
atria and the ventricles. However, if one or more accessory connections persist beyond the 
initial stages of cardiac development, additional and/or conflicting wavefronts are present, 
and may permit bidirectional or only antegrade or retrograde conduction (latter referred 
to as concealed connection) [¹⁴]. 
 The anatomic boundaries of the AV node (Koch’s Triangle)
The position of the AV node is at the apex of Koch’s triangle, where the penetrating bundle 
extends upward from the ventricular septum, and emerges into the atrial myocardium. 
When viewed in the anatomic position, the triangle of Koch has its base horizontal and its 
apex pointing upward [⁸,¹⁵] (FIGURE ). On the atrial aspect, the triangle itself is delineated 
by the tendon of Todaro, a fibrous extension running from the union of the Eustachian 
and Thebesian valves to insert into the aortic root. The ventricular border is formed by 
the septal leaflet of the tricuspid valve, which crosses the membranous septum, becoming 
attached to the aortic root. The right fibrous trigone demarcates the posterior boundary of 
the root in the left ventricle, and is the rightward end of the fibrous continuity between the 
aortic leaflet of the mitral valve and the aortic valvar leaflets. The trigone forms together 
with the membranous septum the central fibrous body. The tendon of Todaro inserts in 
the atrial aspect of this central fibrous body to mark the apex of Koch’s triangle. The base 
of the triangle is marked by the inferior right atrium around the orifice of the coronary 
sinus (cavo-tricuspid isthmus), along with the musculature extending to the hinge of the 
septal leaflet of the tricuspid valve (septal isthmus). Some important anatomic structures 
can be identified, in relationship with Koch’s triangle. Immediately above the mouth of the 
coronary sinus, positioned posteriorly relative to the apex of the triangle is the oval fossa. 
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The inferior part (floor) of the fossa is the true atrial septum, and is only a small portion of 
that part of the atrial wall regarded as the ’septal area’. Because, the tricuspid valve annulus 
is displaced apically with respect to the mitral valve annulus, a large portion of the inferior 
limbus fossae ovalis (free border of the septum secundum) separates the right atrium from 
the left ventricular inflow tract. The anterior part of the limbus fossae ovalis, anterior to 
the right fibrous trigone (the most anterior part of the central fibrous body) is the right 
atrial free wall, separating the right atrium from the aortic outflow tract. The region sur-
rounding the orifice of the coronary sinus has direct contact with the tissue of the coro-
nary sulcus (the atrioventricular groove), and is therefore no part of the septum. Therefore, 
according to the anatomy of the septum, only accessory pathways, classified as ‘midseptal’ 
are related to both the atrial and ventricular septum, and are the only true septal pathways 
[¹⁶-¹⁹]. As ’anteroseptal’ pathways skirt anteriorly along the right fibrous trigone (at the 
right anterior free wall), they have no septal connections at all. Finally, pathways classified 
as ’posteroseptal’ are located posterior to the central fibrous body, around the mouth of the 
coronary sinus, and this region is definitely not part of the septum.
 Lateral and posterior to the mouth of the coronary sinus is the inferior caval vein, 
with the musculature between both venous orifices forming the so-called sinus ’septum’. 
Finally, the terminal crest skirts the orifice of the inferior caval vein and turns toward the 
triangle of Koch, terminating in an area of musculature located inferiorly relative to the 
base of the triangle. 
 The blood supply to the AV node is in approximately 90% of the hearts provided by the 
ramus septi fibrosi, a branch of the right coronary artery reinforced by branches of the 
anterior descending artery. The cardiac plexus surrounding the arch of the aorta is respon-
sible for the cardiac innervation. This plexus is formed by sympathic fibers from the upper 
thoracic spinal cord, and by parasympathic ones (nervus vagus) originating from the me-
FIGURE . 
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dulla. It supplies the sinoatrial node, and its approaches, the atrial septum, the approaches 
of the AV node, the AV node, and to a lesser degree the AV bundle [²⁰]. Although, the exact 
distribution of these nerves is still not known, the AV conduction is preferentially sensitive 
to sympathic adrenergic regulation.
  Electrophysiologic characteristics of the AV node  
and its direct environment
 The AV node 
The structure of the AV junction makes it likely that nodal architecture as well as cellular 
morphology contributes to nodal electrophysiology. To understand AV nodal behavior and 
underlying functional properties is still a challenge. The complexity of rate-induced AV 
nodal responses, for example the Wenckebach cycles that develop a heart rates slightly 
faster than those compatible with : AV conduction, are controlled by 3 main factors: 
. the previous recovery time; 2. a facilitatory factor called facilitation, and 3. a time-and 
rate-dependent cumulative effect called fatigue [²¹-²⁵]. The recovery property is reflected by 
a typical exponential-like increase in A2H2 with decreasing recovery time, and is indepen-
dent of the basic cycle length, which can be illustrated by a “drawing” a resulting recovery 
curve [²⁶]. Facilitation refers to the shortening of A2H2 and persistence of conduction at 
shorter HA2 than expected from the recovery alone [²⁷]. Facilitation develops within one 
short cycle length, dissipates within one long cycle length, and increases with the shorten-
ing of the inducing cycle. It affects nodal conduction time only in the short coupling range. 
Fatigue refers to the rate- and time-dependent prolongation in nodal conduction time that 
develops during fast rates [²¹,²⁷-²⁹]. These intrinsic nodal properties remain present after 
autonomic blockade but can be modulated by both cholinergic and adrenergic tone [³⁰-³²]. 
From the resulting recovery curve 2 important AV nodal parameters can be determined. 
One is the nodal functional refractory period (FRNP; shortest HH2 reached), which is 
controlled by the fast pathway, the superior (anterior) aspect of the atrial septum, close 
to the site of the His bundle (explained later), and is largely cycle-length-dependent. The 
other one is the effective refractory period (ERPN; the longest AA2 that results into a 
blocked beat in the node), which is controlled by the slow pathway, the inferior (superior) 
septum between the coronary sinus (CS) ostium or inferiorly inside the CS within -3 cm 
of the ostium and the tricuspid annulus (explained later) and is also cycle-length-depen-
dent. In conclusion, the above mentioned basic rules, called recovery, facilitation, fatigue 
or combined facilitation of fatigue, control intrinsic AV nodal conduction and refractory 
periods [³³].
 AVNRT and arrhythmias in the AV node 
Cardiac arrhythmias are caused either by abnormal impulse formation or by reentrant ex-
citation. The latter mechanism is responsible for the vast majority of clinical arrhythmias. 
For a reentry arrhythmia to occur three conditions must be fulfilled: . the occurrence of 
unidirectional block; 2. conduction of the impulse through an alternative pathway around 
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the block, and 3. retrograde invasion of the zone of block with sufficient delay to allow the 
fibers proximal to the block to restore their excitability [³⁴]. Heterogenicity in conduction 
properties and slow conduction and/or a short refractory period will enhance the chance 
that reentry arrhythmia will originate.
 Experimental and clinical studies have revealed different forms of reentry: . circuits 
which are based on macroanatomic pathways (for example atrial flutter type ); 2. small 
functionally determined circuits without the involvement of a gross anatomical obstacle; 
3. reentry in nonuniform anisotropic tissue, and 4. random reentry of multiple wandering 
wavelets (Moe’s theory of explaining the mechanisms of self-perpetuating atrial fibrilla-
tion) [³⁵].
 The AV node frequently is the site of reentrant beats and reentry tachycardia. Moe 
was the first one to demonstrate the presence of two anatomic or functionally distinct AV 
nodal pathways and hypothesized that dual AV nodal pathways may be the pre-requisite 
for reciprocal rhythm and paroxysmal nodal tachycardia [³⁶]. Dependent on their conduc-
tion time, these pathways were called “slow” or “fast” (FIGURE 2). 
 The most conclusive evidence of dual AV nodal pathways is not the AH-jump (>50 ms 
over a 0 ms increase in prematurity) with delivery of increasingly premature atrial beats, 
eventually followed by an atrial echo or initiation of AVNRT [³⁷-⁴²]. It is the demonstration 
that, during AVNRT, a ventricular impulse could reach the atrium retrogradely without 
colliding with the anterograde impulse of the AVNRT [⁴³] and obtaining two ventricular 
responses from one atrial impulse (44), that confirm the dual pathway physiology concept 
FIGURE 2. 
Simplified, schematic view of 
the “fast” and “slow” pathway in 
relation to the compact AV node
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in AVNRT. Nowadays, in the clinical setting, the slow and fast pathway refer to specific 
anatomic sites where the earliest retrograde atrial activation is recorded within the tri-
angle of Koch during AVNRT. If the earliest retrograde atrial activation is registered at the 
superior (anterior) aspect of the atrial septum, close to the site of the His bundle recording 
this is considered the fast pathway. Demonstration that the inferior (posterior) septum, 
between the coronary sinus (CS) ostium or inferiorly inside the CS within -3 cm of the 
ostium, is retrogradely activated first, this is called the slow pathway [⁴⁵-⁴⁷]. Untill now it 
is unclear what the slow pathway really is. Human studies failed to demonstrate a discrete 
nodal-type structure or bundle. Three possible anatomic substrates are considered [⁴⁸]: 
 First, the group of transitional fibers approaching the AV node in the region between 
the coronary sinus orifice and tricuspid annulus, the so-called posterior atrionodal con-
nections are a likely substrate. They form no discrete bundle but consist of multiple strands 
with no clear demarcation between the anterior and posterior atrionodal connections. The 
posterior fibers do not appear to be the normal path of AV conduction, since destruction of 
these fibers does not destroy the compact AV node or impair AV conduction in the normal 
heart, in contrast to the anterior fibers [⁴⁹]. The posterior fibers exhibit nodal-type action 
potentials. Furthermore, like the compact AV node, these cells lack the gap-junctional 
protein connexin43, and this may contribute to the slow conduction [⁵⁰]. 
 Secondly, extensions of nodal-type tissue extending form the posterior end of the AV 
node for variables lengths posteriorly along the tricuspid annulus, was suggested to repre-
sent the substrate of the slow pathway [⁵¹,⁵²]. However, this structure was not consistently 
found in the slow pathway region, and slow pathway could be ablated without any nodal 
tissue found at the site of the radiofrequency lesion [⁵³]. 
 Third, 3 distinct atrionodal bundles are not consistently described which converge to 
form a proximal AV bundle [⁵⁴]. It remains unclear if the lateral atrionodal bundle repre-
sents the same structure as the posterior nodal extension. 
 Also, other different mechanisms of slow pathway conduction are considered. Conduc-
tion may be slow in the slow pathway because of a longer conduction path. Considering 
the conduction speed in atrial tissue, and assuming that the slow pathway consists of “nor-
mal” atrial tissue, the pathway should be 2.5 cm long, considering the conduction speed 
in atrial tissue. This is clearly not the case. If the slow pathway was entirely composed of 
nodal tissue, the pathway would be 5-5 mm long [⁵⁵,⁵⁶]. This is consistent with the as-
sumed length of the slow pathway. Therefore, slow conduction can be entirely explained 
by the presence of nodal tissue. However, in most studies the presence of compact nodal 
tissue in the slow pathway region is not demonstrated [⁵³]. Another explanation for slow 
conduction can be cellular properties. Most of the conduction delay that occurs during 
normal AV conduction occurs in the transitional zone, where transitional cells are located 
that have light microscopic properties intermediate between nodal and atrial cells [⁵⁷]. 
The cells in the slow pathway region have nodal-type action potential [⁵⁰]. Cells closest to 
the tricuspid annulus have action potentials resembling true nodal cells, and cells moving 
gradually away from the annulus, have more atrial-like characteristics. Although, there 
is a lack of cells with nodal morphology in the slow pathway region, nodal-type behavior 
can explain slow conduction. A decreased cell diameter with an increase in intracellular 
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resistance may also contribute in a small part to the amount of slow conduction [⁵⁸]. As 
mentioned earlier, slow conduction can also be the result of missing the gap-junctional 
protein connexin43 in this region, in comparison with rapidly conducting atrial tissue 
[⁵⁰]. Finally, slow conduction can be caused by nonuniform anisotropy [⁵⁹,⁶⁰]. Anisotropic 
conduction is conduction that is perpendicular to muscle fiber orientation. Since cardiac 
myocytes have fewer side-to-side than end-to-end connections, transverse conduction is 
slower than longitudinal conduction. If fibrosis develops, with a further decrease in con-
nections, nonuniform anisotropy occurs with even more slowing in conduction. However, 
these effects are unlikely to play an important role in the slow pathway region. 
 In conclusion, the substrate of the slow pathway is probably a normal structure, and ex-
ists of posterior nodal connections of transitional fibers containing cells with nodal-type 
action potentials. 
 Thus, AVNRT is probably a functional abnormality. It is likely that any of the transi-
tional fibers may have appropriate properties of conduction velocity and refractoriness 
to form a reentrant circuit. To describe the different subforms of AVNRT, terms as slow 
anterograde-fast retrograde (typical), fast anterograde-slow retrograde(atypical), and slow 
anterograde-slow retrograde are used [6-63]. However, the definitions of these subforms 
are ill-defined. Recently, Heidbuchel provided an useful definiton of these 3 subforms, de-
pending especially on the identification of the site of earliest retrograde atrial activation 
and not on the HA interval during tachycardia [64]. Hereby, slow-fast AVNRT is charac-
terized by: . antegrade conduction over a slow pathway with an AH interval >200ms; 2. 
earliest retrograde atrial activation in the superior septum (fast pathway conduction); 3. H-
Ap (interval during pacing at the same cycle length of the tachycardia, immediately after 
termination of the tachycardia) is <70 ms, and 4. there is generally no evidence for a lower 
common pathway (LCP). In fast-slow AVNRT: . an AH interval <200 ms: 2. earliest ret-
rograde activation at the inferior septum, and 3. the presence of a LCP is essential. Finally, 
slow-slow AVNRT is defined by: . antegrade conduction over a slow pathway with an AH 
interval >200ms; 2. earliest retrograde atrial activation in the inferior septum or proximal 
CS; 3. H-Ap usually of >70 ms; and 4. evidence for a significant LCP. The small number of 
AVNRT that do not fit in any of these categories, is called undetermined.
 Cavo-tricuspid dependent atrial flutter
The region between inferior caval vein (IVC) orifice an tricuspid valve orifice, known as 
cavo-tricuspid isthmus, which is the base of the triangle of Koch, is known for its slow 
conduction properties. Atrial flutter type  (AF) is an unique arrhythmia, characterized 
by regular atrial depolarizations at a rate between 250 en 350 beats per minute (BPM) and 
a saw tooth morphology of the flutter-waves [⁶⁵,⁶⁶]. Electrophysiological studies, including 
activation mapping and entrainment techniques supported that AF is based on a right 
atrial macro-reentrant movement with an excitable gap, where the cavo-tricuspid isth-
mus is the critical part of the reentry circuit [⁶⁷,⁶⁸]. The double potentials recorded along 
the crista terminalis during AF suggest that it forms the posterior barrier of the flutter 
circuit, whereas the TV annulus forms the anterior barrier [⁶⁹-⁷¹]. Thus, the anatomical 
barriers provided by the endocardial architecture seems to determine the location of the 
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AFL circuit in the RA. Counter clockwise AF is characterized by a broad band of peri-tri-
cuspid activation that enters the isthmus, slows in its medial part, ascends up the septum, 
reaches the root of the superior caval vein, usually crossing it anteriorly and rarely fushing 
around it to descend down the free wall [⁷²]. Clockwise AF shares the same circuit in the 
opposite direction.
 It is known that atrial fibrillation (AF) is the most frequent, sustained, symptomatic 
tachyarrhythmia in patients with or without structural heart disease [⁶⁵,⁷³,⁷⁴]. The inci-
dence of this tachyarrhythmia increases with age and is twice as common in males as 
females. It remains a therapeutic challenge and the success rate of maintaining long-term 
sinus rhythm with pharmacologic therapy alone is less than optimal. Class C antiarrhyth-
mic drugs (AAD) have been recommended as first line therapy to prevent AF recurrences 
in patients with no or minimal heart disease [⁷⁵]. Amiodarone, a class III AAD, is the 
key-stone agent to prevent AF recurrences in patients with structural heart disease, and 
superior to class C AAD. Under both classes of AAD ‘transformation’ of AF to atrial flut-
ter (AFL) is well-known [⁷⁶,⁷⁷] (FIGURE 3). Increase in wavelength due to increase in the 
atrial refractory period in a tachycardia dependent manner , and the unique arrangement 
and orientation of the atrial muscle fibers between inferior vena caval orifice (IVC) and 
tricuspid valve annulus (TV) may promote nonuniform anisotropic slow conduction in the 
cavo-tricuspid isthmus, and therefore promote the conversion of AF in AFL [⁷⁸,⁷⁹]. 
FIGURE 3.
Example of a Class C atrial flutter
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The initiation of AF can be achieved by premature extrastimuli [⁸⁰]. However, termina-
tion with an extrastimulus is rare. Trains of rapid pacing are almost always required to 
terminate AF [⁸⁰,⁸¹]. Atrial activation mapping during AF is feasible, but was limited by 
the fact that: . access to the left atrium is mostly only obtained form recordings of the 
coronary sinus, and 2. the anatomy of the right atrium is rather complex [⁸²-⁸⁴]. Nowadays, 
more insight in both isthmus and non-isthmus dependent atrial flutter became available 
with electroanatomic, and non-contact mapping [⁸⁵,⁸⁶]. Concealed entrainment can be 
demonstrated by pacing in the cavo-tricuspid isthmus at a cycle length 20 msec shorter 
than the atrial flutter cycle length with a post-pacing interval equal to the flutter cycle 
length. 
 (Para)Septally located acessory pathways 
 Common characteristics
Unlike the AV node, conduction over an accessory pathway usually behaves in an all-or-
none fashion [⁸⁷]. Rapid pacing or atrial premature depolarizations almost always either 
conduct without delay (no change in P-to-delta wave) or block suddenly. Decremental con-
duction, visible as a prolonged P-delta wave interval is mostly due to intra-atrial conduc-
tion delay between the site of stimulation and the bypass tract [⁸⁸,⁸⁹]. Intermittent con-
duction over a bypass tract can be observed. It has to be distinguished from inapparent 
preexcitation that is due to prolonged intra-atrial conduction, accelerated AV conduction, 
prolonged conduction over a bypass tract, or any combination of these. Intermittent pre-
excitation can be caused by: . phase-3 and phase-4 block in the accessory pathway [⁹⁰-⁹²]; 
2. AV bypass tracts with long refractory periods and supernormal conduction [⁹³,⁹⁴], and 
3. antegrade or retrograde concealed conduction produced by an atrial premature depo-
larization (APD) [⁹⁵,⁹⁶]. 
 With the absence of preexcitation at long cycle lengths, followed by evidence of preexci-
tation at short cycle lengths, with the sudden disappearance again of preexcitation at even 
shorter cycle lengths, it is possible to demonstrate phase-3 and phase-4 block in accessory 
pathways. Supernormal conduction is demonstrated by the existence of preexcitation at 
long cycle lengths , followed by block at shorter cycle lengths (but still relatively long), and 
long bypass refractory periods. At shorter pacing cycle lengths preexcitation occurs again 
with the same P-to delta interval. Concealed conduction can be demonstrated by the dis-
appearance of preexcitation caused by an APD that is nonconducted over the bypass tract 
or a ventricular premature depolarization (VPD) influencing antegrade conduction over 
the bypass tract at subsequent beats. An example is atrial fibrillation with runs of preex-
cited beats followed by runs of absent preexcitation.
 Most accessory pathways permit bidirectional conduction. However, approximately 25 
% only conduct in retrograde direction and are referred to as concealed bypass tracts. A 
minority (less than 5 %) only conducts antegradely [4].
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 Specific characteristics of Accessory Pathways in Koch’s Triangle
Typical electrocardiographic findings in anteroseptal accessory pathways include a posi-
tive delta wave in leads I, II, III, aVF, a biphasic or positive delta wave in V, an R/S ratio 
< from V to V2 or V3, and an R/S ratio > in III. A midseptal accessory pathway is con-
sidered if there is a positive delta wave in I, II, aVL, and an isoelectric or negative delta 
wave in III, aVF, V. The surface ECG suggests a right posteroseptal accessory pathway in 
patients with a negative delta wave in III, aVR, V, and a isoelectric or negative delta wave 
in II, aVF. A positive or isoelectric delta wave in V indicates a left posteroseptal accessory 
pathway (TABLE ). During incessant long RP-tachycardia a negative P-wave in the inferior 
leads, and a biphasic P-wave in I, aVL, V suggested a posteroseptal origin of the accessory 
pathway. The final classification can only be made according to the successful ablation 
site [¹⁶-¹⁹]. By definition, pathways are classified as anteroseptal if an accessory pathway 
activation potential as well as a His bundle potential are simultaneous recorded from a 
catheter placed at the His bundle region. A pathway is classified as midseptal if an acces-
sory pathway potential is recorded through a catheter located in an area bounded anteri-
orly by the tip electrode of the His bundle catheter and posteriorly by the coronary sinus 
ostium. Accessory pathways located within the pyramidal space posterior to the septum 
may be classified as right and left posteroseptal. Right posteroseptal accessory pathways 
insert along the tricuspid ring in the immediate vicinity of the coronary sinus ostium. Left 
posteroseptal accessory pathways have an anatomic course close to the terminal portion 
of the coronary sinus and may be located either at a subepicardial site around the proximal 
coronary sinus or middle cardiac vein or at a subendocardial site along the posteromedial 
ventricular aspect of the mitral annulus [⁹⁷].
I II III aVL aVR aVF V1 R/S V1 R/S V2
R/S 
V3
anteroseptal pos pos pos pos Bif/pos < 1 < 1 < 1
midseptal pos pos Iso/neg pos Iso/neg Iso/neg
Right posteroseptal Iso/neg neg neg Iso/neg neg
Left posteroseptal Iso/neg neg neg Iso/neg Iso/pos
TABEL 1. 
Discrimination of accessory pathways based on delta wave polarity.
Bif = bifasic Neg = negative
Iso = isoelectric Pos = positive
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  Transvenous catheter ablation of arrhythmias in Koch’s triangle  
and their pitfalls
 Atrioventricular nodal reentrant tachycardia ablation
Nowadays radiofrequency (RF) catheter ablation has become the therapy of choice to per-
manently cure AVNRT [⁹⁸,⁹⁹]. It is highly effective with a success rate of about 95% and a 
low recurrence rate [¹⁰⁰-¹⁰⁴]. The target is slow pathway ablation/modification guided by 
both anatomical landmarks and intracardiac electrograms. This is achieved by position-
ing the catheter at the posterior and middle third of the triangle of Koch, anterior to the 
coronary sinus, just superior to the tricuspid annulus insertion into the inferior interatrial 
septum [⁴⁷,¹⁰⁰]. Others are searching for slow pathway potentials, though their elimination 
has not been proven necessary to cure AVNRT. Furthermore, similar potentials can also 
be recorded in other patients, with or without tachyarrhythmias [¹⁰⁵]. The slow pathway is 
considered to be ablated if dual pathway physiology is completely abolished, and is modi-
fied if the slow pathway conduction time is lengthened or echo beats are still inducible, 
but without sustained arrhythmia. The anterior approach or fast pathway ablation is per-
formed by placing the ablation catheter across the tricuspid annulus to record a His bundle 
potential. It is thereafter slowly withdrawn until the amplitude of the atrial electrogram 
exceeds that of the ventricular electrogram with a small or absent His bundle potential 
[¹⁰⁶]. A 30% prolongation of the PR-interval is considered to be a successful ablation [06]. 
This approach is reserved for highly symptomatic patients in whom the slow pathway ab-
lation is not successful. It can also be the initial approach in patients with preexisting 
prolonged PR interval at baseline, which seems to be dependent on the slow pathway for 
antegrade conduction [⁴⁷]. However, even in these patients slow pathway ablation can be 
curative with preservation of antegrade AV conduction, further supporting the functional 
nature of the AV nodal propagation. The endpoint for both slow or fast pathway ablation is 
noninducibility of AVNRT with or without isoprotenol.
 Pitfalls in AVNRT
 Whom to ablate?
RF catheter ablation is highly effective in definitively curing patients with recurrent 
AVNRT [¹⁰⁰-¹⁰⁴]. The recurrence rate is low, and patients can discontinue their antiar-
rhythmic drugs, eliminating the risk of side-effects and proarrhythmia. Although the 
complication rate is low, there is a risk of thromboembolic events, bleeding, cardiac per-
foration, inadvertent right bundle branch block, or even worse, complete AV block [¹⁰⁷-¹⁰⁹]. 
Furthermore, ablation procedures are accompanied by a relatively long radiation exposure, 
especially in the treatment of arrhythmias in the triangle of Koch, because of the risk of 
catheter dislodgement in this area in close proximity to the compact AV node [¹⁰¹]. Newer 
imaging systems as the LocaLisa mapping system, RPM or Ensite NavX enable continuous 
visualization of the ablation catheter in respect to the His bundle, reducing fluoroscopy 
time significantly [¹¹⁰, ¹¹¹, ¹¹²]. Because of the aforementioned complications and the fact 
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that most patients present between late adolescence and age 40, catheter ablation is re-
served for symptomatic patients with recurrent AVNRT.
 Where to ablate ?
 
Slow pathway ablation is guided by both anatomical landmarks and intracardiac electro-
grams [¹⁰⁰-¹⁰⁴] (FIGURE 4a and 4b). The successful ablation site is mostly located either 
5 mm above or below the level of the upper margin of the coronary sinus ostium [¹¹³]. 
Fractionated atrial signals and/or slow pathway potentials can be recorded. A longer atrial 
potential-slow pathway potential is attended with a higher success, as is an AV ratio of 
0. to 0.5 [¹¹⁴]. An accelerated junctional rhythm during low energy (0 J) application can 
FIGURE 4A.
Anterior-posterior fluoroscopy view of a successful 
slow pathway ablation site. Shown are a decapolar 
catheter, positioned in the coronary sinus via the left 
suclavian vein; a quadripolar catheter positioned in 
the the right atrial appendage, a quadripolar catheter 
positoned at the His bundle, and an RF ablation 
catheter via the right femoral vein.
FIGURE 4B.
Intracardiac electrogram of the successful slow path-
way ablation site. Shown is a fragmented atrial signal, 
no His spike, and an atrial/ventricular ratio < 0.5
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also be used to identify a potentially successful ablation site, reducing the risk of immedi-
ately irreversible damage to the compact AV node [¹¹⁵]. Another method is subthreshold 
stimulation at target sites until termination of AVNRT is achieved or capture occurs [¹¹⁶]. 
Furthermore, the distance between the ablation target site and the distal end of the AV 
nodal artery should be >2 mm to avoid any damage to the artery [¹¹⁷]. Also, the distance 
to the His bundle catheter, or the “drawn His bundle” registered by the LocaLisa system 
should be >0 mm, again to avoid inadvertent complete AV block [¹¹⁸]. Left-sided ablations 
for AVNRT have been reported, suggesting that left-sided atrionodal connections may be 
a critical component of the tachycardia circuit [¹¹⁹-¹²¹]. However, the significance of earliest 
retrograde atrial activation in the CS, which occurs in 8% during AVNRT, as an indica-
tion that left-sided ablations may be required is unclear. Successful RF ablation can be 
performed at standard sites in the triangle of Koch, suggesting that these left-sided atrial 
inputs are not crucial to the AVNRT reentrant circuit [¹²²].
 How to ablate ?
As mentioned before, conventional RF catheter ablation of AVNRT in experienced hands 
is highly successful with a low complication, and a low recurrence rate [⁹⁸-¹⁰⁵]. Besides the 
standard 5 catheter (HRA, His, RV, CS, and ablation catheter), a 3 catheter (HRA, His, 
and ablation catheter), or a single catheter approach can be used, without the necessity 
of special equipment, such as non-fluroscopic mapping systems [23]. Because the target 
site is in close proximity of the compact AV node, continuously fluoroscopy during ap-
plication is necessary to be sure that catheter dislodgement does not occur with the risk 
of causing and inadvertent complete AV block. This limitation of catheter stability is even 
further compromised by pain during energy delivery [¹⁰³,¹²⁴]. Although non-fluoroscopic 
equipment and other energy sources are expensive, it can lead to less radiation exposure, 
and after a learning curve also to shorter procedure times. Furthermore, a better insight in 
unusual anatomical features is provided. Intracardiac echo could play a role in this respect 
[25-27]. All together, this may lead to less applications and thus less tissue disruption 
with less thrombus formation, also being potentially less proarrhythmic [¹⁰⁸,¹⁰⁹,¹²⁸]. 
 How do we know that we are successful ? 
The final endpoint of catheter ablation in AVNRT is non-inducibility of AVNRT with or 
without isoprotenol after a 30 minutes waiting period [⁹⁸-¹⁰⁵]. Again, an accelerated junc-
tional rhythm during ablation is a sensitive but not very specific sign of success [¹¹⁷]. This 
means that if it occurs, the application maybe is successful, but if it doesn’t happen it prob-
ably is not [⁴⁷]. Complete slow pathway ablation is achieved if dual pathway physiology is 
entirely abolished after ablation. However, AVNRT can be cured with only slow pathway 
modification, characterized by lengthened conduction times or echo beats that are still 
inducible, but without sustained arrhythmia. Unfortunately, RF catheter ablation of the 
slow pathway can not be performed on this electrophysiologic basis, because normal AV 
conduction has to be observed during the whole application. This can only be investigated 
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after irreversible effect is created. On the other hand, VA block is predictive for long term 
success after fast pathway ablation [¹²⁸].
 How do we know if complete AV block will occur ?
If transient AV block occurs during or immediately after the application, and the block 
still persists at the end of the procedure, this is accompanied by a high incidence of perma-
nent AV block requiring a definitive pacemaker implantation [¹²⁴,¹²⁹,¹³⁰]. Also, junctional 
tachycardia is frequently observed during RF ablation, probably due to thermal injury of 
the compact AV node and/or the perinodal tissue forming the input of fast and slow path-
way into the AV node. A relatively fast rate of this junctional tachycardia with loss of VA 
conduction is associated with an increased risk of inadvertent AV block with a positive 
predictive value of 9 % [¹³¹]. However, these markers for impending complete AV block do 
not allow risk stratification before radiofrequency delivery. A useful electrophysiological 
marker to assess the risk of block before an application is started is the interval between 
the atrial component of the His bundle electrogram (H) and the atrial signal of the distal 
mapping (Md) catheter. A short A(H) – A(Md) is associated with a high risk of inadvertent 
complete AV block [¹³²]. Another method is to perform a pacemapping of the triangle of 
Koch to recognize patients in whom the anterograde conducting fast pathway is located 
abnormally far from the anteroseptal region or in whom the anterograde conduction of 
the fast pathway is absent [¹³³]. On stimulating close to the site where the fast pathway is 
present, a short stimulus to His (St-H) interval is recorded and, conversely, the greater the 
distance between the stimulating catheter and the anterograde fast pathway the longer 
the St-H interval. Also, the distance between the distal end of the AV nodal artery and the 
ablation target site can be determined. If this is more than 2 mm, the complication of AV 
block virtually never occurs [¹¹⁷]. Nowadays the LocaLisa system can be used to reduce 
the risk by ’drawing the His bundle’ on the basis of intracardiac His bundle electrograms, 
from its most distal part (small atrial electrogram with a large ventricular electrogram 
with a His signal in between) to its most proximal part (large atrial electrogram and small 
ventricular electrogram with a His signal in between), and to avoid an ablation catheter 
position within 0 mm of this ’line’ [¹¹¹,¹¹⁸]. However, as this indicates the His bundle and 
not the compact AV node, displacement of the AV node can not be excluded. Despite these 
precautions the reported incidence of AV block following RF catheter ablation is between  
and 2%. As mentioned before, it almost always occur during or shortly after the procedure, 
but it also can happen even several months later, or even after several years [¹⁰⁴,¹³⁴].
 How proarrhythmic is RF catheter ablation of AVNRT ?
Previous studies have suggested that there is an association between atrial flutter and 
AVNRT. A shared pathway in the low right atrium is possible [¹⁰⁴,¹³⁵,¹³⁶]. It is already point-
ed out that slow pathway modification can eliminate AVNRT, while maintaining slow 
pathway conduction. The late occurrence of atrial flutter is maybe due to damage of this 
specific area, causing further slowing of conduction and therefore providing a substrate 
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for atrial flutter to occur. On the other hand, slow pathway ablation can interrupt cavo-tri-
cuspid isthmus conduction, curing both AVNRT and isthmus dependent atrial flutter [¹⁰⁴]. 
It is also known that lesions created by radiofrequency energy are inhomogenic [¹⁰⁷]. This 
maybe a source for reentry tachycardia to occur around the created obstacle. However, 
until now, no studies have directly address to this possible issue. Therefore, no conclusions 
can be made to this day in this respect.
 Cavo-tricuspid dependent atrial flutter ablation
Before RF ablation is started, a standard electrophysiologic study is performed to proof 
that atrial flutter is cavo-tricuspid dependent. Then, mostly a 8-mm tip electrode abla-
tion catheter is used for temperature controlled sequential point by point RF application 
between the tricuspid annulus and IVC [¹³⁷]. RF delivery begins at the right ventricular 
annulus and is withdrawn towards the IVC after each application, and sometimes already 
during an application after a pause at each point for 30-45 seconds. The key is to create a 
complete line of block. Ablation can be performed during SR, pacing from the low lateral 
right atrium or ostium of the coronary sinus, or during atrial flutter (FIGURE 5). If carried 
out during pacing, the obvious chance of atrial activation around the isthmus instead of 
through can not be misunderstood. However, the line between the IVC an TA has to be 
completed to be successful. Another possibility is to deliver RF energy during atrial flutter 
on the basis of intracardiac electrograms from the ablation catheter within the isthmus 
Ablatie tijdens os CS pacing
FIGURE 5. 
Ablation during coronary sinus pacing in a patient suffering from isthmus dependent 
atrial flutter. An obvious change in atial activation pattern is seen during the 
application, suggesting a line of a block
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region coinciding with the center of the surface ECG flutter wave plateau all the way from 
the TV annulus to the IVC edge [¹³⁷]. Upon completion of the line of block, widely sepa-
rated double potentials can be recorded all along the line [⁸³,¹³⁸-¹⁴⁰]. Recently, a functional, 
rather than anatomic, isthmus is identified, characterized by a preexisting double poten-
tial barrier at the cavo-tricuspid isthmus (4). Successful ablation can be achieved by de-
livering consecutive RF pulses from one anatomic border (always the TA, if applicable) to 
the blocking double-potential barrier. The endpoint of the ablation, independent of the 
used method, is bidirectional isthmus block, and not termination of atrial flutter during 
energy delivery [¹³²,¹⁴⁰,¹⁴²].
 Pitfalls in isthmus ablation
 Is a complete, linear, transmural line always feasible ?
It can be very difficult to create a linear, transmural line between the tricuspid annulus 
and the IVC edge. The width of the the isthmus can vary from .8-5 cm [¹⁴³,¹⁴⁴]. A longer 
distance may implicate insufficient reach of the RF catheter to get to the TA. The use of a 
longer sheath may resolve this problem. The anatomy and in particular the length of the 
Eustachian crest which in effect forms the posterior boundary of the so-called septal isth-
mus also varies affecting the functional width of the isthmus [¹⁴⁴⁾] (FIGURE 6). An isthmus 
TV
VCI
Cavo-tricuspid isthmus
SC
Septal isthmus
FIGURE 6.
A 3D intracardiac echo-
cardiographic view of the right 
atrium, showing the tricuspid 
valve, inferior caval vein, 
the coronary sinus and the 
so-called “septal and cavo-
tricuspid isthmus”
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area which presents as a deep pouch, can lead to insufficient contact between the ablation 
catheter and the underlying tissue. Thick pectinate muscles can also cause loss of tissue 
contact, implicating holes in the ablation line. A more medial approach, the use of a bigger 
catheter tip or an irrigated tip catheter may solve this problem [¹⁴⁵-¹⁴⁷]. If the alternative 
ablation line between the TA and the CS os and the CS os to the IVC is choosen, sedation 
may be mandatory as the CS os area is very sensitive. Moreover, in about 40 % of the hearts 
the CS os-IVC area is probably not conducting, because of fibrous tissue. This means that 
a single ablation line between the TA and the CS os is likely to be sufficient and successful 
to achieve a bidirectional conduction block in those hearts. Another important issue can 
be lack of catheter stability, and the difficulty to create a continuous line by this point by 
point approach which can be difficult to judge by fluoroscopy alone. The use of a longer 
sheath, the LocaLisa system, intracardiac echocardiography, 3D electroanatomical map-
ping system, RPM, or Ensite NavX can help to overcome those problems [¹¹⁰-¹¹², ¹⁴⁸-¹⁵⁰] 
(FIGURE 7). 
 How do we know that we are successful ?
As emphasized before, termination of atrial flutter during RF delivery is not a sufficient 
endpoint [¹³⁸,¹⁴¹,¹⁴³]. Mechanical induced termination and/or transient block or conduction 
A. catheters
B. inferior vena cava
C. coronary sinus
D. tricuspid valve
A B
C
D
ICE-probe
Intracardiac echo with a 9 Mhz US catheter
 Intracardiac echo with a 9 Mhz US catheter
FIGURE 7.
Visualisation of the cavo-tricuspid isthmus during RF ablation by intracardiac echocardiography. 
The isthmus can be seen, as well as the catheters, the tricuspid valve, and coronary sinus.  Inserted is 
the anterior-posterior fluoroscopy view
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slowing are enough to terminate AF. However, this can be achieved without eliminating or 
necessarily affecting the substrate. Thus, assessment of complete bidrectional conduction 
block after termination remains the keystone of a successful ablation procedure. Pacing 
from one side of the ablation line, time to activation on the opposite side and an atrial ac-
tivation sequence in the right atrium, showing a 80 degrees change in the direction of ac-
tivation have been used to demonstrate isthmus block [¹³²,¹⁴¹,¹⁵¹]. However, activation time 
to the other side of the line by itself is a variable continuum and a specific cutoff is difficult 
to define. To establish activation sequences and their changes an extensive coverage of 
the right atrium is necessary, and this is difficult to achieve with duodecapolar catheters, 
especially on the septal side. The lack of mapping coverage in the immediate surrounding 
of the ablation line also reduces the specificity of criteria for isthmus block. Occasionally, 
atrial flutter still is inducible despite apparently complete isthmus block, suggesting that 
the isthmus is not blocked, or has recovered conduction, or is not a critical part of the 
circuit [¹⁵²,¹⁵³]. To overcome these issues, the use of non-fluoroscopic three-dimensional 
mapping systems seems very helpful in visualizing the flutter circuit and to demonstrate 
conduction block [¹⁵⁴]. Several studies suggest that morphological changes in bipolar atrial 
electrograms recorded at sites lateral and adjacent to the target line of block may be used 
as a unique and robust criterion to validate isthmus conduction block [¹⁵⁵,¹⁵⁶]. Another 
criterion that is feasible, is using on-site atrial potential analysis with the recording of 
parallel, widely spaced double atrial potentials along the ablation line [¹⁵⁷]. This analysis 
seems to be inferior to the classic activation mapping technique, mainly because of the 
ambiguity of electrogram interpretation along the ablation line. However, when it is com-
bined with the activation mapping technique, it provides additional information regarding 
isthmus conduction properties in some cases. Therefore, optimally, both methods should 
be used concomitantly. If with the aforementioned criteria bidirectional isthmus block is 
not accomplished, locating and ablating residual conduction gaps is necessary. Such re-
sidual gaps can be identified by local electrograms with a single or a fractionated potential 
centered on or spanning the isoelectric interval of adjacent double potentials [⁸³,¹³⁸-¹⁴⁰]. 
Also, a three-dimensional non-fluoroscopic Localisa mapping system can be very helpful 
in showing the gaps in the ablation line. Activation mapping is required to show real leak-
age along the line.
 Are there any side effects ?
Although the procedure is well tolerated, a minority of patients require sedation for pain 
relief during RF delivery [¹⁵⁸]. Long fluoroscopy times have been described, although this 
can be reduced by using earlier mentioned mapping and navigation systems. There is a 
small risk of creating complete AV block, especially when ablating in the ‘septal isthmus’ 
[¹³⁷]. Using a more lateral approach eliminates this risk. Furthermore, thrombo-embolic 
complications can occur with the creation of long, linear lines with tissue disruption, re-
quiring anticoagulant therapy during the procedure [¹⁵⁹].
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  Is a hybrid pharmacologic and ablative therapy for the management of symptomatic 
atrial fibrillation useful ?
Several studies have shown that in patients with atrial fibrillation and the development 
of a class IC atrial flutter, ablation of the TV-IVC isthmus may reduce the incidence of 
subsequent episodes of AF while continuing antiarrhythmic drugs [¹⁶⁰-¹⁶⁵]. This hybrid 
therapy of combined RF ablation and AAD therapy seems to be more effective in achieving 
and maintaining SR, in comparison with only pharmacological therapy, or only isthmus 
ablation. Furthermore, it is also quite common to observe atrial flutter in patients with 
untreated AF, with periodic transition from one arrhythmia to the other, suggesting a 
mechanistic and possibly causative relationship between AFL and AF [¹⁶⁶]. The mecha-
nism by which atrial arrhythmias trigger AF is uncertain, but rapid atrial rates may in-
crease atrial vulnerability by shortening atrial refractory period or electrical remodelling 
[⁸⁰]. Assessment of isthmus conduction is impossible during atrial fibrillation, thus either 
electrical cardioversion is required, or ablation is aimed at abolishing all local electrical 
activity. The latter seems to be a reasonable, though unproven option. Patients who suffer 
mainly from atrial flutter (AF episodes > Afib episodes) seem to benefit the most from this 
hybrid therapy, with 20-30 % freedom of atrial fibrillation recurrences. 
 (Para)septally located accessory pathways ablation
First, mapping is performed beginning at the anteroseptal region at the His deflection 
down to the coronary os and further to the right posterior region [⁹⁷,¹⁶⁷,¹⁶⁸]. In patients 
with manifest ventricular preexcitation during sinus rhythm, the site of earliest ventricu-
lar activation is identified, characterized by a short local AV interval, with local ventricular 
activation preceding the onset of the delta wave on the surface ECG. The earliest retro-
grade atrial activation is identified during orthodromic circus movement tachycardia and 
ventricular pacing. If local activation is clearly late, either a transseptal or a retrograde 
approach is used for the left side. The ability to record an accessory pathway potential 
can also provide useful information to guide the localization of the accessory fiber along 
the atrioventricular annulus. However, the finding of such a potential alone does not au-
tomatically mean a successful site, as it can be registered in quite a high percentage in 
unsuccessful sites [¹⁶⁹]. Therefore, selection of an optimal ablation site requires proper 
interpretation of local parameters, as well as adequate and stable catheter tissue contact 
before and throughout the application. After identification of a prospective ablation site, 
RF ablation is performed. RF energy normally is switched off after maximally 30 seconds 
if no effect is observed at that moment. Otherwise, it is continued for a maximum of 60 
seconds. Disappearance of accessory pathway conduction within a few seconds almost al-
ways indicates a successful ablation. Slow disappearance means a remote spot with a high 
recurrence rate of conduction.
 After a successful application incremental atrial pacing and ventricular pacing as well 
as single atrial and ventricular extrastimuli are repeated to conclude a successful ablative 
procedure. Eventually, intravenous adenosine can be administered, during both atrial and 
ventricular pacing to show complete AV and VA block, respectively. The patients are ob-
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served in the electrophysiology laboratory for 30 minutes to make sure that there was no 
recurrence of accessory pathway conduction.
 Pitfalls in (para)septal accessory pathway ablation
 Reasons for lengthy and failed ablation attempts?
In 5 -5 % of RF ablation attempts of (para)septal accessory pathways, no success is achieved 
despite the presence of optimal local electrograms [⁹⁷,¹⁰³,¹⁶⁷-¹⁷²]. This tends to occur most 
often with posteroseptal accessory pathways. Several reasons for this can be mentioned. A 
more complex geometry of the accessory pathway, a thicker epicardial fat pad, and a course 
too deep in the epicardial layer to be affected by the RF energy delivered at the endocardial 
aspect of the atrioventricular annuli can result in failed ablation [¹⁷³-¹⁷⁵]. Other reasons 
can be: . inability to position the ablation catheter at the effective target site; 2. instability 
of the ablation catheter or inadequate tissue contact at the target site, or both; 3. mapping 
errors due to an oblique course of the accessory pathway; 4. failure to recognize a postero-
septal accessory pathway as being left-sided instead of right-sided; 5. the failure to rec-
ognize abnormal structures such as coronary sinus aneurysms or diverticuli that harbor 
the culprit pathway; 6. occurrence of a complication; 7. recurrent atrial fibrillation [¹⁷³]; 8. 
mechanical block, especially in midseptal position; 9. close proximity to the His bundle.
Several strategies can be used to overcome these problems. The simplest one is the sub-
stitution of the operator by a more experienced one. The use of other ablation catheters of 
varying configurations can also be helpful. Irrigated tip catheters can be used to improve 
the diameter and depth of the lesion. The rationale behind it is that these catheters can 
increase the temperature in deep tissue by increasing the current density as impedance 
rise is prevented by cooling the electrode with saline irrigation.
 Furthermore, switching from a retrograde aortic to a transseptal approach, from an 
inferior to a superior caval vein approach, or the use of a 60-cm guiding sheath all can con-
tribute to a better positioning and increasing stability of the ablation catheter and there-
fore to a higher success rate. Finally, epicardial instrumentation and ablation is another 
approach that can be used and appears to be feasible and safe [¹⁷⁷]. 
 How to reduce the risk of inadvertent complete heart block ?
Radiofrequency (RF) catheter ablation of accessory atrioventricular (AV) connections in 
the proximity of His bundle or AV node carries a high risk of developing complete heart 
block, varying from 0 to 20 % [⁹⁷,¹⁶⁷,¹⁶⁸,¹⁷¹,¹⁷²]. Right bundle branch block has been reported 
in up to 40-50 % of patients with anteroseptal pathways. Incidentally, during ablation of 
posteroseptal accessory pathways heart block occurrs, preceded by junctional tachycardia. 
Therefore, if junctional tachycardia is observed, especially with VA block, careful attention 
should be paid to normal AV conduction. In pathways where there is concern about the 
proximity to the AV node, an accessory pathway potential should be sought and distin-
guished from the His bundle deflection. The optimal ablation site is where the accessory 
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pathway potential is maximal, and the His deflection is later in timing and considered as 
far field [⁹⁷]. To reduce the risk of complete heart block, a small atrial deflection with a larg-
er ventricular deflection is ideal. The presence of preexcitation may mask the occurrence 
of AV block during RF ablation. To overcome this problem, RF ablation can be carried out 
during orthodromic circus movement tachycardia so that the integrity of the normal AV 
conduction system can be closely monitored. Energy delivery is immediately stopped if 
tachycardia terminates in the antegrade limb, if junctional tachycardia occurs, or if tachy-
cardia does not terminate within 5 seconds. On the other hand, catheter dislodgement 
at the time of termination of the tachycardia during RF application, carries an increased 
risk for heart block [¹⁷⁸]. Pacing at rates when the accessory pathway is refractory can be of 
help. Titrating power output with temperature monitoring is also used. Importantly, after 
a successful ablation, additional applications (insurance or bonus burns) are not indicated 
and should be avoided.
 The rationale for cryoablation
Radiofrequency (RF) energy has become the preferred modality for catheter ablation 
and has proven to be highly effective in the treatment of atrioventricular nodal reentrant 
tachycardias (AVNRT), (para)septal accessory pathways, and atrial flutter with a low com-
plication rate [⁸³,¹³⁸-¹⁴⁰,¹⁴²⁾,⁽⁹⁸,¹⁰⁴⁾,⁽⁹⁷,¹⁰³,¹⁶⁷-¹⁷²]. Despite this successful approach in definitive 
treatment of tachyarrhythmias in Koch’s triangle, several disadvantages can be expected 
with RF energy. Lesions created by RF ablation, inevitably involve some degree of tissue 
disruption with intralesional hemorrhage and ragged edges, not clearly demarcated from 
the underlying normal myocardium, making it potentially more arrhythmogenic [¹⁰⁴,¹⁰⁷-
¹⁰⁹,¹⁰⁷,¹³⁵,¹³⁶]. High temperature at the subendocardium and endocardium may result in co-
agulum formation on the electrode, endocardial disruption, steam popping or perforation. 
Because of the endocardial disruption, this method is accompanied by a high percentage 
of thrombus formation, which can cause thrombo-embolic events [¹⁰⁷-¹⁰⁹]. Also bleeding, 
cardiac perforation with or without tamponade can occur. Furthermore, an increased risk 
exists of causing a right bundle branch block or inadvertent complete heart block, espe-
cially in the treatment of tachyarrhythmias in Koch’s triangle, as these arrhythmias are 
located in close proximity to the compact AV node. Finally, RF ablation can be painfull, 
especially during energy delivery close to the os of the coronary sinus or the junction of 
the right atrium and VCI [¹⁵⁸,¹⁷⁷]. In response to the above limitations, alternative energy 
sources have been developed, of which cryoablation seems to be very promising. 
 As cryothermy has the ability to reversibly demonstrate loss of function of tissue with 
cooling at less negative temperatures (‘ice mapping’), prospective ablation sites can be 
investigated, before a definitive, and irreversible lesion is created [¹⁸⁰-¹⁸³] (FIGURE 8). Theo-
retically, this should lead to less applications and abolish the risk for permanent conduc-
tion disturbances. The depth of a cryolesion is dependent on colder temperatures, how-
ever, lesion area or volume are not significantly associated with cooling rate, temperature, 
or ablation site [¹⁸⁴,¹⁸⁵]. In AVNRT, it is the only method to target the slow pathway on EP 
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basis [¹⁸⁰,¹⁸⁶-¹⁸⁸]. This is possible as during ice mapping, atrial extrastimulus testing can be 
performed. Disappearance of an AH-jump, termination or non-inducibility of AVNRT is 
considered to be an identification of abolition or modification of slow pathway conduc-
tion, and therefore a potentially successful ablation site. Theoretically, on the basis of these 
aforementioned characteristics of cryothermy, this should lead to less applications, less 
tissue damage, and abolish the risk for permanent conduction disturbances. As progres-
sive ice formation at the catheter tip causes adherence to the adjacent tissue, ablation can 
also safely be performed at otherwise unstable catheter positions, or even during tachy-
cardia, without carrying the risk for catheter dislodgement at termination of the tachycar-
dia. Therefore, cryothermy could be especially useful in ablation of tachyarrhythmias in 
Koch’s triangle to reduce the risk of inadvertent right bundle branch block, or complete AV 
block [⁷³,¹⁸⁹,¹⁹⁰]. The more precise delivery of therapy (due to ice mapping and the smaller 
lesions both in area and volume) with a decrease of tissue damage (less applications), to-
gether with the formation of a homogenous fibrosis with a well demarcated border, makes 
it potentially less proarrhythmic (FIGURE 9). Together with the proven preservation of 
the extracellular matrix, the incidence of thrombus formation is significantly less than 
FIGURE 8.
Right posteroseptal accessory pathway.  The insert shows the curve of temperature versus time. 
Shown are leads I, aVF, V, His bundle electrogram (HBE), and signal from the ablation catheter. 
Appearance of right bundle branch block (arrow), without intermediate stage of normal ventricular 
activation, 26 seconds after ice-mapping is started, and a few seconds after –30° C was reached. 
Ablation is commanded at 36 seconds (which allowed 0 seconds of additional observation of the 
rhythm), with immediate lowering to –73°C for 4 minutes
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FIGURE 0.
An anatomical section of a pig heart, 4 days after cryoablation. Shown is a  
lesion in the superior caval vein, with intact vessel wall
FIGURE 9. 
An anatomical section of a pig heart, 4 days after cryoablation. Shown is a well  
demarcated cryo-lesion on the spot of the AV node
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with RF energy [¹⁸⁵]. This is especially important when linear lesions are made in the left 
heart, or ablation has to be carried out in pulmonary veins or coronary sinus, which has 
been shown to be effective and safe [¹⁹¹] (FIGURE 0). Another issue is that cryothermy is 
painless. This can be of interest during ablation near the os of the coronary sinus, or the 
border of the right atrium and IVC during cavo-tricuspid isthmus ablation in atrial flutter 
[¹⁵⁸,¹⁷⁹,¹⁹²,¹⁹³]. Because of these aformentioned advantages of cryothermy, and as experience 
with cryoablation will grow, there is the potential for it to replace RF for ablation of specific 
arrhythmic substrates, as tachyarrythmias in Koch’s triangle, PV isolation, or to create 
long linear lesions that are transmural. However, several remarks on have to be made. 
Until now only a limited number of patients have been treated with cryoablation, and 
therefore, no definitive conclusions can be made so far. The actual cryocatheters are less 
steerable than a conventional RF catheter, and this can limit proper catheter positioning. 
An important question remains if cooling to minus 30 degrees always means maximum 
effect. In other words, can we always rely on ice mapping in words of safety and/or efficacy, 
also for intramural or more epicardially located accessory pathways [¹⁹⁴,¹⁹⁵]? Finally, as 
tissue temperature rises away from the center, tissue effects that occur late during a cryo-
application are expected to be reversible. Although, cryothermy has some advantages in 
comparison with RF, and as experience with cryoablation will grow, there is the potential 
for it to replace RF for ablation of specific arrhythmic substrates, as tachyarrythmias in 
Koch’s triangle, PV isolation, or to create long linear lesions that are transmural. However, 
clinical evaluation is needed. 
 Conclusion
Koch’s triangle is a fascinating area. In the previous chapters an overview is given from 
the embryology of the atrioventricular conduction axis which already exists in the fith and 
sixth week of the development of the heart, to the anatomy and electrophysiologic charac-
teristics of these region with the development of different tachyarrhythmias and their cure 
with transvenous catheter ablation. Although it has been a source for intensive research, a 
lot of questions on anatomy and physiology of this region are still unresolved. This intro-
duction intended to provide a state-of-the-art in todays knowledge about Koch’s triangle. 
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 Aims: Fluoroscopy does not allow identification specific anatomical landmarks dur-
ing electrophysiological studies. Intra-cardiac echocardiography permits visualization 
of these structures with excellent accuracy, but the optimal method has not been fully 
described. The aim of this study was to assess the capability of intra-cardiac echocar-
diography for the visualization of such structures using two different approaches. We also 
assessed its capability for the evaluation of radio frequency lesions 20 min after catheter 
ablation of the cavo-tricuspid isthmus.
 Methods: Intra-cardiac echocardiography was performed using a 9 MHz rotating 
transducer in eight consecutive patients (age range: 37–76 years) after radio frequency 
ablation of the cavo-tricuspid isthmus. The ultrasound catheter was inserted through the 
femoral vein into the superior vena cava and was pulled back to the inferior vena cava. The 
echo catheter was then reinserted through the subclavian vein and advanced into the right 
ventricular apex and was pulled back from the right ventricular to the superior vena cava. 
Qualitative evaluation and intracardiac measurements were performed off-line.
 Results: The fossa ovalis, the tricuspid valve, and the terminal crest were visible in all 
patients regardless of the method of introduction of the echo catheter. Left-sided struc-
tures were less accurately seen by intra-cardiac echocardiography. The horizontal diam-
eter of the fossa ovalis was 8·9 ± ·8 mm. The cavo-tricuspid isthmus was visible using the 
femoral approach in three patients. The isthmus could be visualized in all patients, and 
in three patients together with the ostium of the coronary sinus, using the subclavian ap-
proach. radio frequency lesions were not visible 20 min after ablation. Additionally, both 
the left and right ventricles could be seen using the subclavian approach.
 Conclusions: The subclavian approach is feasible, safe and superior to visualize the 
isthmus. Twenty minutes after radio frequency ablation of the cavo-tricuspid isthmus ra-
dio frequency lesions are not visible using intra-cardiac echocardiography.
 Keywords: intracardiac echocardiography; ablation; isthmus; flutter.
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 Introduction
Arial flutter is a frequent arrhythmia due to re-entry around the large vascular structures 
in the right atrium [¹,²]. Radio frequency (RF) catheter ablation is an effective method in 
management of atrial flutter [³]. However, a considerable proportion of the cases is unsuc-
cessful and a substantial number of patients have recurrences [3]. One possible explanation 
for the unsuccessful procedures and recurrences is related to anatomical variations of the 
cavo-tricuspid isthmus. Furthermore, radio frequency lesions can be inadequate, allowing 
slow conduction through the cavo-tricuspid isthmus. Fluoroscopy does not allow identi-
fication of important anatomic landmarks during electrophysiological studies. Improved 
imaging techniques such as intra-cardiac echocardiography may have a role to improve 
success rate of radio frequency ablations by guiding these procedures [⁴,⁵]. Although intra-
cardiac echocardiography allows guiding of electrophysiological procedures by visualizing 
important structures, there are controversial data available about its capability to assess 
the radio frequency lesions after ablation [⁶-⁸]. The aim of the present study was to test 
two different approaches for visualization of anatomical structures and radio frequency 
lesions. We compared the capability of intracardiac echocardiography imaging using two 
different entry sites such as the femoral vein (inferior approach) and the subclavian vein 
(superior approach). Furthermore, we assessed radio frequency lesions in the cavotricus-
pid isthmus region 20 min after radio frequency ablation of the cavo-tricuspid isthmus.
 Methods
 Study Patients
Eight consecutive patients who underwent radio frequency ablation of typical atrial flutter 
were included in this study. The mean age of the patients was 56 ± · years (range: 37–76). 
Three patients were women.
 Electrophysiological Procedure
Standard electrophysiological studies were performed under intravenous sedation with 
5–0 mg diazepam. After a subclavian venipuncture, a 5 F decapolar diagnostic catheter 
(Supreme CS, DAIG Corp. St. Jude Medical Inc, Minnesota, MN, U.S.A.) was inserted into 
the coronary sinus through a short vascular sheath. In one patient there subclavian venous 
access could not been achieved. A steerable 20-pole Orbiter catheter (Bard, U.S.A.) was 
positioned around the tricuspid annulus. 5000 IU of heparin was administered intrave-
nously. A Cosio radio frequency mapping/ablation catheter (Medtronic, U.S.A.) was used 
for mapping the critical isthmus between the inferior vena cava and the posterior tricus-
pid annulus. All patients underwent an anatomically guided catheter-based ablation with 
creation a line of lesions from the posterior part of the tricuspid annulus to the inferior 
vena cava. Successful ablation was assessed by demonstration a bi-directional block using 
conventional pacing techniques.
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 Intra-cardiac Echocardiography Imaging
The mechanical intravascular ultrasound and intracardiac echocardiography system 
ClearView (Cardio- Vascular Imaging Systems Inc, Fremont, CA) was used with a 8F 
sheath-based intra-cardiac echocardiography imaging catheter that incorporated a 9 MHz 
bevelled single-element transducer rotating at 800 rpm (model 9900, EP Technologies, 
Boston Scientific Corp., San Jose, CA, U.S.A.). These catheters are equipped with an -cm 
long sonolucent distal sheath, which has a lumen housing the imaging transducer (FIGURE 
). This sheath prevents direct contact of the imaging core with the cardiac wall. The intra-
cardiac echocardiography catheter is filled with 3–5 cc sterile water and then connected 
to an ultrasound console (model I5007, Boston Scientific Corp., San Jose, CA, U.S.A.). This 
catheter obtains cross-sectional images in a plane, which is perpendicular to its long axis. 
The images are displayed on a monitor and recorded on videotape. The position of the 
catheter is checked in three fluoroscopy views (AP, LAO, RAO). The ultrasound catheter is 
initially inserted through the femoral vein into the superior vena cava and is pulled back 
to the inferior vena cava inferior vena cava. The multipolar electrode catheter was removed 
FIGURE 1.
The ultrasaound transducer, showing a distal 
sonolucent sheath, which houses the rotating 
echotransducer
FIGURE 2.
AP fluoroscopy view of the intra-cardiac echocardiography transducer introduced into the heart. 
Left panel: subclavian approach
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from the coronary sinus, and the short vascular sheath was exchanged for an 8F and 60 
cm long straight vascular sheath. The echo catheter is then reinserted through this sheath 
into the right ventricular apex and pulled back from the right ventricle to the superior vena 
cava during recording of two-dimensional images (FIGURE 2). Qualitative analysis and 
intra-cardiac measurements are performed off-line. Data are reported as mean_standard 
deviation.
 Results
Clinical characteristics of the patients are shown in TABLE . Radio frequency catheter ab-
lation of the flutter circuit was successful in all cases. The mean number of radio frequency 
applications was 9 ± 4·2. The procedure and fluoroscopy times were 203 ± 9·6 min and 
55 ± 34·4 min, respectively. The results regarding visualization of anatomically important 
structures and radio frequency lesions are shown in TABLE 2. The fossa ovalis, the tricus-
pid valve, the terminal crest were visible in all cases regardless the way of introduction 
of the echo catheter (FIGURE 3). The size of the fossa ovalis was 8·9 ± ·8 mm. Left-sided 
structures such as the mitral valve, aortic valve and the aorta were less visible but were not 
different using the two approaches. The cavotricuspid isthmus was poorly visible (three 
patients/37%) using the femoral approach (FIGURE 4). The isthmus could be visualized 
in all patients using the subclavian approach (eight patients/00%). In addition, in three 
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patients the ostium of the coronary sinus was visible (three patients/37%) (FIGURE 5). Both 
the left and right ventricles could be seen using the subclavian approach, and were not 
visualized by the femoral approach (FIGURE 6). Radio frequency lesions and more particu-
larly craters were not observed 20 min after ablation. There were no observable differences 
between the ablated region and other cardiac walls (FIGURES 4 and 5). The echodensity of 
the wall was not different from adjacent regions. There were no complications related to 
radio frequency ablation and/or intra-cardiac echocardiography catheterization.
 Discussion
The main findings of our study are that, the isthmus is better visualized using the sub-
clavian approach rather than by the femoral approach using a non-steerable catheter. The 
radio frequency lesions are not visible using this technique 20 min after the procedure. 
 The Role of Intra-cardiac Echocardiography in Ablation of Atrial Flutter
Radio frequency catheter ablation is an option in management of atrial flutter [³]. The aim 
of the procedure to create a lesion over the isthmus, the region between the inferior vena 
cava and the posterior region of the tricuspid valve interrupting the re-entry circuit.
 Although the procedure has a success rate over 90%, approximately 0% of the patients 
have recurrences necessitating a second procedure. Obviously, these procedures add sig-
nificant radiation exposure and a risk of other complications [³]. Intra-cardiac ultrasound 
can visualize intra-cardiac structures [⁹-¹¹]. Occasionally, atrial malformations can be de-
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tected in the region of interest. Dimensions of the isthmus can be measured and the alig-
nation and correct apposition to the tissue of the catheters can be judged [¹²]. According 
to our results, pulling back the intra-cardiac echocardiography catheter from the right 
ventricle through the tricuspid valve after left subclavian venipuncture provides a better 
image than a pullback from the superior vena cava to  inferior vena cava on this important 
region. Therefore visualization of important anatomical structures and observation ana-
tomical variations is more appropriate with a superior approach.
 Ablation Lesion Assessment
It was hypothesized that tissue changes may be detected using intra-cardiac echocardiog-
raphy. Crater formation and increased echodensity was reported immediately after radio 
frequency ablation [⁷]. Despite these early and promising reports we could not observe any 
changes in the ablated region after linear ablation. We did not see craters 20 min after ra-
dio frequency ablation. Possible explanation for this finding is related to the timing of our 
examinations, as we assessed the lesions 20 min after radio frequency ablation to exclude 
temporary changes.
 Future Clinical Applications
The ostium of the coronary sinus could be optimally visualized in some patients during 
subclavian insertion of the intra-cardiac echocardiography catheter. Similar images could 
not be obtained using the femoral approach and this non-steerable ultrasound system. 
Novel, steerable catheters are also available[¹³]; however, these catheters substantially in-
crease the cost of the procedure. Regardless this issue, intra-cardiac echocardiography 
seems to be a feasible guiding tool for cannulation the ostium of the coronary sinus if 
necessary during electrophysiology and multisite pacing procedures.
 For visualization of radio frequency lesion further developments such as tissue charac-
terization are necessary.
 In conclusion, the subclavian approach is a feasible technique to perform intra-cardiac 
echocardiography and using a non-steerable echocardiography probe it is more appropri-
ate to visualize the inferior vena cavatricuspid annulus isthmus than the conventional 
femoral approach. Radio frequency lesions cannot be identified 20 min after creation us-
ing this 9 MHz fixed frequency intracardiac ultrasound probe in the absence of baseline 
pre-ablation intra-cardiac imaging.
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 Abstract
 Aims Although arrhythmia surgery and radiofrequency catheter ablation to cure atrio-
ventricular nodal reentrant tachycardia differ in technical concept, the late results of both 
methods, in terms of elimination of the arrhythmogenic substrate and procedure-related 
new and different arrhythmias, have never been compared. This constituted the purpose 
of this prospective follow-up study.
 Methods and Results Between 988 and 992, 26 patients were surgically treated us-
ing perinodal dissection or ‘skeletonization’, and from 99 up to 995, 20 patients under-
went radiofrequency modification of the atrioventricular node for atrioventricular nodal 
reentrant tachycardia. The acute success rates of surgery and radiofrequency catheter 
ablation were 96% and 92%, respectively. Late recurrence rate in the surgical and radio-
frequency catheter ablation groups was 2% and 7%, respectively. Mean follow-up was 
53 months in the surgical group and 28 months in the radiofrequency catheter ablation 
group. The final success rate after repeat intervention was 00% in the surgical group and 
98% in the radiofrequency catheter ablation group. Comparison of the initial and recent 
series of radiofrequency catheter ablated patients showed an increased initial success rate 
with fewer applications. In the radiofrequency catheter ablation group, a second- or third-
degree block developed in three patients (2%), requiring permanent pacing, whereas in 
the surgical group no complete atrioventricular block was observed. Inappropriate sinus 
tachycardia needing drug treatment was observed in 3 patients (%), mostly after fast 
pathway ablation, but was never observed after surgery. New and different supraventricular 
tachyarrhythmias arose in 27% of the patients in the surgical group and in % of the radio-
frequency catheter ablation group, but did not clearly differ.
 Conclusion This one-institutional follow-up study demonstrated comparable initial 
and late success rates as well as incidence of new and different supraventricular arrhyth-
mias following arrhythmia surgery and radiofrequency catheter ablation for atrioven-
tricular nodal reentrant tachycardia. Today radiofrequency catheter ablation has replaced 
arrhythmia surgery for various reasons, but the late arrhythmic side-effects warrant refine-
ment of technique.
 Keywords: Atrioventricular nodal reentrant tachycardia, arrhythmia surgery,
 radiofrequency catheter ablation, supraventricular tachyarrhythmia.
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 Introduction
Initially, surgical modification of the atrioventricular node was the only method to inter-
rupt atrioventricular nodal reentrant tachycardia. Both cryosurgery for modification of the 
perinodal tissues along the perimeter of the triangle of Koch [¹,²] and ‘skeletonization’, a 
dissection technique to interrupt all atrial inputs of the atrioventricular
node except the ‘deep’ left atrial input [³], resulted in successful cure of the tachycardia 
while preserving atrioventricular conduction. For several reasons radiofrequency catheter 
ablation is today’s treatment of choice for abolishment of recurrent atrioventricular nodal 
reentrant tachycardia [⁴-⁸]. While the early results of surgical and radiofrequency catheter 
atrioventricular nodal modification show a high immediate success rate and a low complica-
tion rate [⁴-⁸], the late clinical outcome and arrhythmic side-effects of these interventions 
have rarely been reported [⁹-¹⁴]. The purpose of this prospective one-institutional study 
was to compare these effects of both interventions in order to examine our therapeutic 
progress.
 Patients and Methods
Between 988 and 992, 26 patients atrioventricular nodal reentrant tachycardia under-
went operative perinodal dissection, and from 99 to 995, 20 patients were treated with 
radiofrequency catheter ablation (TABLE ). In the surgical group, one patient had mild mi-
tral valve stenosis. In the radiofrequency catheter ablated group there were three patients 
with associated coronary artery disease, three patients suffered from chronic obstructive 
pulmonary disease, one patient had a surgically corrected ventricular septal defect, and 
another patient a concomitant non-sustained ventricular tachycardia unassociated with 
structural heart disease.
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 Electrophysiological testing before intervention
The electrophysiological study was performed in the post-absorbative state. If necessary, 
the patients were sedated with diazepam, fentanyl or a combination of these drugs. Prior to 
the study, antiarrhythmic drugs were discontinued for at least five half-lives. For recording 
of intracardiac electrocardiograms and performing programmed electrical stimulation, 
diagnostic catheters were positioned high in the right atrium, in the His bundle region, 
the coronary sinus and the right ventricular apex. Standard criteria were used to establish 
the diagnosis of dual atrioventricular nodal pathways and typical and atypical atrioven-
tricular nodal reentrant tachycardia [¹⁵,¹⁶]. If atrioventricular nodal reentrant tachycardia 
could not be induced by programmed electrical stimulation with different paced heart 
rates, using up to three extrastimuli, isoprenaline (titrated to increase heart rate by >20%) 
or atropine were administered intravenously (maximum dose of 2 mg). This procedure was 
repeated if atrioventricular nodal reentrant tachycardia recurred after a previously suc-
cessful procedure.
 Surgical atrioventricular node modification (‘skeletonization’)
Using normothermic cardiopulmonary bypass, the atrioventricular node region was ex-
posed through a right atriotomy along the tricuspid annulus, extending to the atrial mem-
branous septum [¹]. The tendon of Todaro was identified. The inferior medial right atrial 
wall was incised along the septal segment of the tricuspid annulus below the atrial mem-
branous septum. Dissection of the right atrial wall was completed and extended inferiorly 
towards the coronary sinus orifice and superiorly where a plane of cleavage was identified 
between the right atrial wall and the intermediate atrioventricular node, to meet the ante-
rior septal incision. The septal atrial wall was divided and deflected posteriorly to expose the 
atrioventricular node. The intermediate atrioventricular node was identified by its oblique, 
pale myocardial fibres and dissected from surrounding tissue to separate superficial and 
posterior atrial inputs while deep inputs were left intact. Atrioventricular nodal conduction 
was monitored during the operation. The end-point of the procedure was the non-inducibil-
ity of atrioventricular nodal reentrant tachycardia during electrophysiological testing, prior 
to closure of the atrium. Inducibility of no more than one nodal echo beat was accepted.
 Radiofrequency atrioventricular node modification
A quadripolar Steerocath or Tracfinder catheter (EP Technologies), or a quadripolar 4 mm 
tip catheter (Cordis-Webster) with deflectable curves were used. Radiofrequency energy 
pulses of 7 to 50 Watt at a frequency of 500 kHz were delivered by a custom-made available 
electrosurgical device by delivering current between the distal electrode and a cutaneous, 
indifferent, dispersive pad positioned on the patient’s back.
 Selective fast pathway ablation
During a fast pathway ablation procedure, the ablation catheter was positioned across the 
tricuspid annulus to record a His bundle potential during sinus rhythm and thereafter 
slowly withdrawn until the amplitude of the atrial electrogram exceeded the ventricular 
electrogram and the His bundle potential was small or hardly visible [¹¹]. Radiofrequency 
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application was initially delivered at this target site. After each application of radiofre-
quency energy, electrophysiological induction of the tachycardia was attempted and when 
still inducible, the above procedure was repeated in an attempt to reach a better position or 
better tissue contact as described above. Ablation was considered immediately successful 
when atrioventricular nodal reentrant tachycardia was no longer inducible or when a 30% 
prolongation of the PR interval or an inadvertent second- or third-degree atrioventricular 
block occurred. Atrial pacing at a cycle length of 500 ms was started at the onset of the 
accelerated atrioventricular junctional rhythm, thereby permitting continuous monitoring 
of atrioventricular conduction.
 Selective slow pathway ablation
The site of slow pathway ablation was established by positioning the ablation catheter sep-
tally, just across the tricuspid valve posterior to the atrioventricular node immediately pos-
terior, anterior or at the level of the ostium of the coronary sinus. That area was examined 
for the presence of slow pathway potentials thought to be presented by double potentials in 
the bipolar atrial electrocardiogram of the ablation catheter. When these signals could not 
be located within a time frame of 20 min, a more aspecific ablation of the posterior peri-
nodal atrium was performed. Radiofrequency energy was applied between the tricuspid 
valve and the os of the coronary sinus, whereas the amount was titrated to inducibility of 
atrioventricular nodal reentrant tachycardia [⁵,¹⁵,¹⁶] The end-point of slow pathway abla-
tion was non-inducibility of atrioventricular nodal reentrant tachycardia with preserved 
atrioventricular nodal conduction.
 Combined slow and fast pathway ablation
If initially a slow pathway approach was chosen and ablation was not successful after more 
than an arbitrary 20 radiofrequency applications, the previously described fast pathway 
ablation approach was applied during the same procedure. Conversely, if fast pathway abla-
tion was unsuccessful, slow pathway ablation was carried out, again during the same ses-
sion. The end-point of this approach was based on the previously mentioned end-points for 
fast and slow pathway ablation.
 Patient follow-up
All patients were followed for at least  year in our outpatient clinic or by the referringcardi-
ologist. If a patient experienced symptoms of palpitations, a 24-h Holter recording or a self-
activating ambulatory single channel ECG recording and exercise testing were performed. 
An electrophysiological study was scheduled if recurrence of atrioventricular nodal reen-
trant tachycardia could not be confirmed while symptoms remained present. When the 
diagnosis of atrioventricular nodal reentrant tachycardia was established, a second abla-
tion procedure was carried out.
 Statistical analysis
Data are expressed as mean+SD. Chi-square and Student’s t-test were used for statistical 
comparison whenever appropriate. For censored data the logrank test was used. A two-
tailed P value <0·05 was considered significant.
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 Results
One hundred and thirty-four of the 46 patients (92%) had typical atrioventricular nodal 
reentrant tachycardia, and in 2 patients (8%) it was atypical. There were no significant 
differences in electrophysiological baseline characteristics between the surgical and vari-
ous ablation groups (TABLE ). Fast pathway ablation significantly increased the PR and 
AH intervals (P<0·05) compared with the values observed after slow pathway ablation and 
surgery (Table 2).
 Surgical atrioventricular node modification
In 25 of 26 patients (96%), immediate success was achieved (TABLE 2). In 0 patients (38%), 
transient complete atrioventricular block was observed, but atrioventricular conduction 
normalized in all patients within a few minutes, except for two patients (8%) in whom a 
first degree atrioventricular block persisted (TABLE 3). One patient had a pneumothorax, 
and in one patient an occlusion of the left anterior descending coronary artery occurred, 
associated with an anterior myocardial infarction. Three of the 25 immediately successful 
surgical patients experienced recurrences of atrioventricular nodal reentrant tachycardia 
(TABLE 3). In two of these patients atrioventricular nodal reentrant tachycardia recurred 
in the early 7 months after surgery, in one patient a recurrence was documented 3 years 
after surgery. Two of the latter three patients had a subsequently successful radiofrequency 
catheter ablation, one patient underwent three successive radiofrequency catheter ablation 
sessions because of repetitive recurrences of atrioventricular nodal reentrant tachycardia. 
In this patient, the tachycardia did not reoccur during a mean follow-up of 7 months. The 
patient with an immediately unsuccessful first procedure had a successful second opera-
tion. New and different supraventricular tachycardias arose in seven patients (TABLE 3). 
Two patients underwent radiofrequency catheter ablation of the His bundle and pacemaker 
implantation since these arrhythmias (type  atrial flutter and atrial fibrillation) became 
drug refractory.
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 Radiofrequency atrioventricular node modification
 Selective fast pathway ablation
Immediate success was obtained in 36 of 40 patients (90%) treated with this technique 
(TABLE 2). One patient developed complete atrioventricular block requiring pacemaker 
implantation (TABLE 3). Immediately after catheter ablation, eight patients suffered from 
inappropriate sinus tachycardia and required a beta-blocking agent for 2 weeks to 3 months. 
Atrioventricular nodal reentrant tachycardia recurred in three patients (8%) with an im-
mediately successful ablation (TABLE 3). They were successfully treated with a second fast 
pathway catheter ablation procedure. Two of the four patients with an unsuccessful first 
attempt had no recurrence of atrioventricular nodal reentrant tachycardia after a second 
ablation session. One patient required a third and one a fourth session. Eventually, all were 
free of atrioventricular nodal reentrant tachycardia. Table 3 displays the onset of late new 
supraventricular tachycardias.
 Selective slow pathway ablation
Forty-six of 47 patients (98%) had an immediately successful slow pathway ablation (TABLE 
2). One patient developed complete atrioventricular block requiring pacemaker implanta-
tion (TABLE 3). Four patients had inappropriate sinus tachycardia and received a betablock-
ing agent for 2 to 8 weeks. Nine of 46 patients with an immediately successful ablation 
suffered from recurrences of atrioventricular nodal reentrant tachycardia and required a 
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second attempt (seven patients) or a third session (two patients) (TABLE 3). Eventually, all 
were successfully controlled. The patient with an unsuccessful first ablation was controlled 
after two successive repeat catheter ablations. Table 3 displays the onset of new supraven-
tricular tachycardias.
 Combined slow and fast pathway ablation
After unsuccessful fast or pathway ablation, 33 patients underwent additional slow path-
way ablation or vice versa during the same session. Immediate success was reached in 27 of 
33 patients (82%) (TABLE 2). Symptomatic second-degree atrioventricular block was seen 
in one patient requiring pacemaker implantation (TABLE 3). After an immediately suc-
cessful procedure, six patients had recurrences of atrioventricular nodal reentrant tachy-
cardia (TABLE 3). Successful slow and fast pathway ablation was performed again in four 
of them. The two remaining patients were treated with a repeat slow pathway ablation, of 
which only one was successful. Two of the six patients with an immediately unsuccessful 
ablation refused a second ablation attempt and were treated with antiarrhythmic drugs. 
Three patients were successfully treated in a second ablation session and one needed a third 
procedure. Table 3 displays the onset of new supraventricular tachycardia. Recurrences 
of atrioventricular nodal reentrant tachycardia after an immediately successful radiofre-
quency modification of the atrioventricular node, emerged most frequently (73%) in the 
early months (maximum 7 months) after ablation, although one recurrence was docu-
mented after 25 months. Time of recurrence was not associated with the applied method 
of atrioventricular node modification. Considering all radiofrequency catheter procedures, 
the following complications were observed. Three patients suffered from a pneumothorax 
due to a subclavian vein puncture, two developed pericarditis and one had an ischaemic 
cerebral infarction 2 h after the procedure, despite adequate intravenous heparinization. 
The latter patient fully recovered with conventional drug therapy.
 Discussion
 Immediate results
From a historical perspective this study provides a unique opportunity to compare the 
early and late results of a relatively large series of surgically treated patients with those of 
radiofrequency catheter ablated patients. It should be noticed that surgery was practised 
only briefly and was quickly overtaken by radiofrequency catheter ablation. There was no 
statistical difference in patient characteristics between either group regarding clinical pre-
sentation and failure of drugs, although during the years the indication for radiofrequency 
catheter ablation has extended because of the easier approach. Despite differences in tech-
nical approach, the immediate success rates of surgery (96%) and radiofrequency catheter 
ablation (92%) are well comparable, and agree closely with the results of earlier studies in 
which radiofrequency catheter atrioventricular node modification was exclusively applied 
[⁴-⁸], although our immediate success rate of radiofrequency catheter ablation is slightly 
lower. However, the immediate success rate of the 40 recently treated patients was 95%, 
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in comparison with 89% of the 80 first treated patients (P=0·26). The mean number of 
applications also differed significantly between the 80 first treated patients and the 40 
recently treated patients, namely 6 and seven respectively (P<0·05). Opposite to surgery, 
radiofrequency catheter modification of the atrioventricular node caused complete atrio-
ventricular block in two patients (2%) and a second-degree atrioventricular block in one 
patient (%), requiring pacemaker implantation. One of these patients underwent catheter 
modification of the slow pathway in an area anatomically distant from the His bundle, an 
approach which is assumed to be related to a low risk for complete atrioventricular block 
[¹³,¹⁴,²⁴,²⁸-³⁰]. Other studies describe a higher incidence of atrioventricular block, specifi-
cally complicating fast pathway ablation, varying from 3·5% in experienced investigators up 
to 2% in inexperienced operators [⁴,⁶,⁹,¹³,¹⁴,¹⁷,²⁴,²⁶-³⁰]. Therefore, one may question whether 
the atrioventricular node can functionally or even anatomically be regarded as a distinct 
structure, as suggested by earlier experimental data [³⁷,³⁸]. Persistent inappropriate sinus 
tachycardia requiring treatment with a beta-blocking agent, was observed in 3 patients 
(%), and occurred mostly after fast pathway ablation. This observation is in agreement 
with previously reported incidence of inappropriate sinus tachycardia after catheter atrio-
ventricular node modification [³¹-³³] but was never found to be complicating the surgical 
procedure [¹-³,⁹-¹¹].
 Late results and new arrhythmias
After an immediately successful surgical or radiofrequency catheter modification of the 
atrioventricular node, atrioventricular nodal reentrant tachycardia recurred in three (2%) 
and 8 (7%) patients, respectively. Most recurrences (73%) occurred in the early months 
(maximum 7 months) after the intervention, but recurrence after 3 years was also doc-
umented in the surgical group, and after 2 years in the radiofrequency catheter ablated 
group. In comparison with earlier studies, the recurrence rate in the radiofrequency cath-
eter ablation group was high [⁴-⁸,¹²,¹³,¹⁵,¹⁶,¹⁸,²³-²⁵]. However, the recurrence rate of the 40 
recently treated patients was 8%, in comparison with 2% in the 80 first treated patients 
(P=0·07), and in agreement with these studies. The final outcome after repeat interventions 
was also very comparable between both approaches, namely 00% in the surgical group and 
98% in the radiofrequency ablation group. These results are in agreement with earlier stud-
ies [⁹,¹⁰,¹²,¹³,¹⁷-²⁵]. Both procedures for atrioventricular node modification were associated 
with the onset of new and different supraventricular tachycardia, including paroxysmal 
and chronic atrial flutter, atrial tachycardia and atrial fibrillation. The incidence was 27% 
in the surgical and % in the radiofrequency catheter ablation group. Despite a difference 
in follow-up interval, the incidence of these new arrhythmias did not differ in either group 
(log rank test: P=0·2).
Ventricular tachyarrhythmias were never observed. Previous studies have suggested 
a causal relationship between type  atrial flutter and atrioventricular nodal reentrant 
tachycardia, because of a possibly shared pathway in the lower right atrium [³⁴,³⁵]. In our 
study, two out of three patients with preexistent paroxysmal type  atrial flutter had no 
recurrence of either atrioventricular nodal reentrant tachycardia or atrial flutter after suc-
cessful radiofrequency catheter ablation of only the atrioventricular node, supporting the 
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aforementioned hypothesis. On the other hand, in a few other patients, both surgery and 
radiofrequency catheter ablation were able to eliminate atrioventricular nodal reentrant 
tachycardia, but type  atrial flutter arose afterwards or persisted in one patient (TABLE 3). 
This can be explained by an inter-patient difference in size of the critical area in the peri-
nodal atrium to allow the initiation of atrial flutter and atrioventricular nodal reentrant 
tachycardia. Furthermore, successful cure of atrioventricular nodal reentrant tachycardia 
can be achieved with discrete lesions that interrupt the zone of slow conduction in the low 
right atrium. However, such lesions are not sufficient to cure type  atrial flutter [³⁴]. This 
latter assumption is supported by the observation that atrioventricular node modification 
can be successful, while maintaining slow pathway conduction [⁵-⁷,²⁴]. The late occurrence 
of atrial flutter in these patients can probably be ascribed to the damage produced to this 
specific area, which instead of generating conduction block may have caused further slow-
ing of conduction, thereby providing a substrate for type  atrial flutter to emerge. Because 
the patients in whom atrial fibrillation became manifest had either mitral valve disease or 
dilated atria, it is more likely that the mechanism of this arrhythmia can be attributed to an 
ongoing atrial disease, rather than being procedure-related [³⁶]. Patients with atrial tachy-
cardia after successful atrioventricular nodal reentrant tachycardia treatment did not show 
underlying heart disease, and therefore it is postulated that this arrhythmia is caused by 
unfavourable effects on radiofrequency energy on cardiac node innervation and/or atrial 
tissue. More data on late follow-up is required to support this hypothesis.
 Limitation of the study
The results of both interventions represent the outcome of a ‘learning curve’ by our centre. 
Additionally, training facilities must also be taken into account. This explains the initially 
large number of applications as well as the initially high recurrence rate. Furthermore, the 
time of follow-up for patients who underwent radiofrequency catheter ablation was shorter 
than for the surgically treated patients, but it was at least  year for all patients. Because 
most recurrences of atrioventricular nodal reentrant tachycardia can be expected to occur 
within the first months after the procedure, the results of both procedures appear valid, 
although during late follow-up recurrences of atrioventricular nodal reentrant tachycardia 
were registered in both the radiofrequency and surgical group, even after 25 months and 
3 years, respectively, which also contributed to the high recurrence rate. Electrophysiologi-
cal follow-up studies were performed only in patients with symptoms suggesting recurrent 
atrioventricular nodal reentrant tachycardia. However, it has been reported that atrioven-
tricular nodal reentrant tachycardia was only inducible at follow-up electrophysiological 
study in patients who had a clinical recurrence of atrioventricular nodal reentrant tachy-
cardia [⁸].
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 Conclusion
Radiofrequency catheter ablation has become today’s choice for elimination of recurrent 
atrioventricular nodal reentrant tachycardia because this intervention avoids thoracotomy 
and reduces hospitalization. Despite differences in methodology, initial and late results of 
both interventions were very comparable in this one-institutional study. The percutaneous 
approach has therefore rightly replaced arrhythmia surgery, but its late arrhythmic side-
effects warrant refinement of the technique.
 The authors wish to thank Mrs Gerda van der Kuijl for preparation of the manuscript.
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Surgery or radiofrequency catheter ablation  
for atrioventricular nodal reentrant  
tachycardia – the impossible choice
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Direct surgical techniques employed to ablate an arrhythmogenic substrate have been 
proved  very useful in the treatment of many supraventricular arrhythmias, including 
atrioventricular nodal reentrant tachycardia[¹-³]. Development of these techniques has 
paralleled the evolution of our understanding of electrophysiology and created the con-
ditions for the study and use of new forms of treatment, such as radiofrequency catheter 
ablation. Today, radiofrequency catheter ablation has become the treatment of choice for 
atrioventricular nodal reentrant tachycardia and no single argument can be used to defend 
a direct surgical approach. Nevertheless, recognition of the contribution of surgery to the 
development of actual catheter ablative techniques is mandatory. The paper by Kimman et 
al.[⁴] in this issue is probably the best possible tribute to atrioventricular nodal reentrant 
tachycardia surgery. It demonstrates that, in selected, highly motivated centres, surgery 
was at least as effective as radiofrequency catheter ablation techniques. Due to its techni-
cal difficulties, very few centres around the world were prepared in the past to use direct 
surgery for the treatment of this arrhythmia. Also, the need of a median sternotomy was 
a strong limitation for its widespread use and many thought that this treatment was too 
aggressive for a benign arrhythmia. They were probably right, but these pioneers acceler-
ated the arrival of what we think of as the ‘golden age’ of arrhythmology. It is impressive 
to see how complicated the surgical techniques used to be with complete ‘skeletonization’ 
of the atrioventricular node, and how the placement of a radiofrequency lesion in the slow 
atrioventricular nodal pathway can be accomplished easily today. The former required a 
long hospitalization, general anaesthesia, a slow recovery, and left permanent marks of the 
intervention procedure. Radiofrequency catheter ablation can be done on an outpatient ba-
sis, using local anaesthesia, recovery is almost immediate and no scars will remain. These 
facts have expanded indications of radiofrequency catheter ablation to almost all patients 
with the arrhythmia. In the vast majority of cases there is no objective reason to initiate or 
continue pharmacological treatment and today it is probably unethical to propose a direct 
surgical approach. Universal use of radiofrequency catheter ablation has also produced an 
expected, undesired effect. Surgeons are no longer interested in a direct surgical approach 
to reentrant supraventricular tachycardias. They are no longer trained in this technique, 
they are unfamiliar with it and they are not motivated to carry it out. In most centres in the 
world, it will be impossible to find a surgeon prepared to perform such an intervention. This 
brings the discussion on the hypothetical choice between surgery or catheter ablation to 
an impossible position. Surgery is no longer an option for atrioventricular nodal reentrant 
tachycardia. The paper by Kimman et al.[⁴] raises the question of complications using one 
or other technique, in particular the occurrence of complete atrioventricular block and the 
development of new and different supraventricular tachyarrhythmias after the procedure. 
These issues will still need to be refined in years to come. Many invasive electrophysiolo-
gists probably think it will be very difficult to do better, just as did surgeons some years ago. 
Let us see whether in years from now training in catheter ablation will have been surpassed 
by safer and more effective approaches, developed, for instance, by molecular biologists. 
Until then we will have to accept that we were lucky to live in the silver but not yet the 
golden age of arrhythmology.
EDITORIAL
050285 thesis Kimman bw.indb   69 12-08-2005   09:37:52
CHAPTER 3
[70]
References
[] Cox JL, Gallagher JJ, Cain ME. Experience with 8 consecutive patients undergoing surgery for 
the WolV-Parkinson-White syndrome. J Thorac Cardiovasc Surg 985; 90: 490.
[2] Klein GJ, Guiraudon GM, Perkins DG et al. Surgical correction of the Wolff-Parkinson-White 
syndrome in the closed heart using cryosurgery: A simplified approach. J Am Coll Cardiol 984; 3: 
405.
[3]  Ross DL, Johnson DC, Denniss AR, Cooper MJ, Richards DA, Uther JB. Curative surgery for 
atrio-ventricular junctional (‘AV Nodal’) reentrant tachycardia. J Am Coll Cardiol 985; 6: 282.
[4]  Kimman GP, van Hemmel NM, Jessurun ER et al. Comparison of late results of surgical or radio-
frequency catheter modification of the atrioventricular node for atrioventricular nodal reentrant 
tachycardia. Eur Heart J 999; 20: 527–34.
050285 thesis Kimman bw.indb   70 12-08-2005   09:37:53
4Hybrid pharmacologic and ablative therapy  for the management of  
symptomatic atrial fibrillation
GP Kimman MD, T Szili-Torok MD, M Nieudorp, DAMJ Theuns MS,  
M Scholten MD, L Jordaens MD, PHD
Department of Clinical Electrophysiology, Erasmus Medical Centre, Rotterdam,
The Netherlands
Neth Heart J 2002;0:8-2
[7]
050285 thesis Kimman bw.indb   71 12-08-2005   09:37:54
CHAPTER 4
[72]
 Abstract
 Background Hybrid therapy for atrial fibrillation Class c and class III antiarrhyth-
mic drugs (AAD) can convert atrial fibrillation (AF) into an isthmus-dependent atrial flut-
ter (AFL) in more than 0 % of the patients. Hybrid pharmacologic and ablative therapy 
offers a safe and effective means of achieving and maintaining sinus rhythm. We evaluated 
the efficacy of this hybrid approach for the management of paroxysmal or persistent AF.
 Methods Eighteen patients with symptomatic AF treated with AAD and typical 
counterclockwise/clockwise AFL underwent radiofrequency (RF) ablation of AFL with an 
anatomical approach. 
 Results RF ablation was successful in all patients. All but  patient continued AAD. 
Four patients (22%) had recurrences of AFL. Two of them also had a recurrence of AF. An-
other three patients had recurrences of AFonly, and finally, one patient developed an atrial 
tachycardia more than  year after the procedure. In conclusion,  patients (6%) did not 
experience recurrences of AF/AFL after tricuspid valve annulus (TV) – inferior caval vein 
(IVC) isthmus ablation with continuing of antiarrhythmic drugs.
 Conclusion Hybrid pharmacologic and ablative therapy is a safe and effective treat-
ment for the management of patients with symptomatic AF. 
 Keywords Hybrid therapy, atrial fibrillation 
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 Introduction
Atrial fibrillation (AF) is the most frequent, sustained, symptomatic tachyarrhythmia in 
patients with or without stuctural heart disease [¹-³]. The incidence of this tachyarrhyth-
mia increases with age and is twice as common in males as females [⁴,⁵]. It remains a 
therapeutic challenge and the success rate of maintaining long-term sinus rhythm with 
pharmacologic therapy alone is less than optimal [⁶,⁷]. Under class c, but also class III 
antiarrhythmic drugs (AAD), which are the first line agents to prevent AF recurrences, 
‘transformation’ of AF to atrial flutter (AFL) is well-known [⁸-¹¹]. Increase in wavelength 
due to increase in the atrial refractory period in a tachycardia dependent manner , and the 
unique arrangement and orientation of the atrial muscle fibers between inferior vena caval 
orifice (IVC) and tricuspid valve annulus (TV) may promote nonuniform anisotropic slow 
conduction in the so-called ‘isthmus’, and therefore promote the conversion of AF in AFL 
[¹²-¹⁴]. Nowadays, ‘isthmus dependent AFL’ can be succesfully treated by radiofrequency 
catheter (RF) ablation of the aforementioned region between the IVC and TV annulus. A 
bidirectional isthmus block is accompanied by a high success rate and a low recurrence 
rate of AFL. Recent studies demonstrated that maintenance of AAD after successful AFL 
ablation, continuously modifies the atrial substrate to prevent fractionation in atrial acti-
vation leading to recurrence of AF [¹⁰,¹¹,¹⁵-¹⁸]. This hybrid therapy for AF offered a safe and 
effective means of achieving and maintaining sinus rhythm (SR). In this present study the 
first results of this hybrid approach for management of AF in the Thoraxcentre Rotterdam 
are evaluated.
 Methods
 Patient Population
Eighteen patients with symptomatic paroxysmal or persistent AF treated with antiarrhyth-
mic drug therapy who had subsequent conversion to AFL by 2-lead ECG were included. 
The 2-lead ECG recorded during clinical AFL episode was classified with regard to the 
morphology of the flutter waves. Typical counter-clockwise or clockwise AFL was defined 
using standard surface ECG characteristics [¹].
 Electrophysiologic study and Radiofrequency catheter ablation
All patients underwent electrophysiologic study with a standard decapolar catheter (DAIG 
Corp.) placed in the coronary sinus (CS), a steerable 20-pole Orbitercatheter (Bard), posi-
tioned around the tricuspid annulus. A Cosio ablation catheter (Medtronic) was used for 
mapping and ablation. When a patient had sustained AFL, mapping of the atrial activa-
tion sequence was carried out. Concealed entrainment of the tachycardia was attempted 
by pacing with the ablation catheter from the anatomic isthmus at 20 or 40 ms below the 
atrial cycle length. Concealed entrainment was defined as fulfillment of all the following 
criteria: . postpacing interval equaling tachycardia cycle length ± 0 ms; 2. identical in-
tracardiac atrial activation pattern during pacing from the isthmus as during tachycardia; 
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3. stimulus to surface flutter wave interval equaling electrogram to surface flutter wave 
interval ± 0 ms [¹⁰,¹⁹]. If a patient was in SR, bidirectional isthmus conduction was evalu-
ated at pacing cycle lengths of 600 and 400 ms [²⁰]. No attempt was made tot induce AFL, 
because of the risk of inducing sustained AF.
 All patients underwent anatomically guided catheter-based ablation with creation of 
linear lesions in the TV annulus-IVC isthmus and/or the TV annulus-CS-IVC isthmus. 
Succesful ablation was assessed by demonstrating bidirectional block with pacing at two 
different cycle lengths (600 and 400 ms) [²¹-²³]. 
 Follow-Up
After the procedure all patients were advised to continue treatment with AAD. Patients 
were followed for recurrences via outpatient clinics, contacts with primary physicians, 
and Holter recordings were requested when symptoms suggested an arrhythmia recur-
rence. Patients having a recurrence of AFL underwent re-ablation. After isthmus ablation, 
patients having no AF recurrences, or symptomatic but short-lasting AF recurrences were 
considered to be well-controlled. Patients with frequent or symptomatic recurrences of AF 
were considered as inadequately controlled.
 Statistical analysis
Data are presented as mean ± SD and were compared using a two-tailed Student’s t-test. P 
< 0.05 was considered statistically significant.
 Results
 Patient characteristics 
All eighteen patients were classified as typical counterclockwise/clockwise AFL on docu-
mented standard surface ECG. Demographic characteristics are shown in TABLE . There 
were 3 men, and the mean age was 59.5 years (SD ± 9). In all patients at least one AAD 
had failed. At the time of the procedure 3 patients were on class III AAD and 4 patients 
were on Class IC AAD. One patient was taking only verapamil. Six patients (33%) had 
daily, weekly or monthly episodes of paroxysmal AF/AFL (i.e. self terminating AF/AFL, 
lasting <24 hours per episode), and 2 patients experienced one or more episodes of per-
sistent AF/AFL (sustained AF/AFL lasting 24 to 72 hours, requiring direct current (DC) 
cardioversion in the six months before ablation). Twelve patients had structural cardio-
vascular disease: 3 with mitral valve replacement, 2 with coronary artery disease, 2 with 
both aortic valve replacement and coronary artery bypass grafting (CABG),  with hyper-
tension, and 4 with sick sinus syndrome with prior pacemaker implantation.
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 Electrophysiologic characteristics and Radiofrequency ablation (TABLE 2)
At the time of the EP study seven patients (39%) were in AFL. Intracardiac mapping and 
entrainment pacing revealed 6 of these patients to have typical counterclockwise (cranio-
caudal along the right free wall) and one patient typical clockwise (caudocranial along the 
right free wall) flutter circuits traversing through the TV-IVC isthmus. In these patients 
RF ablation was performed during AFL. Eleven patients were in SR. Bidirectional conduc-
tion isthmus conduction was present in all of them, and ablation was performed during 
sinus rhythm. However, in one of these patients AF was induced during manipulation of 
the ablation catheter. After unsuccessful external DC cardiovision, it was decided to ablate 
this patient during AF. 
 Linear ablation of the TV-IVC isthmus was carried out under anatomic and electro-
gram guidance. This created a complete line of block in 9 patients. The other nine patients 
subsequently underwent RF ablation of the TV-CS and CS-IVC isthmus with finally bidi-
rectional isthmus conduction block in eight. In  patient this could not be demonstrated, 
Table 1. Demographic characteristics
age (years) ± SD 59.5 ± 9
male/female (n/n) 13/5
structural heart disease (n) 
• none 5
valvular disease 3 
• coronary artery disease 2
• valvular and coronary artery disease 2
• hypertension 1
• sick sinus syndrome 4
• amiodarone/class IC AAD (n/n) 13/4
• verapamil (n) 1
TABLE .
Demographic characteristics
Table 2. Electrophysiologic Study Results
• Number 18
• Counterclockwise/clockwise AFL (n/n) 17/1
• RFA during SR/AFL (n/n) 10/7
• RFA during AF (n) 1
• Site(s) ablated(n)
TV-IVC 9
subsequently TV-CS and CS-IVC 9
• Success (n)
BICB 17
unkown 1
TABLE 2.
Electrophysiologic Study Results
AAD = antiarrhythmic drug
AFL = atrial flutter, AF = atrial fibrillation, RFA = radiofrequency ablation,  
SR = sinus rhythm, TV = tricuspid valve, IVC = inferior caval vein,  
CS = coronary sinus, BICB = bidirectional isthmus conduction block
Table 1. Demographic characteristics
age (years) ± SD 59.5 ± 9
male/female (n/n) 13/5
structural heart disease (n) 
• none 5
valvular disease 3 
• coronary artery disease 2
• valvular and coronary rtery disease 2
• hypertension 1
• sick sinus syndrome 4
• amiodarone/class IC AAD (n/n) 13/4
• verapamil (n) 1
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because of persisting AF during the procedure, despite repeated external electric cardio-
versions. After the procedure SR was restored spontanously, In the end, 17 (94%) patients 
were considered to be succesfully ablated. One patient with severe systolic left ventricular 
dysfunction and a history of malignant ventricular arrhythmia developed complete AV 
block during the procedure, requiring dual chamber ICD implantation. In one patient an 
arteriovenous fistula was diagnosed, and corrected surgically. All patients were advised to 
continue antiarrhythmic drug therapy. 
 Follow-Up (TABLE 3)
During a mean follow-up of 8.1 months, ± 5.9, in total 4 patients had recurrences of AFL 
and two of them also had recurrences of AF. One patient had a recurrence after only 1 
day, developed AF the next day, and underwent His ablation with pacemaker implanta-
tion. Two other patients had recurrences of AFL within 1 month, and in one patient AFL 
recurred after three months with a recurrence of AF als well. Two patients underwent 
reablation for AFL. One of them was in AFL at the time of reablation and entrainment 
mapping clearly showed an isthmus dependency. This patient was cardioverted to obtain 
a more stable catheter position during ablation. In both patients restoration of bidirec-
tional isthmus conduction could be demonstrated and reablation of the so-called gaps in 
the line was performed. Bidirectional block was achieved again in both patients. However, 
during follow-up one of them experienced recurrent AFL with demonstration of restora-
tion of isthmus conduction. He underwent a third ablation. In the end, both patients were 
free of recurrences. Three patients only experienced recurrences of AF. One patient had 
two episodes of AF, after two days and 15 months, respectively. Another patient developed 
-
nostic EP study was performed. During this procedure bidirectional isthmus block was 
was interrupted accidentally, but after reinitiation no recurrence of AF has been observed 
in a 6 months follow-up. Finally, one patient developed atrial tachycardia 1 year after abla-
tion. FIGURE 1 shows the overall event free survival. 
• Number
• Follow-up duration (months) ± SD
• AAD after RFA (n)
• AFL recurrence (n)
• AF recurrence (n)
• AF/AFL recurrence (n)
• AT occurrence (n)
• Repeat RFA of AFL (n)
• Hisablation and PM-implantation (n)
TABLE 3.
Follow-up results after successful RFA of AFL
Abbreviations as in Tables 1 and 2.
AT = atrial tachycardia, PM = pacemaker
18
8.1 ± 5.9
17
2
3
2
1
2
1
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one arrhythmia to the other, suggesting a mechanistic and possible causative relationship 
between AFL and AF [²⁴]. This was also seen in our patients treated with verapamil. In this 
patient, ablation of AFL could have reduced recurrences of AF by eleiminating a potential 
trigger for AF. The mechanism by which atrial arrhythmias trigger AF is uncertain, but 
rapid atrial rates may increase atrial vulnerability by shortening atrial refractory period or 
electrical remodelling [²⁵,²⁶].
 In the present study four patients had recurrences of AFL. In all four patients, the 
morphology of the flutter waves on the 2-lead ECGs during AFL was similar before and 
after ablation. Two of them underwent a reablation. In both patients the first ablation was 
performed during SR after demonstration of bidirectional isthmus conduction. However, 
in both patients AFL was not induced before the first ablation, because of the risk of in-
ducing AF. Therefore, a non-isthmus dependent AFL could be an explanation, although 
entrainment mapping of AFL during reablation clearly showed isthmus dependency in 
one patient. Again, the other patient underwent reablation during sinus rhythm, without 
inducing AF. Data from initial studies, using the demonstration of complete isthmus block 
as an endpoint, had comparable outcome with a recurrence rate between 9-6% [²⁷,²⁸]. 
 In total five patients (27%) had recurrences of AF (including two patients with recur-
rent AFL, as well), although one patient only had a recurrence of AF after accidentially 
stopping his AAD. This patient did not experience recurrent AF in six months after reini-
tiation of pharmacological therapy. These patients were considered to be inadequately con-
trolled. So finally, 4 patients (78%) were free of recurrences of AF with continuing AAD, 
and were considered well controlled. This is comparable with earlier studies and again 
illustrates that continuing of antiarrhythmic agents is important for a favourable outcome 
[¹⁰,¹¹,¹⁵-¹⁸]. 
 One patient developed an atrial tachycardia one year after ablation, and the morphol-
ogy of the P wave suggested a focus in the low septal region of the right atrium. Possibly, 
this can be a late proarrhythmic effect of the ablation, as suggested in an earlier study after 
slow pathway ablation for AVNRT [²⁹].
 Study Limitations
In  patients, RF ablation was performed during SR. In these patients no attempt was done 
to induce AFL, because of the risk for inducing sustained AF. In the absence of entrain-
ment studies, determining of an isthmus dependent AFL is limited. Therefore, a non-isth-
mus-dependent AFL could be an explanation for recurrences of AFL. However, in one of 
the two patients who underwent reablation, an isthmus-dependent AFL could clearly be 
demonstrated.
 Therapeutic success in this study was determined by symptomatic recurrences on rou-
tine surveillance. Asymptomatic recurrences could go undetected, however all patients 
were highly symptomatic prior ablation. One patient was only treated with verapamil. It is 
quite common to observe AFL in patients not treated with IC/III AAD, or with untreated 
AF. Therefore, this patient did not receive hybrid pharmocological and ablative therapy, 
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and should be excluded. However, this patient is still free of recurrent AF/AFL, and il-
lustrates that with the ablation of AFL a possible potential trigger for AF is eliminated. 
Finally, in the present study there was only a short follow-up period. 
 Conclusions
Both class C and class III AAD are able to convert AF into an isthmus dependent AFL. 
Linear isthmus ablation with creating bidirectional conduction block, in combination 
with continuing of AAD can be an effective therapy in achieving and maintaining SR. 
This hybrid approach offers a substantial improvement in the management in a subset of 
patients with AF.
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 Abstract
 Background Radiofrequency (RF) catheter ablation is highly effective with a low 
complication rate. However, lesions created by RF energy are irreversible, inhomogenous, 
and therefore potentially proarrhythmic. 
 Objectives The aim of this study was to focus on the magnitude and importance of 
long-term proarrhythmic effects of RF energy. 
 Methods and results Between 99 and 995, 20 patients underwent RF ablation 
for AVNRT. Of these patients, data were collected by contacting patients and/or fill out 
a questionnaire. Medical files were screened for recurrent, documented arrhythmias, 
medical treatment, and repeated EP study. Referring cardiologists were asked about recur-
rences of tachyarrhythmias. Fourteen patients (%) were lost to follow up. During a mean 
follow-up of ten years, six patients died. In total 29 pts (24%) suffered from new arrhyth-
mias, 6 from type  atrial flutter, 6 from atrial tachycardia, 9 from atrial fibrillation, and 
finally 6 pts from symptomatic PAC’s, needing medical treatment, or a combination of 
these arrhythmias. Seven patients underwent pacemaker implantation, 4 after developing 
procedural AV conduction disturbances, 2 after His ablation for permanent atrial fibril-
lation, and  patient for sick sinus syndrome. Another 2 patients developed late AV block, 
respectively 7 and 9 years after ablation, also requiring pacemaker therapy.
 Conclusion During long term follow-up after RF ablation for AVNRT, a significant 
number of patients (24%) suffered from new arrhythmias or late AV block. This study pro-
vides a new insight in the magnitude and importance of a possible proarrhythmic effect of 
RF energy, and supports the search and use of new energy sources. 
  Keywords: atrioventricular nodal reentrant tachycardia; radiofrequency;  
catheter ablation; proarrhythmia; long-term follow-up
 List of abbreviations:
AF atrial fibrillation
AFL atrial flutter
AT atrial tachycardia
AVNRT atrioventricular nodal reentrant tachycardia
PAC premature atrial contraction
PM pacemaker
RF radiofrequency
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 Introduction
Atrioventricular nodal reentrant tachycardia (AVNRT) is the most common regular small 
QRS-complex tachycardia. Nowadays, transvenous radiofrequency (RF) catheter ablation 
is the treatment of choice for treatment of patients with recurrent AVNRT and in most 
cases should be considered as first line therapy [¹,²]. Although it is accompanied by a high 
success rate and a low complication rate, RF is not the optimal energy source. Lesions 
created by hyperthermia cause some degree of tissue disruption or “carbonisation” of the 
targeted tissue that increases the risk for perforation and thromboembolism [³,⁴]. It is dif-
ficult to obtain stable lines of block, and it is neccessary to have reliable tissue contact. 
Furthermore, the inhomogeneous lesions, produced by RF, appear proarrhythmic [⁵]. 
 Until now no study has focussed on a possible long-term proarrhythmic effect of RF 
energy. This study can provide a deeper understanding of the magnitude and importance 
of this adverse effect and eventually will enhance the search and use of new energy sources 
for the treatment of both supraventricular and ventricular arrhythmias. 
 Hypothesis
It is postulated that RF catheter ablation is associated with new supraventricular arrhyth-
mias during long term follow up due to proarrhythmic effects of this therapy.
 Study Design
A retrospective, single centre study.
 Patients and Methods
Between 99 and 995, 20 patients underwent RF ablation/modification of the AV node 
for AVNRT in the Antonius Hospital Nieuwegein [⁶]. After an electrophysiological study 
was performed to confirm the diagnosis of AVNRT (TABLE ), a quadripolar Steerocath or 
Tracfinder catheter (EP Technologies) or a quadripolar 4 mm tip catheter (Cordis-Webster) 
with deflectable curves were used for ablation. Radiofrequency pulses of 7 to 50 Watt at a 
frequency of 500 kHz were delivered by a custom-made available electrosurgical device by 
delivering current between the distal electrode and a cutaneous, indifferent dispersive pad 
positioned on the patient’s back. A selective fast pathway, or selective slow pathway was 
carried out, using both intracardiac electrograms as anatomical landmarks. Which ap-
proach was used, depended on the operator’s own insight and experience. If the initial fast 
or a slow pathway ablation was not successful after more than an arbitrary number of 20 
applications, the other approach was applied during the same procedure. A fast pathway 
ablation was considered immediately successful when AVNRT was no longer inducible 
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or when a 30% prolongation of the PR interval or an inadvertent second- or complete AV 
block occurred. The end-point of a slow pathway ablation was non-inducibility of AVNRT 
with preserved AV nodal conduction. The slow pathway was considered to be ablated if 
dual pathway physiology was completely abolished, and was modified if the slow pathway 
conduction time was lengthened or echo beats were still inducible, but without sustained 
arrhythmia.  
 Patients follow-up
All the aboved mentioned patients were included in this long term follow-up study. If pos-
sible, all patients were contacted either by telephone or letter, and asked to answer to or 
fill out a questionnaire. Furthermore, all medical dossiers were screened for recurrent, 
documented arrhythmias, medical treatment, and/or repeated EP study. Referring cadi-
ologists were asked about recurrent, documented arrhythmias, and to send, if available, 
electrocardiograms of these arrhythmias.
TABLE 1. 
Demographic and electrophysiological data before ablation.
Preablation data Fast pathway Slow pathway Slow and fast 
pathway 
Number of patients (n) 40 47 33
Male/female (n) 12/28 12/35 10/23
Age (years) 45 ± 17.5 42 ± 15.5 44 ± 10.9
Duration of symptoms (years) ± SD 14.6 ± 12.0 12.9 ± 11.4 13.9 ± 10.8
Typical AVNRT (n) 38 41 32
Atypical AVNRT (n) 2 6 1
PR interval (ms) ± SD 154 ± 21.5 152 ± 30.4 151 ± 16.9
AH interval (ms) ± SD 73 ± 18.1 73 ± 26.9 70 ± 14.7
Jump in AH interval present (n) 17 (43%) 23 (49%) 16 (48%)
Jump in AH interval (ms) ± SD 122 ± 53.3 103 ± 61.1 98 ± 40.4
AVNRT cycle length (ms) ± SD 332 ± 49.8 326 ± 59.9 341 ± 75.2
Preexistent paroxysmal type 1 AFlut (n) 2 1 1
Preexistent ATach (n) 1
Preexistent AFib 2
AFib = atrial fibrillation; AFlut = atrial flutter; ATach = atrial tachycardia; n = number of patients; 
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 Statistical analysis
Data will be expressed as mean ± SD. Chi-square and Student’s t-test will be used for sta-
tistical comparison whenever appropriate. For censored data the log-rank test will be used. 
A two tailed p value < 0.05 will be considered significant.
 Results 
There were no significant differences in baseline characteristics between the various abla-
tion groups (TABLE ) Patients were divided into the fast pathway group after a selective 
fast pathway ablation, in the slow pathway group after a selective slow pathway ablation, 
and in the slow and fast pathway group after a slow and fast pathway approach during the 
same procedure. Two patients in the fast pathway group, and  patient in both the slow, 
and slow and fast pathway group were also suffering from type  atrial flutter (AFL). An-
other patient in the slow and fast pathway group had experienced paroxysms of an atrial 
tachycardia (AT), and in 2 patients in the slow pathway group, atrial fibrillation (AF) was 
registered before ablation.
 Of 9 patients in the fast pathway group, 8 patients in the slow pathway, and 2 patients 
in the slow and fast pathway group, an AH jump was still present during electrophysiologi-
cal study shortly after ablation, suggesting persisting slow pathway conduction (TABLE 2). 
However, in not all patients these data were available. The final success rates after  or 
more ablation procedures was 00 % in both groups with a selective fast or slow pathway 
ablation, and 9 % in the slow and fast pathway group, respectively (TABLE 3). 
TABLE 2. 
Electrophysiological data immediate after ablation
Postablation data Fast pathway Slow pathway Slow and Fast 
pathway 
Number of patients (n) 40 47 33
Initial succces (%) 90 98 82
Ablation time (min) 76 ± 47.6 44 ± 34.4 84 ± 47.2
Number of applications (n) ± SD 14 ± 17 13 ± 15 25 ± 28
PR interval (ms) ± SD 199 ± 49.0 158 ± 27.7 183 ± 41.8
AH interval (ms) ± SD 121 ± 43.6 79 ± 25.6 101 ± 48.9
Jump in AH interval present (n) 9 (23%) 8 (17%) 2 (6%)
Jump in AH interval (ms) ± SD 126 ± 60.4 103 ± 39.9 110 ± 56.6
VA block (n) 13 (33%) 5 (11%) 7 (21%)
N = number of patients; min = minutes; SD = standard deviation
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TABLE 3. 
Success rates of RF catheter ablation 
Fast pathway Slow pathway Slow and fast pathway
Number of patients (n) 40 47 33
Initial success (%) 90 98 82
Pts with recurrent AVNRT (n) 3 9 6
Final success after 1 or more 
repeated RF ablations (%) 100 100 91
n = number of patients
TABLE 4. 
Late clinical outcome after RF ablation for AtrioVentricular Nodal Reentrant 
Tachycardia (AVNRT) in the period 1991-1995
Follow-up data (120 pts) Fast pathway Slow pathway Slow and Fast pathway
Number of patients (n) 40 47 33
Follow-up < 3 years 6 4 4
Mean follow-up (years ± SD) 10.1 ± 3.3 9.3 ± 3 9 ± 2.9
Total number of pts with new 
arrhythmias:
10 14 5
Type 1 atrial flutter 4 1 1
Atrial tachycardia 3 1 2
Atrial fibrillation
Structural heart disease
3
0
5
2
1
0
Type 1 Aflut/AF
Structural heartdisease
3
0
0
0
1
0
Type 1 Aflut/AF/AT
Structrural heartdisease
1
0
0
0
1
0
Medical therapy for symptomatic 
PAC’s
5 7 4
Late AV block 1 1
Pacemaker therapy 4* 3° 2”
Death 2˘ 4ˆ 0
* pt procedural complete AV bock;  pt 0 years later for Sick Sinus Syndrome;  pt 5 years later His 
ablation and PM implantation
°2 pts procedural complete AV block ( after 4 ablations);  pt  year later His ablation and PM 
implantation
” pt procedural complete AV block
˘2 pts sudden cardiac death
ˆ pt myocardial infarction and cardiogenic shock;  pt lung cancer
AF = atrial fibrillation; AFlut = atrial flutter; AT = atrial tachycardia; n= number of patients; PAC = 
premature atrial contraction; SD = standard deviation
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The mean follow-up was 0. ± 3.3 years in the fast, 9.3 ± 3 in the slow, and 9 ± 2.9 in the 
slow and fast pathway group, which was comparable (TABLE 4). In 6 patients in the fast, 
4 in the slow, and 4 in the slow and fast pathway group the follow-up was less than 3 years, 
and were either lost to follow-up ( patients) or died (3 patients). In total 6 patients died, 
2 in the fast and 4 in the slow pathway group. Both patients in the fast pathway group 
died suddenly. In one of these 2 patients a wide QRS complex tachycardia was registered 
before ablation, but not inducible during the procedure, and was considered as aberrant 
conduction. The second patient suffered from acute myocarditis. One patient in the slow 
pathway group died of myocardial infarction with cardiogenic shock, and one patient of 
lung cancer. In the other 2 patients the cause of death remained unknown. Ten patients 
(25%) in the fast pathway group experienced new arrhythmias. In 4 patients a type  AFL 
was registered, in 3 an AT, and in 3 patients atrial fibrillation (AF), or a combination of 
these arrhythmias. Namely, of the 4 patients with type  AFl, 2 patients also experienced 
episodes of AF, and in  patient both AF and AT was registered besides AFL. In none of 
these patients structural heart disease was diagnosed. Five patients also had symptom-
atic premature atrial contractions (PAC’s), and needed drug therapy. In the slow pathway 
group 4 patients (30%) sufferered from new arrhythmias,  patient with type  AFL,  with 
AT, and 5 with AF, of which 2 had structural heart disease. Seven patients were medically 
treated for symptomatic PAC’s. In the slow and fast pathway group a total of 5 patients 
(5%) experienced new arrhythmias. Type  AFL was seen in  patient, AT in 2, and AF in . 
One patient had both AFL and AF, and another one AFL and AT. No patients were known 
for structural heart disease. Four patients had drug therapy for symptomatic PAC’s. As is 
shown in TABLE 5, there seems to be a tendency for the occurrence of arrhythmias if more 
RF energy was applied, although, as was valid for all 3 groups, the difference was not sta-
tistically significant between patients with or without new arrhythmias.
 In none of the patients with pre-existent type I AFL, AT, or AF a recurrent arrhythmia 
was registered after ablation.
 Two patients developed late AV block,  in the fast pathway, and  in the slow and fast 
pathway group, respectively 7 years after the last ablation at the age of 36 and 9 years after 
the last ablation at the age of 59 years. The patient in the fast pathway group had a transient 
complete AV block during her second procedure, lasting less than 0 seconds. In the other 
patient no transient second or complete procedural AV block was seen. Additionally, 7 
patients underwent pacemaker implantation, of which 4 had a second degree or complete 
AV block during the procedure. In 2 other patients with permanent AF, His-ablation and 
pacemaker implantation was carried out. Finally, in  patient with a sick sinus syndrome a 
pacemaker implantation was performed. 
050285 thesis Kimman bw.indb   87 12-08-2005   09:38:15
CHAPTER 5
[88]
 Discussion
 Treatment nowadays and in the past
In the past the first line treatment for symptomatic patients with recurrent AVNRT was 
drug therapy. If this was unsuccessful, surgical modification of the AV node was the only 
method to permanently eliminate AVNRT. Both cryosurgery and “skeletonization” re-
sulted in successful cure of the tachycardia with preservation of AV conduction [⁷,⁸]. Al-
though highly successful, it was a major intervention for a non life-treatening arrhythmia, 
which only could be performed in specialized centres by a few well trained cardiac sur-
geons. Long term proarrhythmic effects of surgery have been scarcely reported and were 
limited to recurrences of AVNRT, occurrence of other supraventricular tachycardias and 
the induction of non-sustained ventricular tachycardia with standard EP study, which is a 
non-specific finding in this patient population [⁹]. A case report documented spontaneous 
ventricular tachycardia and inducible type  AFL nine years after successful surgery for 
the Wolff-Parkinson-White syndrome, which was considered a remote, unwanted effect of 
arrhythmia surgery that can be applicable for other, non-pharmalogical interventions for 
arrhythmias [⁹,¹⁰]. 
 Nowadays RF catheter ablation has become the first line therapy for patients with re-
current AVNRT [¹,²]. It has proved to be highly successful and safe with a low recurrence 
TABLE 5. 
Differences in used ablation energy
 Fast pathway Slow pathway Slow and fast pathway
New 
arrhythmias
No new 
arrhythmias
New 
arrhythmias
No new 
arrhythmias
New 
arrhythmias
No new 
arrhythmias
Total number 
of patients with 
completed follow 
up (n)
10 24 13 30 5 24
Data available 9 22 12 29 5 24
Mean ablation 
energy (joule) 
± SD
17676 ± 
28041
10682 ± 
12242
26501 ± 
24696
13182 ± 
11622
18872 ± 
14810
26945 ± 
20185
Median ablation 
energy 7840 4575 25370 9260 20520 23480
n = number of patients; SD = standard deviation 
Student’s t-test new and no new arrhythmias:  
Fast pathway group:  P = 0.5
Slow pathway group: P = 0.1
Slow and fast pathway group: P = 0.3
Total group: P = 0.3 
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and complication rate, as was also seen in this patient population [⁶]. During long term 
follow up, sporadic recurrences of AVNRT were registered, even 3 years after the proce-
dure. These observations led to the conclusion that patients, who underwent a successful 
RF ablation for AVNRT, were definitively cured. However, until now no study has focussed 
on the very long term follow-up (>3 years) after RF ablation, and the occurrence of new 
(tachy)arrhythmias.
 New (tachy)arrhythmias and their mechanisms
In this study, 29 (24%) patients suffered from new (tachy)arrhythmias, most frequently 
symptomatic PAC’s, needing drug therapy. It is possible that these PAC’s were already 
existing prior to ablation, being a trigger for AVNRT to occur, and therefore patients were 
not aware of them before treatment. However, after successful ablation, patients became 
conscious of these PAC’s. Another possibility is that these PAC’s were the result of the le-
sions created by RF energy. 
 Previous studies have suggested a causal relationship between type  AFL and AVNRT, 
because of a possible shared pathway in the low right atrium [⁶,¹¹,¹²]. In this patient popula-
tion, 4 patients with preexisting type  AFL had no recurrence of either AVNRT or AFL 
after successful RF ablation of only the AV node, supporting the aforementioned hypoth-
esis. On the other hand, in 6 other patients type  AFL arose after successful ablation for 
AVNRT. It is known that successful cure of AVNRT can be achieved with discrete lesions 
that only modify, and not completely interrupt the zone of slow conduction in the low right 
atrium. Such lesions are not sufficient to cure type  AFL. The damage that is produced to 
this specific area, which instead of generating conduction block, may cause further slowing 
of conduction, can provide a substrate for type AFL to occur. However, 4 patients suffered 
from AFL after fast pathway ablation, which can not directly be explained by the aforemen-
tioned theory. The inter-patient difference in size of the critical area in the perinodal atrium 
to allow the initiation of AFL, or an abnormally located antegrade fast pathway, located in 
the posteroseptal region, which exists in about 3% of patients presenting with AVNRT, [¹³] 
can support the reason for this observation. Eight other patients developed AF, of which 2 
had either mitral valve disease or an enlarged atrium. In these cases it is more likely that 
AF is the result of an ongoing atrial disease rather than being procedure-related. The other 
6 patients were not known for structural heart disease at the time of the occurrence of AF. 
The mean age of these patients at the time of occurrence of AF was 60. ± 9.8 years. The 
prevalence of AF in this patient population during a 0 years follow-up is in agreement with 
the Framingham Heart Study, which showed a biennial prevalence of AF ranged from 6.2 
and 3.8 cases per 000 in men and women aged 55-64 years [¹⁴]. Interestingly, 4 (3 in the 
fast pathway group) patients also suffered from type  AFL. Atrial flutter in patients with 
untreated AF is quite common, with periodic transition from one arrhythmia to the other, 
suggesting a mechanistic and possible causative relationship between AFL and AF [¹⁵]. Six 
patients with AT after successful RF ablation did not show underlying heart disease. In 3 
of these patients a 2 leads surface ECG during tachycardia supported an origin from the 
AV node region. Therefore, it seemes likely that this arrhythmia is caused by unfavourable 
effects of RF energy on the atrial tissue in this area. 
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To support the hypothesis of a possible proarrhythmic effect of RF energy, table 5 showed 
that the more energy was used, the likelihood of developing new arrhythmias seemed to 
increase. A possible explanation for this observation could be that it is necessary to have 
sufficient damaged atrial tissue for a new atrial arrhythmia to occur. However, in the slow 
and fast pathway group this effect was not seen. Maybe this can partly be explained by the 
fact that only a few patients in this group developed a new (tachy)arrhythmia. Another rea-
son could be that both the slow and fast pathway region had been ablated, causing probably 
a more “homogeneous” damage to this region, making it less likely for a (micro)reentry 
arrhythmia to occur. On the other hand, it is known that RF lesions are characterized 
by intralesion hemorrhage and ragged edges less clearly demarcated from the underlying 
normal myocardium [5]. This can cause nonuniform anisotropy, which may be responsible 
for slow conduction and/or unidirectional block that allows (micro)reentry tachycardia to 
occur. In this context, the results shown in table 5, can also support the hypothesis that 
these characteristics of RF are causing new arrhythmias, and not the amount of applied 
RF energy. 
 Late complete AV block
In total 9 patients underwent a pacemaker implantation. Two of them developed late AV 
block, 7 years after fast pathway and 9 years after slow and fast pathway ablation, respec-
tively. It remains unclear if this can be the result of damage to the AV node region by the 
earlier RF ablation, although the occurrence of a late AV block at the early age of 36 years 
after fast pathway ablation is very suggestive for a causal relation.
 Limitations
The results of this study can be related to the technique used in this particular centre in 
the early years of RF therapy. Although, the technique has been refined, the amount of RF 
energy which is applied in this study is comparable with the amount of energy used in cur-
rent practice. This, together with the known characteristic of this energy source of creat-
ing, inhomogeneous lesions, the results in this study may also be valid today. It therefore 
would be interesting to study patients, ablated after 995 until now, to show if indeed the 
outcome will be comparable. In 4 patients (%) follow-up was less than 3 years, of which 
3 died in this period. These patients also could have suffered from both recurrent AVNRT 
and new arrhythmias. However, most recurrences as well as new arrhythmia emerged in 
the first 2 years after the procedure. Furthermore, it seems highly unlikely that these miss-
ing patients had been treated for recurrent tachycardia, without informing the interven-
tion centre. To support the theory of any proarhythmic effect of RF energy, all patients 
with new arrhythmias should undergo a repeated EP study, to map these new arrhythmias 
and compare this to the localisation of the earlier applications. Determining the exact 
localisation of an earlier ablation, however, is impossible. This observational study only 
can make it plausible that at least some new arrhythmias, as AT and AFL, are the result of 
a proarrhythmic effect of RF energy. Finally, as this is an observational study, a matched 
control study is missing.
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 Conclusion
Radiofrequency catheter ablation is highly successful for elimination of AVNRT with a low 
complication rate. Although, it is difficult to prove a direct relation, new supraventricular 
arrhythmias and late AV block, can be the result of the earlier RF ablation. These data pro-
vide a new insight on the magnitude and importance of a possible proarrhythmic effect of 
RF energy, and support research into and use of alternative energy sources. 
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 Abstract
 Transvenous Cryothermal Catheter Ablation In patients with Wolff-Parkinson-
White syndrome, right anteroseptal accessory pathways are uncommon and run from the 
atrium to the ventricle in close anatomic proximity to the normal AV conduction system. 
Radiofrequency catheter ablation is the first-line therapy for elimination of these accessory 
pathways. Although the initial success rate is high, there is a potential risk of inadver-
tent development of complete heart block, and the recurrence rate is relatively high. The 
capability of cryothermal energy to create reversible lesions (ice mapping) at less severe 
temperatures provides a potential benefit in ablation of pathways located in a complex 
anatomic area, such as the mid-septum and anteroseptum. 
  Keywords: arrhythmia, catheter ablation, cryosurgery,  
Wolff-Parkinson-White syndrome
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 Introduction
Catheter ablation currently is the first-choice therapy for paroxysmal supraventricular 
tachycardia, including that involving accessory AV pathways. “Septal” accessory pathways 
are the least common. Anteroseptal pathways account for 4% to 8% of all accessory bundles 
[¹-⁶]. Despite this low incidence, the close proximity to the AV node and His bundle poses 
an increased risk of right bundle branch block or inadvertent complete AV block during 
catheter ablation [¹-⁶]. This, together with a relatively high recurrence rate [¹-⁶], makes this 
site a challenge, as mechanical block also often occurs during procedures. Currently, radio-
frequency current is the main energy source for ablation. However, other methods are being 
investigated. A useful property of cryothermal energy is its ability to reversibly demonstrate 
loss of function of tissue with cooling (ice mapping) at less severe temperatures, thereby 
demonstrating the suitability of prospective ablation sites without inducing permanent 
injury [⁷-⁹]. Furthermore, once the catheter tip temperature is reduced to 0°C, progressive 
ice formation at the catheter tip causes adherence to the adjacent tissue (cryoadherence), 
thus allowing safe ablation during tachycardia without the risk of dislodgement after termi-
nation of the tachycardia [⁷-⁹]. These properties of cryothermal energy are potential assets 
for ablation of “delicate” accessory pathways. In this case report, transvenous cryothermal 
catheter ablation of a right anteroseptal accessory pathway is described.
 Case Report
A 6-year-old boy was referred because of recurrent shortlasting episodes of palpitations. 
Twelve-lead surface ECG showed a positive delta wave in leads I, II, aVL, and aVF, and 
biphasic in lead III, suggesting a right anteroseptal accessory pathway. The decision was 
made to perform an electrophysiologic study and to use cryothermal catheter ablation, 
because of the location of the accessory pathway with the risk of inadvertent complete 
heart block.
 Methods
A standard electrophysiologic study was performed with the patient in the sedated, posta-
bsorptive state. Sotalol therapy was discontinued for five drug half-lives. Two quadripolar 
catheters and one bipolar catheter were inserted via the right femoral vein and advanced 
to the high right atrium, Hisbundle position, and right ventricular apex. A decapolar cath-
eter was inserted in the coronary sinus via the left subclavian vein. An orthodromic circus 
movement tachycardia could easily be induced. The earliest retrograde atrial activation 
during both tachycardia and ventricular premature beats was seen in the His-bundle re-
gion. Single premature ventricular stimuli during tachycardia at the time the His bundle 
was refractory could reset retrograde atrial activation and tachycardia. This confirmed the 
presence of an accessory pathway, right anteroseptally. To allow more precise mapping, the 
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decapolar catheter was positioned over the His-bundle region. After the diagnostic study, 
the high right atrium catheter was replaced by a 7-French Freezor cryocatheter (Cryocath 
Technologies Inc., Kirkland, Quebec, Canada).
 Cryoablation System
The cryocatheter is a 7-French steerable catheter with four electrodes at its distal end: the 
distal cooling 4-mm tip electrode and three proximal ring electrodes. The catheter has a 
hollow shaft with a closed electrode tip into which the refrigerant fluid (nitrous oxide) is 
delivered under pressure from a control console. Within the tip, a phase change occurs 
(liquid to gas), and the resultant gas is removed under vacuum. This transformation causes 
cooling of the tip to temperatures as low as –70°C. The gas is conducted away from the tip 
through the vacuum return lumen and is collected in the console [⁷].
 Ice Mapping and Cryoablation
In this patient with manifest ventricular preexcitation during sinus rhythm, the site of earli-
est ventricular activation was identified. It was characterized by a short local AV interval, 
with local activation preceding the onset of the delta wave on the surface ECG. Slightly 
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anterosuperiorly from the His-bundle region, the earliest retrograde atrial activation was 
identified during orthodromic circus movement tachycardia and ventricular pacing. There 
was concordance with the earliest site of retrograde atrial activation and earliest site of 
ventricular activation. After identification of a first prospective ablation site, ice mapping 
was performed by cooling to –30°C for a maximum of 80 seconds. As the ice mapping had 
no effect, it was discontinued. At the second site investigated (FIGURE ), local activation 
preceded the onset of the delta wave by 43 msec. During ice mapping, there was a sudden 
loss of ventricular preexcitation with a clear His-bundle potential recorded on the cryoabla-
tion catheter after 30 seconds (FIGURE 2). Because of catheter adherence, incremental atrial 
pacing (with the distal electrode of the quadripolar catheter placed in the coronary sinus) 
and ventricular extrastimulus testing were performed, which showed preserved normal AV 
conduction and decremental concentric VA conduction, respectively. At this site of success-
ful ice mapping, cryoablation was performed by cooling to –70°C for a 4-minute period to 
create a permanent lesion. After cryothermy was terminated, the tissue rewarmed passively 
(FIGURE 3). Incremental atrial pacing and ventricular pacing as well as single atrial and 
ventricular extrastimuli were repeated to conclude a successful ablative procedure. During 
an intravenous bolus of adenosine 2 mg, complete AV block occurred. The patient was ob-
served in the electrophysiology laboratory for 30 minutes to ensure there was no recurrence 
of accessory pathway conduction. The next day, 2-lead ECG showed sinus rhythm with a PR 
interval of 60 msec, with no ventricular preexcitation or right bundle branch block. After 
3 months, the patient is free of palpitations, and 2 lead-ECG shows no delta waves.
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 Discussion
Pathways classified as anteroseptal have no septal connection at all, as they skirt along the 
central fibrous body of the right fibrous trigone, i.e., at the right anterior free wall [0].
These accessory pathways are in close proximity to the normal conduction system. Al-
though radiofrequency catheter ablation of these pathways has a high success rate, inad-
vertent complete heart block or right bundle branch block may occur. Also, a recurrence 
rate up to 5% and mechanical block have been reported [¹-⁶].
 Unlike radiofrequency ablation, cryothermal energy creates a lesion that initially is re-
versible. This so-called ice mapping allows demonstration of functionality of tissues before 
the formation of a permanent destructive lesion [⁷-⁹]. Furthermore, the formation of ice at 
the catheter tip causes adherence of the catheter to adjacent tissue (cryoadherence), allow-
ing atrial and ventricular pacing without dislodgment of the cryocatheter.These advan-
tages of cryothermal energy makes it a potential unique new technique to create lesions 
adjacent to sensitive structures such as the compact AV node. Results in this field with 
the earlier generation of catheters were promising, given that it was not possible to cool to 
temperatures <60° with the AZ-20 refrigerant fluid that was used for this trial [⁹].
 To the best of our knowledge, this is the first report of successful transvenous cryo-
catheter ablation of a right anteroseptal accessory pathway. It was demonstrated clearly 
that during ice mapping and cryoadherence, the delta wave disappeared with preserved 
normal AV conduction, despite the registration of a His-bundle potential from the abla-
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tion catheter after loss of preexcitation. Consequently, cryoablation could be performed 
without the risk of development of inadvertent complete heart block. 
 It remains to be determined whether cryoablation also will be successful in left-sided 
procedures, considering the warming effects in that region. The sensitivity of cryoablation 
to blood pool warming while delivering epicardial linear cryoablation lesions was previ-
ously demonstrated [¹¹].
 In conclusion, transvenous cryothermal catheter ablation seems to be an effective new 
technique with unique features as ice mapping and cryoadherence, which make it espe-
cially useful in ablation of “delicate” accessory pathways or the slow pathway in AV reen-
trant tachycardia.
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 Introduction
Approximately 30 % of all accessory pathways are located in the ‘septal’ area. As these 
pathways are in close proximity to the atrioventricular node, there is an increased risk of 
right bundle branch block or inadvertent complete AV block during catheter ablation [¹]. 
Lesions created by radiofrequency (RF) energy, inevitably involve some degree of tissue 
disruption, and are irreversible. 
 As cryothermy energy has the ability to reversibly demonstrate loss of function of tis-
sue with cooling (‘ice mapping’) at less negative temperatures, and progressive ice forma-
tion at the catheter tip causes adherence to the adjacent tissue, this ablation method po-
tentially has advantages over RF for safe ablation of septal accessory pathways [²-⁴]. In this 
retrospective study we compare transvenous RF with cryoablation in patients with septal 
accessory pathways. 
FIGURE . 
Right posteroseptal accessory pathway. The insert shows the curve of temperature versus time. 
Shown are leads I, aVF, V, His bundle electrogram (HBE), and signal from the ablation catheter. 
Appearance of right bundle branch block (arrow), without intermediate stage of normal ventricular 
activation, 26 seconds after ice-mapping is started, and a few seconds after –30° C was reached. 
Ablation is commanded at 36 seconds (which allowed 0 seconds of additional observation of the 
rhythm), with immediate lowering to –73°C for 4 minutes. 
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 Methods
Between January 2000 and October 200, fifteen patients were treated with RF, and the 
next consecutive 9 patients with cryoablation for septally located accessory pathways. The 
final classification of the accessory pathways was made according to the successful abla-
tion site on fluoroscopy.
 A standard EP study was performed and after confirmation of the presence of an acces-
sory pathway, a transvenous RF or cryoablation was carried out. 
 Mapping was performed beginning at the anteroseptal region at the His deflection 
down to the coronary os and further to the right posterior region. For both energy forms 
standard techniques were used to identify prospective ablation sites. For cryoenergy pro-
cedures, initially ice mapping was done by cooling to –30° C for a maximum of 80 seconds, 
using a 7F cryocatheter (Freezor, curve 3, Cryocath Technologies Inc). Because of the cath-
eter adherence, incremental atrial pacing and ventricular extrastimulus testing was used, 
to show preserved normal AV conduction and decremental concentric VA conduction, 
respectively. If there was a sudden loss of ventricular preexcitation, or sudden termina-
tion of the tachycardia, cryoablation was performed by cooling to –70° C for a 4 minutes 
period, to create a permanent lesion (FIGURE ). The pacing protocol as well as single atrial 
and ventricular extrastimuli were repeated to conclude a successful ablative procedure im-
mediately, and after a 30 minutes waiting period. Eight weeks after discharge, the patients 
were seen at the outpatient clinic. Continuous variables were expressed as means ± stan-
dard deviation. Non-parametric data were compared using a Mann-Whitney test. The 
level of significance was set at P < 0.05.
 Results
The localisations of accessory pathways in the RF and cryogroup were left posteroseptal in 
6 versus , right posteroseptal 7 versus 2, midseptal  versus 2, and anteroseptal  versus 2 
patients respectively. Success at the end of the procedure was achieved in 2 patients (80%) 
in the RF group, and in 6 (67%) in the cryogroup. One patient in the RF, and the remaining 
3 patients in the cryogroup had temporary success during and after several applications. 
The not successfully ablated pathways were located left () and right (2) posteroseptally 
in the RF group, and left posteroseptally (), right posteroseptally (), and midseptally () 
patient in the cryogroup. 
 In the RF group a median number of 9 (range: -34) applications were applied, versus 2 
(range: -2) in the cryogroup. Procedure and fluoroscopy times were comparable. In both 
groups  patient developed right bundle branch block. These blocks remained present after 
one day. It was incomplete for the cryothermy patient, and disappeared at the first ambula-
tory control after 6 weeks. One patient in the cryogroup had a temporary inadvertent com-
plete heart block, 30 seconds after icemapping. It resolved spontaneously, and was prob-
ably mechanically induced. One patient in the RF group had a cardiac tamponade, and 
needed pericardiac drainage. After successful procedures, no late recurrences were ob-
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served in the RF group. Six weeks after ablation, one patient in the cryogroup experienced 
recurrent palpitations, although no tachycardia was documented. She is asymptomatic on 
sotalol. In 2 out of 3 patients with a failed first ablation attempt in the RF group a success-
ful redo was performed. Redo with cryoenergy failed in two patients, and was successful in 
one. However, one of the two failing patients had intermittent preexcitation. No cross over 
from cryoablation to RF was performed to have a more reliable comparison between both 
techniques. If we include the redo procedures, RF was successful in all, versus 7/9 complete 
successes (78%) in the cryogroup, with one additional intermittent preexcitation. 
 Discussion
RF ablation of septally located accessory pathways is associated with a higher percent-
age of failures and recurrences in comparison with other localizations, and inadvertent 
complete heart block or new right bundle branch block may occur [¹]. The rationale for 
attempting cryoablation in these sites is double: enhancing safety with ice mapping of 
prospective ablation sites, and improving efficacy [²-⁴].
 This retrospective study compared RF with cryoablation for septally located accessory 
pathways. The primary, acute success rates are for both treatment modalities were compa-
rable. The median number of applications tended to be lower for cryo than for RF energy, 
and this might decrease tissue damage, which can be both harmful and proarrhythmo-
genic on the long term. The procedure and fluoroscopy times remained equal for both 
study groups, although in the cryogroup fluoroscopy time tended to be shorter, certainly 
when considering only successful procedures. This is an important asset, and could be due 
to the fact that continuous fluoroscopy is not necessary during cryoenergy application.
 After performing a redo with the same energy, 00% success was achieved with RF, 
and this was not reached with cryothermy, although the difference was not significant. 
The first explanation could that cryoablation was only carried out if ice mapping was suc-
cessful, that means, effective with preservation of normal AV conduction. This cautious 
approach leads to less applications [⁴]. It is possible that during ice mapping, intramural 
or more epicardially located accessory pathways were not reached at all, as the cooling 
was not deep enough to have any effect (while theoretically, it could have been the right 
spot). However, cooling to temperatures less than –30°C can create irreversible lesions, 
and therefore also inadvertent complete AV block [²,⁴].
 Secondly, lesions created by cryothermy are probably different in size and certainly 
in composition from lesions created by radiofrequency catheters. This could mean that a 
more precise mapping, or a larger catheter tip, or further cooling, is neccessary to achieve 
the same effect. Third, an important explanation for a failing attempt is inadequate map-
ping. As the same operators performed both RF and cryoablation an operator effect can be 
excluded. 
 Finally, as this is a new technique, a learning curve exists [⁵]. The cryocatheter is not yet 
as steerable as a conventional RF catheter, and this could have limited proper positioning 
of the cryoablation catheter, especially for left sided posteroseptal sites.
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This analysis certainly is facing several limitations, including its retrospective character 
and the small patient number. We could easily foresee a similar, prospective trial, but we 
realize that this study can not be repeated, as the environment in ablation is changing very 
fast. New mapping technologies have a serious impact on procedure duration and fluoros-
copy time. Future trials have to be done with such technology. Furthermore, the three (or 
four) different subgroups pose different specific problems, which can not be addressed in 
a small trial. 
 Conclusion
In conclusion, transvenous cryothermy catheter ablation seems to be an effective new 
technique with unique features as ice mapping and cryoadherence, making it especially 
useful in ablation of ‘delicate’ accessory pathways or slow pathways in atrioventricular 
nodal reentrant tachycardia.
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 To the Editor:
Recently, cryothermal energy can be used for transvenous catheter ablation. As cryother-
mal energy has the ability to reversibly demonstrate loss of function of tissue with cooling 
(ice mapping) at less negative temperatures (minus 30 degrees Celsius), and progressive ice 
formation at the catheter tip causes adherence to the adjacent tissue (cryoadherence) [¹-³], 
this energy form provides a potential benefit in ablation of “delicate” accessory pathways 
in close proximity to the AV node [⁴]. In a recent issue of the Journal, Idris et al. reported 
about a cryoablation of a right anteroseptal accessory pathway (AP) [⁵]. They described a 
slowly disappearance of  preexcitation after approximately 8 seconds of cooling down to 
–75 degrees Celsius. Their explanation was that the gradual buildup of the “iceball” coin-
cided with this gradual loss of preexcitation due to progressive slowing anterogradely over 
the AP prior to block. This finding led to the conclusion that in contrast to the sudden loss 
of preexcitation seen during radiofrequency ablation, cryoablation may be associated with 
gradual loss of preexcitation. 
 Despite this interesting observation made by the authors, a few issues should be men-
tioned. The authors did not reported if ice mapping at the successful ablation site was 
performed prior to cryoablation. It would be very interesting to know if also during ice 
mapping a gradually loss of preexcitation was recorded, after how many seconds this oc-
curred, and at which temperature. In this context also the time to reach minus 30 degrees 
Celsius should be mentioned, because that is indeed the moment the catheter adheres to 
the endocardial surface to produce a lesion (),although it is still unknown if this cooling 
is always deep enough to achieve maximal effect. If, in our experience, during ice map-
ping, the time to reach minus 30 degrees Celsius took longer than 40 seconds, a success-
ful cryoablation at this site was unlikely, even if preexcitation subsequently disappeared. 
Therefore, the role of the temperature-time constanceuring ice mapping seems important 
to predict a successful ablation site (Theuns et al., submitted to JCE [⁶]). An explanation for 
this observation is probably a poor wall contact of the ablation catheter, or an suboptimal 
(remote) ablation site. Also a gradually loss of preexcitation during cryoablation usually 
indicated an unsuccessful ablation, with a high incidence of gradually reappearance of 
preexcitation, sometimes more than 30 minutes after the application. The same effect can 
sometimes been seen after radiofrequency catheter ablation, especially in posteroseptal 
accessory pathways. Because the time to reach minus 75 degrees during cryoablation was 
almost always achieved within three seconds a gradual buildup of the “iceball” seems no 
to be the explanation of this phenomenon, rather a suboptimal target position, or intramu-
ral/ epicardially located accessory pathway. 
 Therefore, a successful ablation of an accessory pathway with cryothermal energy is 
characterize by a high temperature-time constant during ice mapping with sudden disap-
pearance of preexcitation. In this respect, there is no real difference with radiofrequency 
ablation. 
050285 thesis Kimman bw.indb   110 12-08-2005   09:38:41
LETTER TO THE EDITOR: A COOL ABLATION
[]
 References
[]  Dubuc M, Talajic M, Roy D, Thibault B, Leung KT, Friedman PL: Feasability of cardiac cryoabla-
tion using a transvenous steerable electrode catheter. J Interv Card Electrophysiol 998;2:285-292.
[2]  Dubuc M, Roy D, Thibault B, Ducharme A, Tardiff JC, Villemaire C, Leung TK, Talajic M: 
Transvenous catheter ice mapping and cryoablation of the atrioventricular node in dogs. PACE 
999;22:488-498.
[3]  Skanes AC, Dubuc M, Klein GJ, Thibault B, Krahn AD, Yee R, Roy D, Guerra P, Talajic M: Cryo-
thermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycar-
dia. Circulation 2000;02:2856-2860.
[4]  Kimman GP, Szili-Torok T, Theuns DAMJ, Jordaens LJ: Transvenous cryothermal catheter ab-
lation of a right anteroseptal accessory pathway. J Cardiovasc Electrophysiol, Vol.2, pp. 45-47, 
December 200.
[5]  Idris F, Green MS, Tang ASL, Lemery R: A Cool ablation. J Cardiovasc Electrophysiol, Vol. 3, p. 
299, March 2002.
[6]  Theuns DAMJ, Kimman GP, Szili-Torok T, Jordaens LJ: icemapping during cryothermal cathe-
ter ablation of accessory pathway and WPW: the role of the temperature-time constance. Submitted
050285 thesis Kimman bw.indb   111 12-08-2005   09:38:42
[2]
050285 thesis Kimman bw.indb   112 12-08-2005   09:38:43
9Ice mapping during cryothermal ablation of accessory pathways in WPW:  
the role of the temperature time constant
Dominic A.M.J. Theuns, Geert P. Kimman, Tamas Szili-Torok,
Jan C.J. Res, Luc J. Jordaens
Department of Clinical Electrophysiology, Erasmus Medical Centre, Rotterdam, 
The Netherlands
Europace 2004;6:6-22
[3]
050285 thesis Kimman bw.indb   113 12-08-2005   09:38:43
CHAPTER 9
[4]
 Abstract 
 Aim Cryothermal energy has the ability reversibly to demonstrate loss of function 
with cooling, ice mapping, at less deep temperatures. The purpose of this study was to 
investigate the time course of the temperature during ice mapping of accessory pathways.
 Methods and results Thirteen patients with the Wolff-Parkinson-White (WPW) 
syndrome underwent cryoablation. After identification of a prospective ablation site, ice 
mapping was performed by cooling the tip to a minimum of –30°C. Successful ice map-
ping was defined by loss of accessory pathway (AP) conduction. A total of 04 ice maps 
were analyzed. Successful ice mapping was demonstrated in 7 attempts. There was no 
significant difference in mapping temperature between successful and unsuccessful ice 
mapping (–29.4 ± 3.2° C vs –30.4 ± :7° C). The temperature time constant t during suc-
cessful ice mapping was significantly shorter compared with unsuccessful ice mapping (7.0 
± : s vs 0. ± :3 s; P <0.000). The response time (RT) to mapping temperature of -30 
(C was significantly prolonged in unsuccessful ice mapping attempts (35.8 ± 4:5 s vs 53.5 
± .0 s; P <0.000). Significant correlations were found between successful ice mapping 
and the temperature time constant, and between RT and the temperature time constant 
(P<0:00).
 Conclusion The ability to identify prospective ablation sites by ice mapping was dem-
onstrated. Successful ice mapping attempts were characterized by a short temperature 
time constant and a short response time to mapping temperature with a sudden disap-
pearance of pathway conduction.
 Keywords: ablation; accessory pathway; arrhythmia; mapping; cryothermal energy
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 Introduction
Radiofrequency (RF) catheter ablation is a very effective and well-recognized treatment 
for abnormal pathway conduction [¹,²]. However, RF energy has several limitations [³-⁵]. 
Success of RF application at a specific site cannot be predicted prior to energy delivery. Le-
sions created by RF energy, inevitably involve some tissue disruption which is irreversible. 
In contrast to RF energy, cryothermal energy has the ability to demonstrate reversible loss 
of function of tissue during progressive lowering of the temperature (ice mapping) [⁶-⁸]. 
Therefore, this property of cryothermy has the potential to predict a successful ablation 
site, without causing irreversible damage.
 The aim of the present study was to investigate whether the time course of temperature 
during ice mapping of the AP in patients with Wolff-Parkinson-White (WPW) syndrome 
would predict a successful outcome.
 Methods
 Study population
The study population consisted of 3 patients who were treated with cryothermal ablation 
of accessory pathways in the WPW syndrome, confirmed by 2-lead ECG and electro-
physiological study. Antiarrhythmic drug therapy was discontinued for a duration of 5 
half-lives prior to the study. All patients underwent a standard electrophysiological study 
in the sedated, postabsorptive state.
 Electrophysiological study 
Two quadripolar diagnostic catheters and one bipolar diagnostic catheter were inserted 
via the right femoral vein and advanced to the high right atrium, His bundle position, 
and the right ventricular apex under fluoroscopic control. A decapolar diagnostic catheter 
was positioned into the coronary sinus via the left subclavian vein. The earliest retrograde 
atrial activation during ventricular extrastimulus testing and tachycardia was registered 
to assess the location of the accessory pathway. The location of the accessory pathways was 
described using the new nomenclature [⁹]. In case of tachycardia, single ventricular pre-
mature stimuli were applied at the time the His bundle was refractory to reset retrograde 
atrial activation and tachycardia. This confirmed the involvement of an accessory pathway. 
After the diagnostic study, the high right atrial catheter was replaced with a 7F Freezor 
cryothermal ablation catheter (Cryocath Technologies Inc, Kirkland, Quebec, Canada). 
Right-sided accessory pathways were mapped and ablated using the cryothermal ablation 
catheter positioned from the inferior vena cava. In case of left-sided accessory pathways, 
mapping and ablation were performed using either the retrograde aortic approach or a 
transseptal approach as previously described [¹⁰].
050285 thesis Kimman bw.indb   115 12-08-2005   09:38:45
CHAPTER 9
[6]
 Cryoablation system
The cryothermal ablation catheter is a 7F steerable catheter with a 4-mm-tip electrode at 
its distal end and 3 proximal ring electrodes. Temperature is recorded at the distal tip by 
using an integrated thermocouple. A refrigerant fluid (nitrous oxide) is delivered under 
pressure through an inner lumen from the console into the hollow tip of the catheter. 
Within the tip, a liquid-to-gas phase change occurs which causes cooling of the tip to tem-
peratures as low as –70 °C. The resultant gas is removed from the tip under vacuum and is 
collected in the console.
 Ice mapping procedure
One of the potential advantages of cryothermal technology is the ability to demonstrate 
reversible loss of function of tissue with cooling which is called ‘‘ice mapping’’. Further, 
the progressive ice formation at the catheter tip during cooling causes adherence to the 
adjacent tissue (cryoadherence) which can prevent dislodgment of the catheter. In pa-
tients with manifest ventricular preexcitation during simus rhythm, the site of earliest 
ventricular activation was identified, characterized by a short local AV interval with lo-
cal ventricular activation preceding the onset of the delta wave on the surface ECG. The 
earliest retrograde atrial activation was identified during orthodromic circus movement 
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tachycardia and/or ventricular pacing. After identification of a prospective ablation site, 
ice mapping was performed by cooling to a minimum of –30 °C, for a maximum time of 80 
s. Successful ice mapping was defined if loss of accessory pathway conduction properties 
was demonstrated (FIGURE ). In case of successful ice mapping, cryoablation was im-
mediately carried out by cooling to –70 °C for a duration of 4 min, creating a permanent 
lesion. If ineffective results were obtained after 80 s, ice mapping was discontinued to al-
low rewarming of the catheter tip. The catheter was relocated to an adjacent site and ice 
mapping was repeated.
 During ablation, ventricular pacing was performed to confirm loss of accessory path-
way conduction. Ablation was defined as successful by atrial and ventricular incremen-
tal pacing and extrastimulus testing, if both antegrade and retrograde accessory pathway 
conductions were completely abolished.
 Data analysis
The entire dataset was reviewed from digitally stored files using time-logged parameters. 
Ice mapping sections were selected and submitted to detailed analysis of the time course 
of the temperature during ice mapping.
 To facilitate comparisons, the time course of the temperature was described in terms 
of an exponential function that was fitted to the data by using a non-linear-regression 
technique. The computation of best fit parameters was chosen to minimize the sum of the 
squared differences between the fitted function and the observed response.
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 Temperature
The mathematical model for the temperature response during ice mapping consisted of an 
exponential term (FIGURE 2). The exponential term began after a time delay
T(t) = T(b) – A (- e –(t-TD)/τ) where T(b) is the temperature baseline value, A is the asymp-
totic value for the exponential term, τ is the time constant, and TD is the time delay. The 
relevant amplitude of the exponential term was set to the value of the steady level of map-
ping temperature.
 The response time (RT) of temperature was calculated as the interval between the on-
set of ice mapping and onset of steady-state of mapping temperature.
 Flow and pressure
The flow and pressure response had a similar but not identical appearance to temperature. 
The monoexponential models were described as
Fl (t) = Fl (b) + A (- e –t/τ)
P (t) = P(b) + A (- e –t/τ)
where Fl(b) and P(b) are the baseline values of flow and pressure.
 Statistical analysis
Continuous variables are summarized as mean ± standard deviation. The level of signifi-
cance was set at P < 0:05. Non-parametric data were compared using Wilcoxon signed-
rank test. Correlations between continuous variables were assessed using the Pearson cor-
relation test. Binary logistic regression analysis was used to test the correlation between 
successful ice mapping, the different time constants and RT. Statistical analysis was made 
with SPSS (Statistical Package for Social Sciences, version 9.0) for Windows.
 Results
Thirteen patients (mean age 33 ± 4 years, 7 men) were treated with cryothermal abla-
tion for accessory pathway conduction (TABLE ). At baseline, ventricular preexcitation 
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with antegrade accessory pathway conduction was seen in all patients. Five patients had 
a left-sided AP and 8 patients had a right-sided AP. For the 5 left-sided APs, a transseptal 
approach was used in 4 patients and a retrograde approach in  patient.
 Ice mapping of accessory pathway
A total of 04 ice maps were analyzed. An average of 8 ice maps (range 2-9) per patient 
with a mean duration of 72 ± 4 s were attempted. Successful ice mapping of the accessory 
pathway was demonstrated in 7 maps at a tip temperature of –30 °C.
 There was no significant difference in mapping temperatures between successful ice 
mapping and unsuccessful ice mapping (–29.4 ± 3.2 °C vs –30.4 ± .7 °C). In  ice maps, a 
sudden loss of accessory pathway conduction was demonstrated. In the remaining 6 maps, 
a gradual disappearance of accessory pathway conduction was registered. No differences 
in electrogram characteristics were demonstrated in maps with sudden or gradual loss of 
accessory pathway conduction. The temperature time constant τ during all successful ice 
maps was significantly shorter compared with unsuccessful ice maps (7.0 ± : s vs 0. ± 
:3 s; P < 0.000). The RT to mapping temperature of –30 °C was significantly prolonged 
in unsuccessful ice mapping attempts compared with successful attempts (35.8 ± 4:5 s vs 
53.5 ± :0 s; P < 0.000). Subanalysis of the temperature time constant and RT between 
ice maps with sudden or gradual disappearance of accessory pathway conduction dem-
onstrated a significantly shorter time constant and RT in ice maps with sudden loss of 
pathway conduction (P < 0.0). In FIGURE 3, examples with a prolonged and a short tem-
perature time constant are displayed.
 Successful ice mapping was not significantly different between left-sided and right-
sided accessory pathways. The temperature time constant τ during successful ice map-
ping was not significantly different between left-sided and right-sided accessory pathways 
(7.4 ± 0.7 s vs 6.5 ±. s).
 The correlation between the temperature measurements is shown in TABLE 2. There 
were significant correlations between successful ice mapping and the temperature time 
constant as well as RT (P < 0.00). The correlation between RT and the temperature time 
constant was significant (r = 0.98; P < 0.00).
 There were no significant correlations between successful ice mapping and the flow 
time constant as well as the pressure time constant. The correlation between the flow time 
constant and the pressure time constant was significant (P < 0.00).
 The correlations between the temperature time constant and the pressure time con-
stant as well as the flow time constant were significant (P < 0.0).
 Cryothermal ablation
Success at the end of the procedure was achieved in 9 patients (69%). The not successfully 
ablated pathways were located right anterior (n = ), right inferoparaseptal (n = ), left 
inferoparaseptal (n = ) and left posterior (n = ). Patients with a successful cryoablation 
demonstrated during ice mapping a sudden disappearance of pathway conduction com-
pared with patients with an unsuccessful ablation. The time interval between the onset 
of ice mapping and the disappearance of accessory pathway conduction was significantly 
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shorter in successfully ablated pathways compared with unsuccessfully ablated pathways 
(2.8 ± 9.7 s vs 44.5 ± 0:7 s; P < 0.05). In 6 ice mapping attempts, the disappearance of ac-
cessory pathway conduction was gradual. In none of these sites could a successful cryoab-
lation be performed.
 Complications
Two patients developed right bundle branch block. This block remained present after  
day, but disappeared at the first follow-up after 6 weeks. One patient had temporary, inad-
vertent, complete heart block, 30 s after ice mapping. It resolved spontaneously and was 
probably a mechanically induced block.
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 Discussion
This report describes the first results of cryomapping during percutaneous catheter cryo-
thermal ablation of accessory pathways in WPW. The use of cryothermal energy for acces-
sory pathway ablation was initially described in cryosurgical reports [¹¹-¹³]. Cryothermal 
energy has several advantages over radiofrequency energy. In contrast to radiofrequency 
energy, cryothermy causes tissue destruction with preservation of the underlying tissue 
architecture which decreases the risk of thromboembolism and tissue perforation [⁴]. 
The potential benefit of cryothermal energy is the ability reversibly to demonstrate loss 
of electrophysiological properties of tissue before the creation of a permanent lesion [⁶,⁸]. 
Furthermore, the formation of ice during cooling causes adherence of the catheter to the 
adjacent tissue (cryoadherence) allowing atrial and ventricular pacing without catheter 
dislodgment.
 The results of this study confirm the concept of ice mapping. The use of cryothermal 
energy to demonstrate reversible loss of function has been described in the surgical litera-
ture [¹¹]. Differences in mapping temperature with reversible effect between surgical map-
ping and our mapping are explained by differences in the warming effect of the blood pool 
circulating around the catheter tip. In this study, a minimum temperature of –29.4 °C ± 3:2 
°C was reached during ice mapping. This mapping temperature is in agreement with ex-
perimental animal data on ice mapping of the atrioventricular node which demonstrated 
only irreversible lesions created by cooling to temperatures lower than –30 °C [⁶,¹⁴].
 The course of the temperature during ice mapping can be described by the tempera-
ture time constant. The time constant is reflected in the time interval between the onset 
of ice mapping and the steady-state mapping temperature of –30 °C. In this study, sudden 
disappearance of accessory pathway conduction was demonstrated during ice mapping 
attempts with a short temperature time constant. The response time to steady-state map-
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ping temperature of –30 °C in those attempts was less than 40 s. The temperature time 
constant is dependent on several factors.
 First, the efficiency of cooling during cryothermal energy delivery can be affected by 
poor electrode contact with the endocardium. A significant ‘‘thermal sink’’ can be created 
when a major part of the electrode is in contact with the bloodstream. This warming ef-
fect will result in a prolonged response time to reach the mapping temperature. A loss of 
freezing power was not reflected in the flow time constant and the pressure time constant, 
although significant correlations between the temperature time constant and the pres-
sure time constant as well as the flow time constant were found. This means that a higher 
pressure to maintain delivery of the refrigerant fluid is necessary to reach the mapping 
temperature when electrode contact with endocardium is poor. Secondly, the warming 
effects of the blood pool in regions with a high blood flow can have effects on the outcome 
[4]. However, our results did not demonstrate a difference in temperature time constant 
between left- and right-sided located accessory pathways. The temperature time constant 
is an indication of the electrode contact with the endocardium. This time constant is re-
flected in the response time to steady-state mapping temperature of –30 °C. During this 
time interval, the electrophysiological properties of accessory pathway conduction can be 
modified.
 In our study, there was a significant difference in time intervals with respect to the dis-
appearance of accessory pathway conduction. In successfully ablated patients, the disap-
pearance of pathway conduction conduction during ice mapping was sudden. This obser-
vation is in agreement with the sudden loss of preexcitation as seen during radiofrequency 
ablation. In the unsuccessfully ablated pathways, there was a gradual loss of preexcitation 
during mapping. This observation was not related to mapping temperature. Possible ex-
planations for this observation are a suboptimal (remote) ablation site or intramurally/epi-
cardially located pathways. Some data suggest that the volume of the lesion is smaller with 
cryothermy compared with radiofrequency energy [¹⁵]. Other data suggested a comparable 
size for both energy forms [6], but the lesion size will be clearly dependent on the catheter 
tip.
 From results in previous studies and the data in our study, the following characteristics 
of the temperature curve during ice mapping can be described. First, the temperature time 
constant is an indication for the electrode contact with the endocardium. The temperature 
time constant is reflected in the response time to steady-state mapping temperature of –30 
°C. Good electrode contact with the endocardium is indicated by a short response time to 
steady-state mapping temperature. Arbitrarily, a cut-off value of 40 s as maximum for the 
response time was chosen, which was based on observations during our study. The second 
point is that during this interval of 40 s, the electrophysiological properties of the acces-
sory pathway conduction have to be modified. A sudden modification of the electrophysi-
ological properties within this interval is an indication of being at the right prospective 
ablation site.
 Therefore, successful cryoablation could be predicted by both a short temperature time 
constant and a short response time to mapping temperature combined with a sudden loss 
of accessory pathway conduction.
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 Study limitations
The number of mapping attempts per patient varied considerably and also reflected our 
learning curve. The results are likely to improve as the experience with this novel tech-
nique increases. Repeated ice mapping, with different time constants at the same spot 
should be performed to prove our point. However, fluoroscopic visualization of the cath-
eter tip has several limitations. With better imaging techniques, a series of ice mapping 
attempts at the same spot could be performed to determine the temperature time constant 
during these attempts and to analyze the concept of ice mapping in a different way. 
 Conclusion
Ice mapping allows accurate localization of accessory pathways before creating a perma-
nent lesion. This technique provides a potential benefit in the ablation of ‘‘delicate’’ ac-
cessory pathways in close proximity of the AV node. The time course of the temperature 
during ice mapping can be used clinically to predict a successful ablation site. Therefore, 
successful ablation of an accessory pathway with cryothermal energy is characterized by 
reaching the mapping temperature of –30 °C within 40 s combined with sudden disap-
pearance of pathway conduction.
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 Case presentation:
A 62-year old man developed syncope during bicycle training. At arrival of the ambulance 
his rhythm was ventricular fibrillation which was terminated by 360J DC shocks. He had 
no history of any significant cardiac or non-cardiac disease and did not take any medi-
cation. Echocardiography showed a slightly diminished left ventricular function with an 
estimated left ventricular ejection fraction of 45%. During exercise testing sustained fast 
monomorphic ventricular tachycardia (VT) started and terminated spontaneously. Dur-
ing electrophysiology (EP) testing a fast monomorphic VT, cycle length (CL) 202 ms, was 
easily and reproducibly induced with programmed ventricular stimulation. Its morpholo-
gy was identical to the one observed during exercise testing. Besides the VT, a regular nar-
row complex tachycardia was easily and repeatedly induced with ventricular programmed 
stimulation during electrophysiological testing (FIGURE ). The patient recognized this 
tachycardia as the source of palpitations during exercise training for at least two decades. 
Programmed atrial stimulation revealed more than one sudden AH “jump” (>50 ms) with 
echo cycles. Intravenous administration of 2 mg adenosine resulted in VA dissociation 
during ventricular pacing at a CL 500 ms. Retrograde conduction was midline and decre-
mental during programmed ventricular stimulation. The above mentioned findings sup-
ported the diagnosis of AV nodal reentrant tachycardia (AVNRT). Several additional find-
ings were noted. Without obvious alteration of CL, there was a significant change in the 
retrograde as well as in the anterograde activation times. The earliest retrograde activation 
was observed in the posteroseptal region. This phenomenon was associated with a notice-
able alteration on the surface ECG. When the retrograde activation was faster there was no 
observable retrograde P-wave on the surface ECG. The longer retrograde activation time 
was associated with a negative deflection at the end of the QRS in leads II, III and aVF. The 
initial decrease in retrograde activation time was always followed by an increased antero-
FIGURE 
Alternation of anterograde and retrograde conduction times during slow-fast AV nodal tachycardia, 
associated with changes on the surface ECG (explanation in text).
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grade activation time (FIGURE ). The slow-fast AVNRT merged into an atrial tachycardia 
with slower rate (FIGURE 2). Furthermore, atrial flutter and atrial fibrillation with fast ven-
tricular response could be easily and repeatedly induced as well.
 Questions: What is the mechanism of the alternation of anterograde and retrograde 
times during AVNRT? 
 Commentary:
When a PAC initiates typical AVNRT, the fast pathway is refractory and anterograde con-
duction occurs over the slow pathway allowing reentry. Alternating CL during AVNRT is 
usually an indication of multiple slow AV nodal pathways [¹]. In the present case, alterna-
tion of the RR intervals could not be seen because the compensatory changes in antero-
grade and retrograde activation times. In the present case there was an initial change in 
the AA interval before the HH interval. Thus the HA actually shortens before the AH 
prolongs substantively. This suggests the presence of multiple fast/retrograde AV nodal 
pathways. The corresponding change in the anterograde conduction can theoretically be 
a result of a rate dependent delay due to prematurity of the retrograde impulse. Another 
possible explanation is the presence of a second anterograde pathway as suggested by the 
basic EP study. In this case the faster retrograde conduction may “switch” the anterograde 
conduction over the other slow pathway having different conduction properties (conduct-
ing slower and having shorter refractory period). 
In order to cure AV nodal tachycardia and to prevent fast AV nodal conduction in the event 
of other atrial arrhythmias we elected to ablate the fast pathway, using cryothermy. By 
FIGURE 2
Termination of the AVNRT with simultaneous induction of an atrial tachycardia.
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using ice-mapping, safe ablation of pathways at locations associated with high incidence of 
inadvertent AV block can be performed [²,³]. After cryo-ablation the PR interval remained 
prolonged and the tachycardia was no longer inducible. A dual chamber implantable car-
dioverter defibrillator was then implanted, allowing optimization of the AV delay. 
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 Abstract
 Background. Transvenous catheter ablation of atrioventricular nodal re-entrant 
tachycardia (AVNRT) with radiofrequency (RF) is effective and safe, but carries a -3% 
incidence of early and potentially late heart block. Cryothermy can create transient effects, 
and identify potentially successful ablation sites and decrease the risk for permanent heart 
block.
 Methods. In this prospective, randomized trial 02 patients with recurrent narrow 
QRS-complex tachycardia suggestive of AVNRT were randomized to either RF or cryo-
ablation before a diagnostic study .
 Results. In 63 patients with AVNRT, 33 were randomized to RF and 30 to cryoablation. 
Procedural success was achieved respectively in 30 (9%) patients in the RF and 28 (93%) in 
the cryoablation group. The median number of cryothermal applications was significantly 
lower than the number of RF applications (2 versus 7, p < 0.005). No accelerated junctional 
rhythm was seen with cryothermy, while it was present in 3/33 RF patients. Both fluoros-
copy and procedural times were comparable. The radiological position of the successful 
site in relation to anatomical landmarks was slightly different (p<0.05). No cryothermy 
related complications were observed, and no permanent AV conduction disturbances oc-
curred. During a mean follow up of 3±7 months long-term clinical success was seen in 
one additional patient in each group. In the same period, 3 patients in both groups experi-
enced recurrent AVNRT.
 Conclusion. Cryoablation is as effective and safe as RF for AVNRT. Significantly few-
er applications are necessary, with comparable procedure times. This makes cryothermy 
useful for the treatment of tachyarrhythmias near the compact AV node.
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 Introduction
Catheter-based radiofrequency (RF) energy has become the preferred modality for tachyar-
rhythmia ablation and has proven to be highly effective in the treatment of atrioventricular 
nodal re-entrant tachycardias (AVNRT), accessory pathway tachycardias, atrial flutter, fo-
cal atrial fibrillation, and ventricular tachycardias. However, lesions created by RF energy 
inevitably involve some degree of tissue disruption, are irreversible and thrombogenic [¹-³]. 
During ablation of the slow pathway in AVNRT, and of (para)septally located accessory 
pathways, there is an increased risk of right bundle branch block or inadvertent complete 
AV-block, as these pathways run in close proximity to the atrioventricular node [⁴-¹⁰]. Ap-
plications should be delivered during sinus rhythm and not during tachycardia, because of 
the risk of catheter dislodgement at termination of the tachycardia.
 Because freezing (cryothermy) has the ability to reversibly demonstrate loss of function 
of tissue with cooling at less negative temperatures (ice mapping), and because progres-
sive ice formation at the catheter tip causes adherence to the adjacent tissue, this ablation 
method potentially has advantages over RF ablation for safe ablation, even during tachy-
cardia [¹¹]. Therefore, cryothermy could be especially useful in AVNRT and (para)septally 
located accessory pathways, to reduce the risk of inadvertent right bundle branch block, or 
complete AV-block [¹²-¹⁴]. The purpose of this prospective, randomized, single centre study 
was to compare cryothermal and RF ablation in AVNRT. We hypothesized that cryoabla-
tion is as effective as RF, that it is a safe method, and in comparison with RF ablation less 
applications will be necessary, with no occurrence of complete AV-block or thrombo-em-
bolic complications.
 Methods
Consecutive patients with recurrent narrow QRS-complex tachycardia, suggestive for 
AVNRT were enrolled. All patients signed informed consent and were randomized by an 
independent institution (Cardialysis) to either cryothermal or RF ablation before the base-
line electrophysiological study. All antiarrhythmic drugs were discontinued for a duration 
of 5 half-lives. A standard electrophysiological study was performed. One bipolar catheter 
and two quadripolar catheters were inserted into the right femoral vein and advanced 
to the high right atrium, His bundle position, and right ventricular apex, respectively. A 
decapolar catheter was positioned in the coronary sinus via the left subclavian vein. A 
detailed measurement of the AV junction in relation to radiological hallmarks was made 
on the CAAS II system (delineation of the His bundle, and its relation and distance to the 
os of the coronary sinus). Images of this position were stored in three radiological views: 
anteroposterior (AP), right anterior oblique (RAO 30), left anterior oblique (LAO 30). In-
cremental atrial and ventricular pacing and extra stimulus testing were performed, with 
determination of the anterograde and retrograde effective refractory periods (ERP) of the 
AV node, as well as the Wenckebach point, and the stable 2: AV-block interval. Diagnosis 
of dual AV nodal pathways (AH-jump) and AVNRT was made on the basis of standard 
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diagnostic criteria. If sustained tachycardia could not be induced, isoproterenol and even-
tually atropine were infused to facilitate tachycardia.
 Ablation
The target in both ablation techniques was slow pathway ablation guided by a combination 
of intracardiac electrogram criteria and anatomical landmarks [¹⁵].
 Catheter positioning and handling was performed during continuous fluoroscopy. The 
target position was labelled in the 3 mentioned radiological planes, with the His bundle 
and coronary sinus catheter as references. The endpoint was non-inducibility of AVNRT.
For RF ablation, a 7Fr 40-60 mm curve, 4 mm tip catheter (Conductr, Medtronic, Minne-
apolis, USA) was used with a conventional electrosurgical generator (Atakr II, Medtronic, 
Minneapolis, USA) as a source of radiofrequency energy. Each application was started 
with power set at 0 W; if AV conduction was preserved, the power was increased up to 40 
W until a maximum of 65°C was reached. Fluoroscopy was used throughout each applica-
tion. For cryoablation, a 7 Fr 53 mm curve, 4 mm tip catheter (Freezor 3, Cryocath Tech-
nologies, Montréal, Canada) was used, and a CCT2 CryoConsole (Cryocath Technologies, 
Montréal, Canada). Initially, ice mapping was performed by cooling to minus 30° C for a 
maximum of 60 seconds. Fluoroscopy was applied until a stable temperature of minus 30° 
C was reached. During these 60 seconds, atrial extra stimulus testing was performed. Dis-
appearance of an AH-jump, termination or non-inducibility of AVNRT was considered to 
be an identification of a potentially successful ablation site, and ablation was subsequently 
performed by cooling to minus 75° C for a 4 minutes period to create a permanent lesion 
(FIGURE ). If there was no clear AH-jump, and AVNRT was difficult to induce at baseline, 
prolongation of the anterograde AV refractory period during atrial extra stimulus testing 
during ice mapping was used to identify a target site.
 In both the cryothermy and RF group, inducibilty of AVNRT was tested after each ap-
plication, and if non-inducible, repeated after a 30-minute waiting period. Conduction and 
ERP-intervals were measured again. Procedure time was measured from the moment of 
arrival of the patient at the EP lab until the end of the treatment, including the 30 minutes 
waiting period.
 Follow-up
After ablation, all patients received an event recorder for 3 months to transmit an ECG 
during symptoms and were seen at the out patient clinic. One year after the procedure all 
patients were approached by telephone and asked about recurrent palpitations.
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 Statistical analysis
Continuous variables were expressed as mean ± standard deviation. Non-parametric data 
were compared using the Mann-Whitney U test. The level of significance was set at P < 
0.05.
Figure 1
FIGURE .
Programmed electrical stimulation in the high right atrium (HRA) 
at baseline (A) and after ice mapping was started (B and C). In 
A, conduction of the extra stimulus A2 is conducted over the slow 
pathway (A2H2 interval 360 ms). When ice mapping is started A2H2 
is conducting over a faster path, 240 ms in B, and AV conduction is 
blocked in panel C. This sign that the fast pathway is preserved can be 
used to start ablation
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 Results
A total of 02 patients were enrolled in this study. After baseline study, AVNRT was di-
agnosed in 63 patients (FIGURE 2). Of the remaining 39 patients, 2 had a (para)septally 
located accessory pathway, and 3 patients suffered from other circus movement tachy-
cardias. Atrial flutter was the target arrhythmia in 3 patients; in another 3 patients it was 
a focal atrial tachycardia, and in 8 patients arrhythmias were non-inducible. Of the 63 
patients with AVNRT, 33 were randomized to RF and 30 to cryoablation before baseline 
EP study (TABLE ). There were 0 men and 23 women in the RF group with a mean age 
of 44 years. The cryothermy group consisted of 4 men and 6 women with a mean age of 
52 years. Successful ablation was achieved in 30 (9%) patients in the RF and 28 (93%) in 
the cryothermy group, respectively (TABLE ). The median number of ice maps (applica-
tions until –30°C) was 5. The median number of applications in the cryothermy group 
was significantly lower than in the RF group, namely 2 versus 7 (p < 0.005). The median 
fluoroscopy time was 35.2 minutes in RF and 29.2 minutes in the cryothermy group and 
were not significantly different. The procedure times were also comparable with both 
techniques, namely 44 minutes in the RF and 42.5 minutes in the cryothermy group. 
Furthermore, there were no differences in electrophysiological characteristics before and 
after the procedure in both groups (TABLE 2). One patient in the RF group had a pericar-
dial effusion (due to the right ventricular lead positioning), which resolved after drainage. 
No other procedural complications were seen. In one patient in the RF group a temporary 
PR prolongation was registered for the duration of a few beats. In the cryothermy group, 
2 patients had temporary complete AV-block, lasting 0 and 3.4 seconds, while this was 
FIGURE 2.
Diagnosis after baseline electrophysiological study in patients 
included in the trial and in whom the arrhythmia was located in 
Koch’s triangle. Atrioventricular nodal re-entrant tachycardia 
(AVNRT), right posteroseptal pathways (RPS); right midseptal and 
anteroseptal pathways (RMS / RAS). Other: focal tachycardia.
AVNRT
RPS
RMS / RAS
Other
%5%
9%
85%
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not observed during cryomapping (FIGURE 3). Transient AV-block was observed during 
icemapping in 2 patients, and 2: block in one during mapping while in AVNRT. No per-
manent AV conduction disturbances were seen. During RF applications, a fast junctional 
rhythm was observed in all but 2 patients in the successful application; it was never seen 
during cryothermy. The radiological position of the ablation tip at the successful site was 
different between both approaches in the RAO 30° angle. The median distance in systole 
between ablation tip and the vertical perpendicular line from the His bundle distal tip 
TABLE .
Result of radiofrequency (RF) and cryoablation in AVNRT
TABLE 2.
Conduction intervals and refractory periods before and after ablation
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FIGURE 3. 
Onset of temporary complete AV block with cryoablation (leads I, aVF, V, HRA, proximal CS, His 
and ablation signal). During ice mapping (–30°) AVNRT could no longer be induced and normal AV 
conduction was present. However, after 7 seconds of cryoablation (-80°) heart block was seen. Freezing 
was discontinued. This temporary AV block lasted for 7 seconds. Inserted is the temperature-time 
curve of the cryoconsole, and the position of the ablation and his catheter in anteroposterior view. The 
arrow points to the moment that the block starts.
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electrode was 2.7 mm for RF and 4.5 mm for cryothermy (p<0.05). The distance with the 
coronary sinus os in horizontal axis also showed a similar difference (p<0.05). During a 
mean follow-up of 2.9 ± 6.3 months in the RF and .7± 7.0 in the cryothermy group, long-
term clinical success was seen in 2 patients (one in each group) after a failed procedure 
(TABLE 3). In the same period 3 patients in each group experienced recurrent AVNRT. One 
patient of the RF group had recurrent palpitations due to atrial fibrillation.
 Discussion
AVNRT is the most common regular narrow QRS complex tachycardia in humans. Nowa-
days, RF catheter ablation is the treatment of choice in patients with recurrent episodes 
of AVNRT. Although RF ablation is highly successful, the success rate is not 00% and a 
risk of an inadvertent RBBB or complete AV-block still exists [⁴-¹⁰]. Because cryothermal 
energy has the ability to create temporary lesions (ice mapping), prospective ablation sites 
can be investigated, before a definitive, and irreversible lesion is created [¹¹-¹⁴]. Theoreti-
cally, this should lead to less applications and abolish the risk for permanent conduction 
disturbances. On the other hand, it still remains to be proven that cryothermy is as effec-
tive as RF both during the procedure and in long-term follow-up. In this study, the acute 
success rate of both cryoablation and RF ablation was comparable. There was no differ-
ence in the median number of ice maps in the cryothermy group in comparison with the 
number of applications in the RF group. However, the number of real applications in the 
cryothermy group was significantly lower than the number of applications in the RF group. 
This can be explained by the characteristics of cryoenergy. Ice mapping provides a tool to 
investigate prospective ablation sites. In both techniques these sites are initially chosen by 
the same kind of intracardiac electrograms and anatomical landmarks. However, if dur-
ing ice mapping, AVNRT is still inducible and/or an AH jump is stil present, ice mapping 
TABLE 2.
Follow-up of patients treated with radiofrequency (RF) or cryoablation in AVNRT
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is terminated and no ablation will be carried out. So, no irreversible lesions are created. 
On the contrary, with RF, ablation is immediately performed on the grounds of the same 
markers, almost immediately causing irreversible tissue damage. This more precise deliv-
ery of therapy with cryothermy results in less tissue damage (less applications), together 
with the formation of homogenous fibrosis with a well demarcated border [¹⁶]. This makes 
cryothermy, in contrast to RF, potentially less proarrhythmic. Earlier studies with RF in 
AVNRT suggested at least a relationship with the late occurrence of atrial flutter [¹⁵,¹⁷-¹⁸]. 
No persisting conduction disturbances were observed in either group, and no thrombo-
embolic complications occurred. During long-term follow up a comparable number of pa-
tients in both groups had recurrent AVNRT.
 Observations with cryothermy
At this time the cryocatheter is not as manoeuvrable as a conventional RF catheter, and 
this could limit the proper positioning of the cryoablation catheter. A question that still 
remains is whether cooling to minus 30 degrees always implies that the observed effect 
is maximal. In other words, is it possible that this is not cold enough to cause an effect, 
while theoretically it could be the right spot? Indirect evidence is the observation that 
while complete AV-block was observed in one case a few seconds after cryoablation was 
started, this conduction delay was not present during ice mapping. Full recovery of AV 
conduction occurred within a few seconds of termination of cryoablation. This is in-line 
with an observation that most conduction damage recovers very quickly after freezing 
[²⁰]. Furthermore, during an earlier study with cryoablation, we observed that, especially 
in left posteroseptally located accessory pathways, ice mapping did not always interrupt 
or modify pre-excitation, while cryoablation at the same spot could still be successful [¹⁴]. 
An explanation for this observation could be a deeper or even epicardially located acces-
sory pathway. On the other hand, as tissue temperature rises away from the centre, tissue 
effects that occur late during a cryo-application are expected to be reversible. This could 
mean that more precise mapping is necessary, or that delivery of more energy, e.g. with 
larger tips, is necessary. At this moment no definitive conclusion can be made, and more 
experimental studies are needed to provide an answer to these observations. The fact that 
we did find a slight radiological difference underscores the importance of cryomapping.
 Fluoroscopy
Finally, because of cryoadherence of the cryocatheter, an important asset could be a dimin-
ished fluoroscopy time. In this study there was only a tendency in favour of cryothermy. 
The relatively long fluoroscopy time can be explained by the fact that ablation was carried 
out in the “old fashioned” way by continuous fluoroscopy, and not directed by a naviga-
tion system, such as LocaLisa [²¹]. Furthermore, catheter handling during ablation was 
mostly done by less experienced physicians, with the senior electrophysiologist operating 
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the EP lab. Indeed, a learning curve was seen, as fluoroscopy time was decreasing during 
the course of the study.
 Conclusion
This study showed that, in AVNRT, cryothermy is as effective and safe as RF – both acutely 
and chronically. Procedures are comparable in length, and results remain similar during 
long-term follow-up. No persisting conduction disturbances or thromboembolic compli-
cations occurred. The lower number of applications also makes it attractive for other sites 
in the heart, as less collateral damage will occur. It is the only method potentially targeting 
the slow pathway on an electrophysiological basis, offering a way to avoid the fast pathway. 
The fact that no accelerated junctional rhythm is seen with cryothermy is another argu-
ment to believe that this energy form is safer [²²]. There is a potential for cryothermy to 
replace RF, or to be used as an alternative for ablation of (para)septal circus movement 
tachycardia and also for pulmonary vein isolation, to create lesions that are deeper and 
transmural, without the danger of creating pulmonary vein stenosis [²³]. With the revers-
ibility, it is an excellent teaching tool.
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 Abstract
 Background To rely solely on clinical symptoms of recurrent palpitations to evaluate 
the success of interventional procedures can be misleading. This study was designed to 
assess the efficacy of event recording in evaluating long-term success in patients treated 
for atrioventricular nodal reentrant tachycardia (AVNRT) or right posteroseptally located 
accessory pathways (RPS) either by radiofrequency (RF) or cryoablation (CA). 
 Methods Sixty-three patients with AVNRT and 8 with a RPS were randomized. Pa-
tients were encouraged to activate an event recorder in case of recurrent palpitations for 
the first three months. One year after the procedure patients were asked specific arrhyth-
mia related questions. 
 Results Thirty-six patients underwent RF and 35 CA. Acute success was finally 
achieved in 34 (94%) patients in the RF and 33 (94%) in the CA group. Assessment of long-
term success demonstrated a similar proportion of palpitations in the RF and CA groups: 
 (3%) versus 7 (49%). Only twelve patients activated the event recorder, 4 patients in 
RF, including one patient with chest pain, and 8 in the CA group. Analysis of recordings 
revealed recurrent AVNRT or CMT in 4 patients ( RF and 3 CA), atrial fibrillation in  
RF patient, and sinus tachycardia in 6 ( RF and 5 with CA). Additionally, a complete 2 
lead ECG of a recurrent arrhythmia was made in 3 RF and 2 CA patients (in hospital, or 
after the event recording). A total of 7 patients underwent a second procedure (4 RF, 3 
CA). Without the event recorder 7 patients would have been misclassified for recurrent 
arrhythmia. 
 Conclusion Event recording enhances the sensitivity of detecting arrhythmia recur-
rences in evaluating therapy efficacy, and should be considered in every interventional fol-
low-up study. Analysis of recordings showed that cryoablation is as effective as RF in the 
treatment of AVNRT and RPS at long-term follow-up.
  Keywords: atrioventricular repentant tachycardia; accessory pathway; 
radiofrequency catheter ablation; cryoablation; event recording; long-term follow-up
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 Introduction
Radiofrequency (RF) catheter ablation has become the first line therapy for patients with 
recurrent atrioventricular nodal reentrant (AVNRT) and circus movement tachycardia 
(CMT) [¹-⁴]. Although it is highly successful, lesions created by RF energy are inhomoge-
neous, irreversible, thrombogenic and potentially proarrhythmic [⁴-⁷]. Cryoablation (CA) 
creates homogeneous and smaller lesions and is less thrombogenic [⁸]. Together with the 
specificic tools of ice mapping and cryoadherence, this therapy has proven to be especially 
useful in AVNRT and (para) septally located accessory pathways to reduce the risk of in-
advertent AV block [⁹-¹⁴]. After interventional procedures, the follow-up is important to 
assess long-term success of the procedure. A follow-up based solely on clinical symptoms 
has a potential risk of misleading results [¹⁵-¹⁹]. The purpose of this study was to evaluate 
long-term success of patients treated either with RF of CA by using an event recorder and 
a specific questionnaire conducted at  year.
 Methods 
As described earlier, all consecutive patients with a recurrent tachyarrhythmia, suggestive 
of AVNRT or a CMT with the use of a right posteroseptally located accessory pathway, 
were randomized by an independent institution (Cardialysis) to either RF or CA before 
baseline electrophysiological (EP) study [¹⁰]. The diagnosis of both dual AV nodal path-
ways, AVNRT and CMT was made on the basis of standard diagnostic criteria. The earliest 
retrograde atrial activation during both tachycardia and ventricular premature beats was 
registered. Single premature atrial and ventricular stimuli were applied during tachycar-
dia at the time the His bundle was refractory to assess if tachycardia could be reset. This 
confirmed the presence or absence of an accessory pathway. In patients with manifest 
preexcitation the site that recorded the earliest ventricular activation was identified. If sus-
tained tachycardia could not be induced, isoproterenol was used. In the case of an acces-
sory pathway, the final classification was made according to the successful ablation site. 
 Ablation
For AVNRT, the target in both ablation techniques was slow pathway ablation guided by 
a combination of intracardiac electrogram criteria and anatomical landmarks. The end-
point was non-inducibility of AVNRT with or without isopreterenol after a 30 minutes 
waiting period. For CMT, mapping was performed beginning at the anteroseptal region 
at the His deflection down to the coronary os and further to the right posterior region. In 
patients with manifest ventricular preexcitation during sinus rhythm, the site of earliest 
ventricular activation was identified, characterized by a short local AV interval, with lo-
cal ventricular activation preceding the onset of the delta wave on the surface ECG. The 
earliest retrograde atrial activation was identified during orthodromic circus movement 
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tachycardia and ventricular pacing. A successful ablation was defined as a sudden loss of 
ventricular preexcitaton, a sudden loss of VA conduction or change from an eccentric to 
a concentric VA conduction, or sudden termination of the tachycardia during an applica-
tion. Patients were also observed for 30 minutes, and a repeated EP study was performed to 
confirm loss of accessory pathway conduction. Specific differences in both ablation tech-
niques for either AVNRT or CMT were described before.
 Follow-up
After hospital discharge, all patients received an event recorder for at least 3 months and 
were encouraged to activate it in case of recurrent palpitations. They all visited the outpa-
tient clinic approximately 3 months after the procedure, and thereafter were send to their 
referring cardiologist. One year after the procedure all patients were approached by tele-
phone or written letter and asked to answer specific questions related to their symptoms, 
recurrences, and repeated ablation. 
 Statistical analysis
Continuous variables were expressed a mean ± standard deviation. Non-parametric 
data were compared using the Mann-Whitney U test. The level of significance was set at 
p <0.05.
TABLE 1. 
Results of radiofrequency (RF) and cryoablation in AVNRT/RPS
RF ablation  
AVNRT
Cryoablation 
AVNRT
RF ablation  
RPS
Cryoablation  
RPS
Number of patients 33 30 3 5
Male/female (N/N) 10/23 14/16 3/0 4/1
Procedural success (N;%) 30 (91%) 28 (93%) 3 (100%) 4 (80 %)
Ice maps (median,N;SD) - 5 (2-42) - 6 (2-23)
Applications (median,N;SD) 7 (1-31) 2 (1-13) 1.5 (1-2) 3 (1-8)
complications 0 0 1* 1°
AVNRT = atrioventricular nodal reentrant tachycardia; N = number of patients; RPS = right 
posteroseptal  pathway; SD = standard deviation 
* = pneumothorax after subclavian puncture
° = tamponade caused by RV catheter (Medtronic, 646, temporary transvenous, active fixation)
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 Results
In 63 patients the diagnosis of AVNRT was made. Of these patients, 33 were randomized 
to RF and 30 to CA. In 8 other patients, a right posteroseptally located accessory pathways 
was diagnosed, in which 3 were randomized to RF and 5 to CA, respectively (TABLE ). 
Procedural success in AVNRT was achieved in 30 (9%) patients in the RF and 28 (93%) in 
the CA group. 
 Radiofrequency ablation for CMT was successful for all 3 patients in the RF group, and 
in 4 out of 5 patients in the CA group. For patients with AVNRT the number of ice maps 
was 5, and 6 with CMT, respectively. The median number of applications was 5 for RF, 
versus 2 (p<0.002) for CA for the total group. The median number of applications in the 
treatment of AVNRT was also significantly lower (p<0.05) in the CA group than in the RF 
group, namely 2 versus 7. In the CMT group 2 complications occurred, one pneumothorax 
after a subclavian puncture, and one tamponade caused by the RV catheter (a Medtronic, 
646, temporary transvenous, active fixation lead), which was used as reference catheter 
TABLE 2. 
One-years follow-up of patients ablated for AVNRT/RPS
RF ablation 
AVNRT
Cryoablation 
AVNRT
RF ablation  
RPS
Cryoablation  
RPS
Number of patients (N) 33 30 3 5
Long term success after  
failed 1st procedure (N)
1 1
Acute success (N;%) 31 (94%) 29 (97%) 3 (100%) 4 (80%)
Recurrence of palpitations  
(N;%)
10 (30%) 13 (43%) 1 (33%) 4 (80%)
ER activated (N;%) 3 (9%) 6 (20%) 1 (33%) 2 (40%)
Documented arrhythmias 
with ER:
• AVNRT or CMT(N)
• Afib (N)
• ST (N)
1
1
1
2
4
1
1
Clinically documented 
recurrence (N)
3 2
Redo procedure (N) 4 2 1
Afib = atrial fibrillation; AVNRT = atrioventricular nodal reentrant tachycardia;  
CMT = circus movement tachycardia; ER = event recorder; N = number of patients;  
RPS = right posteroseptal pathway; ST = sinustachycardia
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for the LocaLisa system. During a follow-up of  year, long-term success was seen in 2 pa-
tients treated for AVNRT (one in each group) after a failed procedure (TABLE 2). Therefore, 
the acute success rate in patients with AVNRT was 3 (94%) in the RF, and 29 (97%) in the 
CA group.
 Recurrent palpitations occurred in 0 patients treated for AVNRT with RF, and in 3 
patients after CA, as assessed by the questionnaire. Nine of these patients activated an 
event recorder, 3 treated with RF, and 6 with CA, respectively. The documented arrhyth-
mia in the RF group was recurrent AVNRT in  patient, atrial fibrillation in , and sinus 
tachycardia in . In the CA group recurrent AVNRT was seen in 2 patients. In 4 other 
patients sinus tachycardia was registered. In patients who underwent ablation for CMT, 
the questionnaire revealed that 5 patients had recurrent palpitations, namely  in the RF 
group and 4 in the CA group. Of these patients, 3 activated an event recorder, once with 
a recurrence of CMT,  with sinus tachycardia, and  with chest pain. In 5 other patients 
recurrent tachycardia was documented in hospital, or after the period with event record-
ing. In conclusion, 32 (45%) patients experienced recurrent palpitations. In only 9 of these 
32 patients recurrent AVNRT/CMT was confirmed. Without the event recorder 7 patients 
would potentially have been misclassified for a recurrence of the treated arrhythmia. A 
total number of 7 patients underwent repeated ablation (6 with AVNRT,  with CMT); this 
was in 4 cases after RF, and 3 treated with CA. Two are scheduled for a new procedure.
 Discussion
RF ablation for AVNRT and (para)septally located accessory pathways is accompanied 
by an increased risk of inadvertent RBBB or complete AV-block [¹-⁴, ²⁰-²²]. Because cryo-
thermy has the ability to create temporary lesions (ice mapping), prospective ablation sides 
can be investigated, before a definitive, and irreversible lesions is created [⁹-¹⁴]. In this 
study it was confirmed that cryoablation is as effective as RF ablation in the treatment of 
these arrhythmias, as is in agreement with other studies [⁹-¹⁴]. It was also shown that in 
patients treated for AVNRT, this can lead to less applications and abolish the risk for AV 
conduction disturbances [⁹-¹²]. In patients treated for right posteroseptally located acces-
sory pathways this could not be confirmed in our study, merely by the fact that the group 
consisted of only 8 patients. As is valid for all interventional studies, an adequate follow-
up is important to assess long-term success of the procedure. To rely solely on clinical 
symptoms of recurrent palpitations has a potential risk of misleading results [¹⁵-¹⁹]. For 
example, in studies of catheter ablation for atrial fibrillation (AF), success is defined as 
absence of symptoms or less symptoms after treatment [¹⁷-¹⁹]. However, it is well-known 
that approximately up to 50% of the episodes of AF are not experienced as such by the 
patients, and therefore success rates can be overestimated. On the other hand, as is shown 
in this study, not all recurrent palpitations are by definition recurrences of the treated 
arrhythmia. Seventeen patients (49%) treated with cryoablation complained about recur-
rent palpitations in comparison with  patients (3%) treated with RF, as was assessed by 
a questionnaire after one year. However, only 8 patients in the cryo group and 4 in the 
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RF group activated the event recorder, because of recognizable palpitations. Probably, in 
patients who did not acitivate the event recorder, the palpitations were not identical in 
comparison with preablation, or were too short lasting. By the event recorder, a recurrence 
of the treated arrhythmia could be registered in 7 patients. In one patient in the RF group 
atrial fibrillation was documented. Sinus tachycardia was seen in  patient in the RF, and 
5 patients in the cryo group. The presence of sinus tachycardia, especially after cryoabla-
tion of the slow pathway ablation, as was seen in 4 patients, is remarkable. It has been as-
sociated with inadvertent damage to the fast pathway [²³]. The reason for this observation 
can be a more anterior position of the ablation catheter, due to the smaller lesions created 
by cryothermy, or an abnormally located antegrade fast pathway, located in the postero-
septal region, which exists in about 3% of patients presenting with AVNRT [²⁴]. Without 
the event recorder, 7 patients (2 in the RF group, and 5 in the CA group) would have been 
misclassified for a recurrence of the treated arrhythmia. 
 Conclusions
Our data demonstrate that event recording and not specific arrhythmia related question-
naire enhances the sensitivity of detecting arrhythmia recurrences. This has implications 
for the interpretation and design of clinical trials in the evaluation of treatment efficacy. 
Based on event recording, CA is as effective as RF for arrhythmias in Koch’s triangle dur-
ing long-term follow-up.
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Koch’s triangle is an intruiging area. On the atrial aspect, the triangular area itself is de-
lineated by the tendon of Todaro, which inserts in the atrial aspect of the central fibrous 
body to mark the apex of Koch s´ triangle. The ventricular border is formed by the sep-
tal leaflet of the tricuspid valve. The base of the triangle is marked by the inferior right 
atrium around the orifice of the coronary sinus (cavo-tricuspid isthmus), along with the 
musculature extending to the hinge of the septal leaflet of the tricuspid valve, i.e. sep-
tal isthmus. The anatomy and electrophysiological chararteristics of this region provide 
a substrate for different arrhythmias to develop. Chapter 1 is devoted to address to all 
these different aspects. In the first part an overview is given of the known embryology of 
the atrioventricular conduction axis and its direct environment, as well as the anatomy 
and electrophysiological characteristics of this region. Until now a lot of questions on its 
anatomy and physiology still exist, despite intensive research. As already mentioned, dif-
ferent arrhythmias can develop, which can be cured with transvenous radiofrequency (RF) 
catheter ablation, although some pitfalls still remain present. 
 Fluoroscopy does not allow delineation of important anatomic landmarks during elec-
trophysiological studies. Imaging techniques such as intra-cardiac echocardiography can 
improve the success rate of RF ablations by guiding catheter positioning. In Chapter 2 it 
was shown that intra-cardiac echocardiography, using a non-steerable 2D probe, was able 
to visualize various atrial structures. RF lesions could not be identified 20 minutes after 
catheter ablation of the cavo-tricuspid isthmus.
 In the past, surgical modification of the atrioventricular node was the only method 
to eliminate atrioventricular nodal reentrant tachycardia (AVNRT). Both cryosurgery for 
modification of the perinodal tissues along the perimeter of the triangle of Koch and ‘skel-
etonization’, a dissection technique to interrupt all atrial inputs of the atrioventricular 
node except the ‘deep’ left atrial input, resulted in successful cure of the tachycardia while 
preserving atrioventricular conduction. Nowadays, transvenous catheter ablation is the 
first-line therapy for patients with recurrent AVNRT. Chapter 3 described that both sur-
gery, and RF catheter ablation in the early days, were effective and safe in the elimination 
of recurrent AVNRT. During mid-term follow-up, sporadic recurrences of AVNRT were 
registered, even 3 years after the procedure. These observations led to the conclusion that 
patients, who underwent successful surgery or RF ablation for AVNRT, were definitively 
cured. 
 The region between the inferior caval vein orifice and tricuspid valve orifice, known 
as cavo-tricuspid isthmus, forms the base of Koch’s triangle, and is known for its slow 
conduction properties. Both class C and class III anti-arrhythmic drugs (AAD) are able 
to convert atrial fibrillation (AF) into a isthmus dependent atrial flutter (AFL). Chapter 4 
presents a study in which is shown that a linear isthmus RF ablation, in combination with 
the continuation of AAD is associated with a high success rate of achieving and maintain-
ing sinus rhythm in patients with AF who developed an isthmus dependent AFL under 
AAD therapy .
 Although, RF ablation is highly effective in the treatment of both supraventricular and 
ventricular tachyarrhythmias with a low complication and recurrence rate, RF is not the 
optimal energy source. Lesions created by RF energy are irreversible, cause some degree of 
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tissue disruption or “carbonisation” of the targeted tissue that increases the risk for perfo-
ration and thromboembolism. The lesions are inhomogeneous, and therefore potentially 
proarrhythmic. Indeed, new tachyarrhythmias, after RF ablation for AVNRT, were already 
seen during mid-term follow-up in Chapter 3. Chapter 5 focussed on the magnitude and 
importance of this adverse effect on the long-term. This study demonstrated an obvious 
risk of developing new supraventricular arrhythmias, such as symptomatic atrial prema-
ture beats, type  AFL, atrial tachycardia and AF, but also late AV block after RF ablation. 
These data and known characteristics of RF energy support the research for and the use of 
new energy sources and other ablative techniques. 
 Furthermore, during RF ablation of AVNRT and (para)septally located accessory path-
ways there is an increased risk of right bundle branch block or inadvertent complete AV 
block, as these pathways run in close proximity to the compact AV node. Applications 
should be delivered during sinus rhythm and not during tachycardia, because of the risk of 
both instable endocardial tissue contact during and catheter dislodgement at termination 
of the tachycardia. As cryothermy has the ability to reversibly demonstrate loss or change 
of function of tissue at less negative temperature (ice mapping), potential ablation sites 
can be investigated, before a definitive and irreversible lesion is created. As progressive 
ice formation at the catheter tip causes adherence to the adjacent tissue, ablation can also 
safely be performed at otherwise unstable catheter positions, or even during tachycardia. 
Therefore, cryothermy could be especially useful in ablation of tachyarrhythmias in Koch’s 
triangle, to reduce the risk of AV conduction disturbances.
 Chapter 6 demonstrates that cryoablation could be performed effectively and safe in a 
patient with a right anteroseptally located accessory pathway. As a result of this, a retro-
spective study was performed, in which RF was compared with cryoablation in the treat-
ment of (para)septally located accessory pathways (Chapter 7). The rationale for attempt-
ing cryoablation in these sites was, besides enhancing safety, also improving efficacy, as 
it is known that RF ablation of septally located accessory pathways is associated with a 
higher percentage of failures, and recurrences. The acute success rates for both treatment 
modalities were comparable, as were procedure and fluoroscopy times. The number of 
applications tended to be lower with cryoablation. After performing a redo with the same 
energy, the final success rate of RF tended to be higher. The reasons of this difference 
remain unclear, because of the small number of patients under study. In Chapter 8 some 
characteristics of cryoablation are discussed, referring to an observation made by other 
investigators, that a successful cryoablation could be accompanied by a slowly disappear-
ance of preexcitation, in contrast to RF ablation [¹]. However, in our experience, as tis-
sue temperature rises away from the center of the ablation site, tissue effects that occur 
late during a cryo-application are expected to be reversible, and indicate a suboptimal 
(remote) ablation site, and/or poor wall contact. In this context, successful ice mapping 
attempts were characterized by a short temperature time constant and a short response 
time to mapping with a sudden loss of pathway conduction, as is described in detail in 
Chapter 9. 
 In Chapter 10 it was shown that a successful cryoablation of the fast pathway could be 
performed without the occurrence of second degree or complete heart block, in a difficult 
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case of AVNRT. Subsequently, in Chapter 11 a prospective, randomized single centre study 
is presented to compare RF and cryoablation in AVNRT. Both success and recurrence rates 
were comparable, and no persisting conduction disturbances or thromboembolic compli-
cations were observed in both methods. Again a lower number of applications was seen 
with cryoablation. It was illustrated that cryoablation provided a method to targeting the 
slow pathway solely on an electrophysiological basis, offering a way to avoid the fast path-
way, even if this latter is located in an anatomically different site. To investigate if cryoab-
lation was also successful during long-term follow-up, the study described in Chapter 12 
was carried out. As it is known that it can be misleading to rely solely on clinical symptoms 
of recurrent palpitations, the efficacy of event recording in evaluating long-term success in 
patients treated for AVNRT and right posteroseptally located accessory pathways was also 
assessed. It was demonstrated that long-term follow-up in these treated arrhythmias was 
comparable between RF and cryoablation, and that event recording enhanced the sensitiv-
ity of detecting arrhythmia recurrences in evaluating therapy efficacy. Therefore, it should 
be considered in every interventional study.
 Conclusions
Transvenous RF catheter ablation has become first line therapy for patients with arrhyth-
mias in Koch’s triangle. Although it is highly successful with a low recurrence and com-
plication rate, several pitfalls remain present. To overcome these issues, new techniques 
are needed like cryothermy with or without intracardiac visualization of anatomical land-
marks. Despite the fact that cryothermy possesses the properties of ice mapping and cryo-
adherence, the technique still has to develop and improve. 
 Future perspectives
 Today’s limitations in cryoablation and suggested solutions
Several remarks on cryothermy have to be made. In AVNRT, several studies have shown 
that the acute procedural success rate of cryoablation was comparable with RF [2-5], al-
though in others the success rate was lower than one would expect from RF ablation [6,7]. 
For atrioventricular reentry tachycardia (AVRT) and pulmonary vein isolation the success 
rates tend to be lower than for RF, although the endpoints in AF ablation studies are not 
that clear and differ from one study to another [⁷-¹¹]. However, comparable success rates 
are achieved in atrial flutter ablation [¹¹,¹²]. The same conflicting results are obtained for 
the rates of arrhythmia recurrences and procedure times [²-⁷]. As this is a new technique 
and energy source, a learning curve exists and this could have been translated into initially 
lower procedural success rates, and longer procedure times. Probably, the latter is mainly 
due to the longer duration of energy application in cryoablation. Larger prospective, ran-
domized studies are necessary to prove the same efficacy and safety of cryoablation, in 
comparison with RF.
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Lesions created by cryothermy are different in size and certainly in composition from 
lesions created by RF catheters. Cryoadherence during ablation results in fixation of the 
catheter, and not passively sliding along a larger area, as under RF [⁵]. This can mean that a 
more precise mapping, a larger catheter tip to create lesions of greater area, or colder tem-
peratures to achieve deeper lesions, are necessary to obtain a similar effect. The current 
cryocatheters are composed of an outer shaft maintained under constant vacuum and an 
inner injection tube through which liquid nitric oxide is injected. This is the cause of more 
stiffness than that of a conventional RF catheter, limiting proper catheter positioning. New 
developments in catheter designs can maybe overcome these problems. 
 An crucial question remains if cooling to minus 30 degrees always means that the 
predicted effect is maximal: this has important consequences for safety and/or efficacy 
[¹⁴]. It is possible that during ice mapping, intramural or more epicardially located acces-
sory pathways are not reached at all, while theoretically, it can be the right spot, as the 
cooling is not deep enough to have any effect. This also depends on differences in regional 
microcirculation, as is valid for RF [¹⁵]. This is a clear limitation of the concept of ice map-
ping. Also the observation that complete AV block can occur after cryoablation is started, 
while this conduction delay is not present during ice mapping [³,⁶], is an evidence that ice 
mapping can be an unreliable diagnostic method. Fortunately, until today, no permanent 
AV block has been reported after interrupting with either ice mapping or cryoablation 
[²-⁵,⁷-⁹]. On the other hand, it is known from experimental animal studies that cooling to 
temperatures less than –30°C can create irreversible lesions [¹⁶]. More experimental data 
can provide important information for the arrhythmia expert about the ideal ice mapping 
temperature and duration.
 Finally, as is mentioned earlier, tissue temperature rises away from the center, and 
therefore, tissue effects that occur late during a cryothermy application are assumed to 
be reversible. Probably, this can be considered as an ‘ice mapping’ effect, and indicates a 
suboptimal (remote) position. 
 In conclusion, there is the potential for cryothermy to replace RF for ablation of specific 
arrhythmic substrates, although several issues still have to overcome.
Besides the use of new energy sources, additional imaging techniques have to be developed 
to improve efficacy and safety of percutaneous ablation procedures and to reduce radiation 
exposure for both patients and investigators, especially in more compex arrhythmias and 
anatomy. For many years both mono- or biplane intermittent fluoroscopy has been used 
to visualize these cardiac target structures. However, by nature, fluoroscopy is only two-
dimensional, and underrepresents the complex cardiac anatomy, which has a potential im-
portant role in arrhythmia genesis. The implementation of several non-invasive 3D imaging 
modalities, such as 3D spiral computer tomography (CT), 3D magnetic resonance imaging 
(MRI) and intracardiac echocardiography (ICE) can provide more detailed knowledge of 
the individual 3D cardiac anatomy. Integration of pre-procedural 3D imaging techniques 
is nowadays already possible for all 3D electrophysiologic mapping systems. However, real-
time 3D imaging still has to develop, and will further improve treatment. Also, the use 
of new navigation systems can contribute to optimizing catheter ablation. The magnetic 
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navigation system is a new platform technology allowing remote-controlled navigation 
of an ablation catheter. In conjunction with a motor drive unit, it has already shown to 
be successful in completely remote-controlled mapping and ablation of arrhythmias [7]. 
The catheter control system is another navigation system, consisting of a remotely placed 
workstation, a robotically controlled catheter manipulator, and an input device, that al-
lows the investigator to steer the catheter in three dimensions. 
What will the future bring? Maybe, a real-time 3D imaging, integrated with a 3D electro-
physiologic mapping system, performing a catheter ablation with the use of a new energy 
source, carried out with a completely remote-controlled navigation system by an inves-
tigator sitting at his office/home behind his computer, is not that far away. On the other 
hand, what will become of the patient, who has to undergo all this, and who is losing 
personal contact with his treating physician. And, last but not least, who has to pay for 
all these expensive new techniques, especially in an area where insurance companies are 
determining what is, or is not permitted. 
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De driehoek van Koch is een intrigerend gebied. Aan de atriale zijde wordt de driehoek 
begrensd door de ‘tendon of Todaro’, die insereert in het atriale gedeelte van het centraal 
fibreuze lichaam om zo de top van de driehoek van Koch aan te geven. De ventriculaire 
zijde wordt gevormd door het septale blad van de tricuspidalis klep. De basis van de drie-
hoek wordt afgegrensd door het basale rechter atrium rondom de uitmonding van de sinus 
coronarius (cavale-tricuspidale isthmus), tesamen met de musculatuur die reikt tot aan 
het ophangapparaat van het septale blad van de tricuspidalis klep (septale isthmus). Door 
de anatomie en de electrofysiologische eigenschappen van deze regio kunnen verschil-
lende aritmieën ontstaan. In hoofdstuk 1 worden deze verschillende aspecten besproken. 
Het eerste deel geeft een overzicht van de embryologie van het atrioventriculaire (AV) 
geleidingssysteem en haar directe omgeving, maar ook van de anatomie en de electrofysio-
logische karakteristieken van dit gebied. Ondanks intensief onderzoek, bestaan hierover 
nog vele vragen. Zoals al eerder vermeld, kunnen verschillende aritmieën zich ontwik-
kelen, die kunnen worden behandeld met radiofrequente (RF) katheterablatie. Echter, bij 
deze behandelmethode zijn nog steeds “adders onder het gras aanwezig”. 
 Met behulp van röntgendoorlichting is het niet mogelijk om tijdens electrofysiologi-
sche onderzoeken belangrijke, anatomische structuren af te grenzen. Nieuwe afbeeldings-
technieken, zoals intracardiale echocardiografie, kunnen het succespercentage van RF 
ablaties verhogen door het beter sturen van de ablatiekatheter. Hoofdstuk 2 laat zien dat 
het mogelijk was om met intracardiale echocardiografie, met gebruikmaking van een niet-
stuurbare twee-dimensionele scoop, verschillende atriale structuren af te beelden. Echter, 
20 minuten na een RF ablatie van de cavale-tricuspidale isthmus, konden geen RF letsels 
worden waargenomen. 
 In het verleden was chirurgische modificatie van de AV knoop de enige methode om 
AV nodale reentry tachycadieën (AVNRT) definitief te behandelen. De chirurgische be-
handeling bestond uit dissectie van het omgevende weefsel van de AV-knoop, waarbij di-
verse methoden beschreven zijn. Tegenwoordig, is transveneuze katheterablatie de eerste 
keuze bij de behandeling van patiënten met herhaalde aanvallen van AVNRT. Hoofdstuk 3 
beschrijft dat zowel chirurgie als RF katheter- ablatie succesvol en veilig waren voor de be-
handeling van AVNRT. Gedurende een middellange follow-up werden sporadisch recidie-
ven gezien, soms zelfs pas 3 jaar na de procedure. Dit leidde tot de conclusie dat patiënten, 
die een succesvolle chirurgische ingreep danwel RF katheterablatie hadden ondergaan, 
definitief waren genezen.
 De regio tussen de vena cava inferior en de tricuspidalis klep, de cavale-tricuspidale 
isthmus, vormt de basis van de driehoek van Koch, en staat bekend om zijn trage gelei-
dingseigenschappen. Zowel klasse C als klasse III antiarrhythmica zijn in staat om atri-
um fibrilleren (AF) te ‘organiseren’, en om te zetten in een isthmus-afhankelijke atriale 
flutter (AFL). In hoofdstuk 4 wordt een studie gepresenteerd, waaruit blijkt dat een li-
neaire isthmusablatie, in combinatie met het continueren van antiarrhythmica, gepaard 
gaat met een hoog succespercentage om sinusritme te verkrijgen en te behouden bij deze 
patiënten.
 Alhoewel RF ablatie zeer effectief is in de behandeling van supraventriculaire en ven-
triculaire ritmestoornissen, en geassocieerd is met een laag aantal complicaties en recidie-
HOOFDSTUK 13
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ven, is het niet de optimale energiebron. De letsels, die door RF worden gecreëerd zijn on-
herstelbaar, ontwrichten de onderliggende weefselstructuur, met als gevolg een verhoogd 
risico op perforatie en thrombo-emboliën. Door het inhomogene karakter van de letsels, 
zijn ze potentieel aritmogeen. Inderdaad werden al nieuwe ritmestoornissen waargeno-
men tijdens de middellange follow-up in hoofdstuk 3. In hoofdstuk 5 wordt aandacht ge-
schonken aan de grootte en belang van dit nadelig effect op de lange termijn. De beschre-
ven studie demonstreerde dat na RF ablatie van AVNRT, er niet alleen een risico bestaat 
om nieuwe ritmestoornissen te ontwikkelen, zoals symptomatische premature atriale con-
tracties (PAC’s), AFL type , atriale tachycardie (AT) en AF, maar ook voor het verkrijgen 
van een laat compleet AV-blok. Deze gegevens en karakteristieken van RF energie onder-
steunen de zoektocht naar nieuwe energiebronnen en alternatieve ablatietechnieken.
 Bovendien, bestaat tijdens RF ablatie van AVNRT en (para) septale extraverbindingen 
een risico op het ontwikkelen van een ongewenst rechter bundeltak blok, of een compleet 
AV-blok, doordat het substraat van deze ritmestoornissen dichtbij het normale geleidings-
systeem is gelegen. Applicaties moeten tijdens sinusritme worden afgegeven om een sta-
biele katheterpositie te verkrijgen en te houden, omdat anders een kans bestaat dat de 
katheter disloceert op het moment dat de ritmestoornis termineert. Cryothermie heeft de 
eigenschap om tijdelijk een verandering in geleidingskarakteristieken aan te tonen door 
het weefsel minder diep te koelen (ice mapping). Hierdoor kunnen toekomstige ablatie-
plaatsen worden onderzocht, voordat een definitief en onherstelbaar letsel wordt veroor-
zaakt. Door de ijsvorming aan de kathetertip plakt deze aan het aangrenzende weefsel 
(cryoadherence), en zodoende kan een ablatie ook veilig worden uitgevoerd tijdens een on-
stabiele katheter positie of een ritmestoornis. Door deze eigenschappen van cryothermie, 
lijkt deze energiebron met name geschikt voor ablatie van ritmestoornissen in de driehoek 
van Koch, om zo het risico op AV geleidingsproblemen te verminderen.
 Hoofdstuk 6 laat zien dat cryoablatie succesvol en veilig kon worden uitgevoerd bij een 
rechts anteroseptaal gelegen extraverbinding. Vervolgens werd een retrospectieve studie 
verricht, waarbij RF met cryoablatie werd vergeleken bij patiënten met een (para)septaal 
gelegen extraverbinding (hoofdstuk 7). Het idee om dat juist bij deze patënten te doen, 
was om de veiligheid en effectiviteit van de behandeling te verhogen, omdat RF ablatie van 
deze extraverbindingen gepaard gaat met een lager succespercentage en een hoger aantal 
recidieven. Het acute succes bleek voor beide behandelingen vergelijkbaar. Dit gold ook 
voor de doorlichtings- en proceduretijden. Er was een trend zichtbaar voor een minder 
aantal benodigde applicaties met cryoenergie. Na het verrichten van een hernieuwde abla-
tie, neigde RF naar een uiteindelijk hoger succespercentage. 
 In hoofdstuk 8 worden enkele karakteristieken van cryoablatie besproken naar aan-
leiding van een observatie dat een succesvolle cryoablatie gepaard kan gaan met het lang-
zaam verdwijnen van de preexcitatie in het kader van de behandeling van het WPW-syn-
droom [1]. Uit onze ervaring blijkt, dat de weefseltemperatuur hoger wordt naarmate de 
afstand tot het centrum van de ablatieplaats toeneemt, en dat effecten die laat tijdens 
een cryoapplicatie optreden meestal reversibel zijn. Dit betekent een suboptimale ablatie-
plaats, en/of een slecht weefselcontact. In dit verband blijken succesvolle “ice mapping” 
pogingen gepaard te gaan met een korte temperatuur/tijdsconstante en een korte respons-
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tijd met het plotseling verdwijnen van de delta-golf. Dit wordt in detail beschreven in 
hoofdstuk 9.
 In hoofdstuk 10 wordt aangetoond dat een succesvolle cryoablatie van het snelle gelei-
dende pad kon worden uitgevoerd bij een atypische casus van AVNRT waarbij de suggestie 
werd gewekt van de aanwezigheid van meerdere snel teruggeleidende paden. Dit kon veilig 
worden gedaan zonder dat een tweedegraads of totaal AV blok ontstond. Als gevolg hiervan, 
wordt in hoofdstuk 11 een prospectieve, gerandomiseerde studie gepresenteerd, waarin RF 
met cryoablatie wordt vergeleken bij patiënten met AVNRT. Voor beide behandelmethoden 
gold dat zowel het succes als recidief percentages vergelijkbaar waren en er geen blijvende 
AV geleidingsproblemen of thrombo-embolische complicaties optraden. Opnieuw werd een 
lager aantal applicaties gevonden bij cryoablatie. Illustratief was dat cryoablatie kon worden 
uitgevoerd puur op basis van de electrofysiologische eigenschappen van het langzaam ge-
leidende pad, zelfs als deze op een afwijkende anatomische positie was gelegen. Zodoende 
kon een ongewenste ablatie van het snelle geleidende pad worden vermeden. Om aan te 
tonen dat cryoablatie ook op de lange termijn succesvol is, is de studie, zoals beschreven in 
hoofdstuk 12 uitgevoerd. Het is bekend dat het misleidend kan zijn om alleen op de klachten 
van een patient af te gaan om te weten of er recidieven zijn. Derhalve werd de effectiviteit 
van een transtelefonische ECG registratie geëvalueerd om het succes op de lange termijn te 
beoordelen van patiënten die geableerd waren voor een AVNRT of een rechts posteroseptaal 
gelegen extraverbinding. Er kon worden aangetoond dat de langetermijns follow-up van RF 
en cryoablatie in deze patiëntengroepen vergelijkbaar was. Bovendien bleek een transte-
lefonische ECG registratie de sensitiviteit voor het vastleggen van recidieven te verhogen. 
Derhalve moet een dergelijke follow-up bij iedere interventie studie worden overwogen.
 Conclusies
Transveneuze RF katheter ablatie is de eerstelijns behandeling van patiënten met ritme-
stoornissen in de driehoek van Koch. Alhoewel dit gepaard gaat met een hoog succesper-
centage en een laag aantal recidieven en complicaties, blijven sommige valkuilen tijdens 
deze behandeling bestaan. Om deze te overwinnen zijn nieuwe technieken, zoals cryoener-
gie nodig, met of zonder intracardiale visualisatie van anatomische structuren. Ondanks 
het feit dat cryoenergie eigenschappen bezit als “ice mapping” en “cryoadherence”, zal deze 
techniek zich nog verder moeten ontwikkelen en verbeteren.
 Toekomstperspectieven
 De huidige beperkingen van cryoablatie en mogelijke oplossingen
Ten aanzien van cryoenergie kunnen een aantal kanttekeningen worden geplaatst. In de 
behandeling van AVNRT laten sommige studies zien dat de resultaten vergelijkbaar zijn 
met RF [²-⁵], terwijl in andere studies het succespercentage lager uitviel [⁶-⁷]. Voor atrioven-
triculaire reëntry tachycadieën (AVRT) en pulmonaal venen isolatie geldt dat het succes 
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hiervan lager lijkt te zijn dan met RF, alhoewel de eindpunten in AF studies niet duidelijk 
zijn en per studie verschillen [⁷-¹¹]. Bij de behandeling van AFL echter zijn de succespercen-
tages weer wel vergelijkbaar [¹¹,¹²]. Ook als men kijkt naar het optreden van het aantal re-
cidieven en de proceduretijden, blijken er tegengestelde resultaten te bestaan [2-7]. Gezien 
het feit dat het hier een nieuwe techniek en energiebron betreft, bestaat er een leercurve, 
en deze kan zich vertalen in een lager procedure gerelateerd succes, en langere procedu-
retijden. Waarschijnlijk wordt dit laatste echter voornamelijk veroorzaakt door de langer 
duur van een enkele cryoapplicatie. Grote, gerandomiseerde studies zijn noodzakelijk om 
te kunnen aantonen dat cryoablatie net zo effectief en veilig is als RF. 
 De letsels die door cryoenergie worden veroorzaakt zijn verschillend in omvang en ze-
ker qua karakter, in vergelijking met RF. Door het plakken van de katheter aan het weefsel 
tijdens een cryoablatie, beweegt deze zich niet passief langs het oppervlakte, in tegenstel-
ling tot RF energie [⁵]. Dit kan betekenen dat een nog nauwkeuriger in kaart brengen van 
de oorsprong van de ritmestoornis, een grotere tip van de katheter om grotere letsels te 
kunnen maken, of het nog dieper koelen van het weefsel om diepere letsels te veroorzaken, 
noodzakelijk zijn om eenzelfde effect te bereiken als met RF. De huidige cryokatheters be-
staan uit een buitenste holle schacht, die onder continue vacuüm staat, en een binnenste 
injectie schacht waardoor vloeibare stikstof word geïnjecteerd. Hierdoor zijn deze katheters 
stijver dan een RF katheter, wat het positioneren van de katheter kan bemoeilijken. Nieuwe 
ontwikkelingen in kathetervormgeving kunnen deze problemen wellicht verhelpen.
 Een cruciale vraag blijft of het koelen tot minus 30 graden Celsius altijd betekent dat 
het voorspelde effect maximaal is: dit heeft namelijk belangrijke consequenties voor de 
veiligheid en/of effectiviteit van “ice mapping” [¹⁴]. Het is mogelijk dat tijdens “ice map-
ping”, intramuraal of epicardiaal gelegen extraverbindingen niet worden bereikt, terwijl 
theoretisch gezien, het wel de juiste plek is. De koeling blijkt dan echter niet diep genoeg 
om enig effect te sorteren. Ook verschillen in de microcirculatie kunnen hiertoe bijdragen, 
zoals dat ook geldt voor RF [¹⁵]. Dit is een duidelijke tekortkoming van het concept van “ice 
mapping”. Een ander bewijs hiervoor is dat een totaal AV blok tijdens cryoablatie kan ont-
staan, terwijl dit niet wordt waargenomen tijdens “ice mapping” [³,⁶]. Gelukkig is, tot op 
heden, geen melding gemaakt van een blijvend totaal AV blok, indien de “ice mapping” of 
cryoablatie direct wordt gestaakt [2-5,7-9]. Aan de andere kant, hebben dierenexperimen-
ten aangetoond dat het koelen tot temperaturen lager dan 30 graden Celsius, onherstelbare 
letsels kunnen veroorzaken [6]. Meer experimentele studies kunnen bijdragen tot een 
dieper inzicht in de optimale “ice mapping” temperatuur en duur hiervan. 
 Tot slot, is al eerder vermeld dat de weefseltemperatuur hoger wordt naarmate de af-
stand tot het centrum van de ablatieplaats toeneemt, met als gevolg dat effecten die laat 
optreden tijdens een applicaties vaak reversibel zijn. Dit kan als een “ice mapping”-effect 
van de omgeving worden beschouwd, en geeft een suboptimale ablatieplaats weer. 
 Concluderend, heeft cryoenergie de potentie in zich om de plaats van RF over te nemen 
bij de behandeling van specifieke aritmogene substraten. Hiervoor zullen nog een aantal 
problemen moeten worden overwonnen.
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Naast het gebruik van nieuwe energiebronnen zullen ook additionele afbeeldingstechnie-
ken moeten worden ontwikkeld om de veiligheid en effectiviteit van de ablaties te verbe-
teren en de doorlichtingstijd voor zowel de patiënt als de behandelaar te verminderen, 
met name bij complexe ritmestoornissen en anatomie. Al vele jaren is röntgendoorlichting 
gebruikt om specifieke cardiale structuren in beeld te brengen. Röntgendoorlichting geeft 
slechts een tweedimensioneel beeld en schiet derhalve tekort bij de complexe cardiale ana-
tomie, die een belangrijke rol kan spelen bij het ontstaan van ritmestoornissen. Het im-
plementeren van niet-invasieve 3D afbeeldingstechnieken, zoals 3D spiraal computer to-
mografie (CT), 3D MRI, en intracardiale echocardiografie (ICE) kunnen bijdragen tot een 
betere kennis van de 3D cardiale anatomie van het individu. De integratie van pre-proce-
durele 3D afbeeldingstechnieken is tegenwoordig al mogelijk voor 3D electrofysiologische 
mapping systemen. Echter, een continue 3D afbeelding is nog in de ontwikkelingsfase, en 
zal zeker bijdragen tot een betere behandeling. Het gebruik van nieuwe navigatiesystemen 
kan de behandeling ook verder verbeteren. Het magnetisch navigatiesysteem is een nieu-
we techniek, waarbij met een afstandsbediening de ablatiekatheter kan worden bewogen. 
Dit heeft al geleid tot volledig op afstand uitgevoerde ablaties van ritmestoornissen. Het 
controle systeem van de katheter is een ander navigatiesysteem, dat bestaat uit een op af-
stand geplaatst werkstation, een robotisch katheter manipulator, en een invoerinstrument, 
waardoor de behandelaar in staat is om de katheter in drie dimensies te bewegen.
 Wat zal de toekomst nog meer brengen? Misschien is een continue 3D afbeelding, geïn-
tegreerd met een 3D electrofysiologisch mapping systeem om de ritmestoornis nauwkeurig 
in kaart te brengen, met het verrichten van een katheterablatie met behulp van een nieuwe 
energiebron, uitgevoerd met een volledig op afstand bediend navigatiesysteem door een 
behandelaar al zittend achter zijn computer op zijn kamer of thuis, niet meer zo ver ver-
wijderd. Aan de ander kant moet men zich afvragen hoe de patiënt zich moet voelen, die 
dit allemaal moet ondergaan, en het contact met zijn behandelaar lijkt kwijt te raken. En 
als laatste, maar zeker niet als minste, blijft de vraag wie dit allemaal moet gaan betalen, 
zeker in een tijd waarin de Zorgverzekeraars bepalen wat wel en niet is toegestaan.
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Bij het tot stand brengen van een proefschrift hoort een dankwoord te worden uitgespro-
ken. Iedereen die mij een beetje kent, weet ook dat dit voor mij geen gemakkelijke opgave 
is. Dat wil niet zeggen dat ik niemand dank verschuldigd ben, integendeel, maar om dit 
vervolgens op papier vast te leggen is een moeizame onderneming. Eén of meerdere perso-
nen zullen worden vergeten, die zich vervolgens al dan niet gepasseerd voelen. Bovendien 
weten zij waar ik veel aan te danken heb dit toch al. Tot slot zit niemand te wachten op een 
tenenkrommende loftuiging mijnerzijds. Het is zoals Theo Maassen (cabaretier) in een 
afscheidstoespraak voor een goede collega verwoordde: “Chapeau, chapeau, chapeau, wa 
bende gij toch sympathiek”, om vervolgens in dezelfde speech te eindigen met: “eigenlijk 
zoude ze oe hier ter plekke kapot moete schiete”. Desalniettemin zal ik hieronder toch een 
welgemeende poging doen, en ik verexcuseer me bij voorbaat al voor de personen die ik 
niet vermeld. 
Prof. dr. N.M. van Hemel, beste Norbert, mijn promotor. Jij bent degene die mij voor het 
eerst wegwijs heeft gemaakt in de wereld van de klinische electrofysiologie. Met de grote 
hoeveelheid uitgedraaid papier welke ik in het begin na de procedures heb moeten uitplui-
zen, zou menig stulpje kunnen worden behangen. Jouw kritische blik, volhardendheid, en 
enthousiasme, heb ik altijd zeer gewaardeerd. Als ik maar een gedeelte hiervan ooit zelf 
zal kunnen bezitten, dan ben ik al een tevreden cardioloog/electrofysioloog. Gelukkig heb 
je de taak van promoter, na wat beslommeringen, alsnog op je willen nemen en je weet dat 
dit voor mij veel betekent.
Prof. dr. L.J.L.M. Jordaens, beste Luc, mijn promotor. Samen met Dominic Theuns zijn 
wij in het Rotterdamse in 998 begonnen met de klinische electrofysiologie. Velen hebben 
gedacht dat dit een onhaalbare kaart was, en ik moet zeggen dat ik mijzelf ook weleens 
heb afgevraagd of wij ooit een eigen volwaardige afdeling zouden worden met een eigen 
EFO-lab. Door met name jouw onvoorwaardelijke gedrevenheid, is dit toch voor elkaar 
gekomen. Dat sommigen, door de soms onnavolgbare ideëen, de weg volledig dreigden 
kwijt te raken, nam jij op de koop toe. In ieder geval staat de klinische electrofysiologie in 
het Erasmus MC als een “Belgisch” huis. Verder ben jij voor mij meer dan alleen maar een 
collega. Ik mis nog weleens de gezellige afzakkertjes en de prachtige anecdotes, waarin 
jijzelf menigmaal de hoofdrol speelde.
Dr. P.F.H.M. van Dessel, beste Pascal. Jij hebt mede bijgedragen tot mijn toetreden in het 
St. Antonius Ziekenhuis te Nieuwegein. Ook bij het tot stand komen van enkele artikelen, 
maar ook dit proefschrift, is jouw steun van belang geweest. Niet alleen op computerge-
bied geldt dat voor jou geen berg te hoog is. Het is voor mij een plezierige gedachte, dat 
onze wegen zich in het AMC wederom gaan kruisen. 
Dr. E.R. Jessurun, beste Emile. De klinische vaardigheden van de katheterablaties heb ik 
van jou geleerd. Het is geen publiek geheim dat de omgang met je soms wat moeizaam kan 
zijn en een gesprek gepaard kan gaan met een langdurige “asystolie”. Je (in)stelling: “better 
is the enemy of good enough”, is juist, echter dit weet je helaas pas achteraf.
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Dr. A.H.L.C. van Kaam, beste Anton, Tony macaroni, mijn beste vriend en paranimf, ie-
mand waarop ik altijd kan terugvallen. Je verwoordt het in je eigen proefschrift al zelf, 
maar alleen trek je de verkeerde conclusies. Het gaat er niet om of ik, als cardioloog, zo 
uitgekookt (en rijk) ben, maar meer of jij, als neonatoloog, zo naïef (en arm) bent. Het blijft 
ongelofelijk, dat een geboren regelneef als jij, voor je eigen promotie alles zelf hebt gedaan 
tegen een “hongerloontje”. Dat neemt niet weg dat ik, mede door jouw drang om altijd het 
naadje van de kous te willen weten, niet alleen wetenschappelijk, maar ook persoonlijk 
meer open sta voor de meningen en gevoelens van anderen. Het heeft deze oppervlakkige 
man in ieder geval meer diepgang gegeven.
Dr. D.A.M.J. Theuns, beste Dominic, “shockrocker” en paranimf. In het Erasmus MC 
dachten ze in het begin dat wij broers waren, omdat voor hen een zachte G, tesamen met 
een lang, slank uiterlijk en donker haar, één pot nat is. Echter, voor echte Brabanders zoals 
ik geldt, dat “Limlanders” nog erger zijn dan Hollanders. Maar alle gekheid op een stokje, 
ik zal onze ablatiesessies en zeker de DFT testen, onder het genot van stevige rockmuziek 
of heavy metal, nooit vergeten. Je geest gaat er lekker van open en inmiddels ben ik ook een 
liefhebber geworden.
Alle specialisten, verpleegkundigen, technici en secretaresses van de afdeling klinische 
electrofysiologie van het Erasmus MC. We hebben een gezellige tijd gehad samen en ik 
dank jullie met name voor de “ijzige” kalmte, die jullie hebben opgebracht tijdens de cryo-
sessies. Het blijft lovenswaardig dat jullie aardig tegen me zijn gebleven, ook nadat ik het 
pandje had verlaten en op vrijdag voor een “totaal blok” van de wekelijkse beslommeringen 
zorgde.
De cardiologen uit het MCA, mijn “maten”, zoals dat zo mooi heet. Ik zeg altijd maar: 
“vrienden heb ik niet, alleen maar vage kennissen”. Dat neemt niet weg, dat jullie zorgen 
voor een goede, ambitieuze groep, alwaar ik nu al meer dan 3 jaar met veel plezier samen-
werk. Ik denk dat wij het juiste “ritme” te pakken hebben.
De cardiologen/electrofysiologen, verpleegkundigen, technici en secretaresses van de af-
deling klinische electrofysiologie van het AMC. In onzer beide beleving is een goede sa-
menwerking tussen een academisch ziekenhuis en een perifere kliniek onontbeerlijk. Als 
het aan mij ligt houden we deze “parasystolie” nog lang gaande.
Mijn ouders, “ons” pa en ma. Wij zijn het nooit zo gewend geweest om onze diepere ge-
voelens bloot te leggen, maar bij deze wil ik toch een keer een uizondering maken. Ik ben 
jullie oprecht, vanuit het diepst van mijn hart, dankbaar voor het warme, liefdevolle nest 
waarin ik ben opgegroeid. Wat jullie met al de beperkte mogelijkheden en financiën niet 
alleen mij, maar ook mijn zus hebben gegeven, vind ik nog steeds onvoorstelbaar. Niets 
was teveel en jullie hebben letterlijk alles opzij gezet om te zorgen dat wij zo goed mogelijk 
terecht kwamen. Als jullie nu ook nog voor een goede erfenis zorgen… (geintje).
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Mijn kinderen, Lars (de witte parel uit de Andes, voetbalnaam: Larsinho), Anne (Annie, 
hou jij mijn tassie effe vast, die kleine). Ik moet zeggen dat ik vreselijk heb moeten wennen 
aan jullie twee “hapsnurkers”. Het verkrijgen van het vaderschap is geen sinicure en is iets 
wat je moet leren. Natuurlijk waren, en zijn jullie nog steeds de liefste kinderen ter wereld. 
Maar laten we eerlijk zijn, wie zit in het begin te wachten op een baby die niets anders 
kan dan huilen, piesen en poepen, en die er ook nog eens voor zorgt dat je vrijwel niets 
meer spontaan kunt ondernemen. Inmiddels zijn jullie echter een wezenlijk onderdeel van 
mijzelf geworden en kan ik me geen leven zonder voorstellen. Jullie zijn mooi “speelgoed” 
geworden waarvan ik elke dag kan genieten. Ik hoop dat ik jullie beide nog wat goeds voor 
de toekomst mee kan geven en anders “sla ik het er wel in”.
Lest best, Foek, mijn dierbare echtgenote en toegewijde moeder. Wat een doorkijkjurk op 
de klasse-afdeling allemaal teweeg kan brengen! Jij bent de reden waarom ik van alles in de 
wereld nog steeds het liefste thuis ben. Laten we hopen dat dit altijd zo blijft.
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